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Abstract
This thesis describes the synthesis o f a series of Ag(I), Pd(II), Rh (I) and Ir(I) 
complexes of quinoline functionalised nucleophilic heterocyclic carbene (NHC) 
ligands. The transmetallation properties o f the Ag(I) complexes were utilised to 
prepare the corresponding Pd(II), Rh (1) and Ir(I) (NHC) complexes.
A series o f quinoline based imidazolium, pyrimidinium salts were prepared and 
characterised as NHC ligand precursors.
Ag(I)(NHC) complexes were prepared by the reaction of the quinoline functionalised 
salts with Ag20 in DCM. All complexes were spectroscopically characterised and the 
results of single X- ray crystallographic studies are reported for two of the complexes 
and the geometry around the silver cation was observed to be distorted linear.
Two quinoline based palladium (II) (NHC) complexes were prepared via 
transmetallation Ag(I)(NHC) complexes is reported.
The synthesis o f a series o f methylene bridged quinoline functionalised Rh (I) and 
Ir(I) (NHC) complexes through transmetallation o f the Ag(I)(NHC) complexes is 
reported and the results o f single X- ray crystal lographic studies are reported for most 
of the complexes showing consistent pattern in term of bond lengths and angles.
Two of the Ir(I) (NHC) complexes were tested as catalysts in transfer hydrogenation 
reactions , showing good activity at low Ir loadings.
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AcOH acetic acid
Ar aryl group
Barf tetrakis[(3,5-trifluoromethyl)phenyl]borate
BAP 4-bromoacetophenone
nBu n-butyl group
lBu tert-butyl group
COD or cod 1, 5-cyclooctadiene
DCM dichloromethane
DMF N, N-dimethylformide
DMSO dimethyl sulfoxide
ESMS electrospray mass spectrometry
Et ethyl group
Et2 0 , ether diethyl ether
GC gas-liquid chromatography
GCMS gas-liquid chromatography/mass spectrometry
HRMS high resolution mass spectrometry
'Pr iso-propyl group
nPr n-propyl group
IR infra red spectrometry
LSIMS liquid secondary ion mass spectrometry
M metal
Me methyl group
Mes mesityl group
MS mass spectrometry
NBS N-bromosuccinimide
NHC nucleophilic heterocyclic carbene
NMR nuclear magnetic resonance
OAc acetate ion
OTf trifluoromethanesulfonate (triflate) anion
Ph phenyl group
Qiun qiunolyl group
R alkyl group
THF, thf tetrahydrofuran
TON turnover number (molproduct/molir/hr)
TMS tetra methyl saline
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Chapter One: Introduction
CHAPTER ONE
1.1 Background
Carbenes are neutral compounds featuring a divalent carbon atom with only six 
electrons in its valence shell [1]. Due to an incomplete octet of electrons, they 
are generally very reactive species. The carbenic carbon can be either linear or 
bent, each geometry describable by a certain degree of hybridization. The sp- 
hybridized carbon carbene adopts a linear geometry with two non bonding 
degenerate orbital (Px and Py). In sp2- type hybridization where the carbon 
adopts bent geometry, the degeneracy is broken in which case the Px is stabilised 
by acquiring some s character (it is usually called a  while the Py (usually called 
P*) remains almost unchanged. It should be noted that most carbenes are bent 
(sp hybridized).
As a result of this break in degeneracy, carbenes can exit in two states: triplet 
state (where two non bonding electrons occur in two different orbital with 
parallel spins and singlet state (two non bonding electrons can pair in the same o 
or P* orbital). Based on this classification, we can have four possible electronic 
configurations as depicted in figure 1.1
Figure 1.1. Electronic configuration o f carbenes.
The ground state spin multiplicity is a fundamental feature of carbenes that 
dictates their reactivity [2]. A singlet state is favoured by a large 0 -P71
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separation and according to Hoffmann; a value of at least 2 eV is needed to 
impose this. Anything below 1.5 eV will favour the triplet state [3].
The substituents on the carbene determine whether a singlet or triplet state is 
formed through a combination of inductive, mesomeric and steric effects. 
Electron withdrawing groups increase the o-P* gap by inductively stabilising the 
d non bonding orbital by increasing its s character and thus favouring the singlet 
state. On the other hand an a-electron donating group will induce small a-P* gap 
and favour the triplet state. For illustration purposes substituents that are 
electron donating can be termed X, while electron withdrawing groups can be 
termed Y. XX carbenes are bent singlet, while most of the YY carbenes are 
predicted to be linear singlet.
N-Heterocyclic carbenes (NHCs) (Figure 1.2, (a)) are the focus o f this work and 
are firmly placed within the singlet state. With two nitrogen substituents next to 
the carbene carbon atom, the NHCs are predicted to stabilise their singlet state 
(two paired electrons in the o-orbital) by push- pull effect (Figure 1.2) [4]. 
Firstly, the a- electron withdrawing nitrogen inductively stabilises the o- non 
bonding orbital by increasing its s-character. Secondly, the energy of the vacant 
Prc-orbital is increased by interaction with the symmetric combination of the 
nitrogen lone pairs.
-I Inductive effect +M mesomeric effect
Figure 1.2: Electronic stabilisation o f NHCs.
The combination of the two effects increases the o-Pn; gap and favours therefore 
the singlet state. Additionally, the sp hybridization adopted by the carbene 
carbon atom in its singlet state matches the bent geometry o f the NHC five 
membered ring. The interaction o f the nitrogen lone pair with the 7i-orbital o f the
Chapter One: Introduction
carbene is reflected by an N-C carbene bond length of 1.365A, which is 
consistent with double bond character. An accurate assessment of the k back 
bonding was found by analysing dynamic lH-NMR behaviour of bis 
(diisopropylamine) carbene 3 [5]. The major process involves rotation about the 
N-C carbene bonds; the measured barrier to rotation of 53 kJ/mol was mostly 
attributed to the substantial n- component o f these bonds.
Dimerisation o f NHCs has been known since the first attempt to isolate them 
[6]. Alder recently showed that dimerisation is thermodynamically unfavourable 
for imidazolin-2-ylidenes 1 (singlet/triplet gap o f 354 KJ /mol), but very likely 
to happen for imidazolidin-2-ylidenes 2 due to lack of aromaticity and acyclic 
NHCs due to loss of conjugation through twisting around N-C carbene bond [7]. 
The i3C-NMR chemical shifts [1] range from 210-220 ppm downfield from 
TMS for aromatic imidazolin-2ylidenes 1 and to 235-245 ppm for imidazolidin- 
2-ylidenes 2 and acyclic NHCs 3 (Figure 1.3).
/ \
'J N
m es^ m es m es' m es
iPr iPr
Figure 1.3: Unsaturated, saturated NHCs and acyclic carbenes
1.2 Brief History of Carbenes
Since the pioneering work o f Doering in 1954, carbenes have been recognised as 
a unique type of intermediate with characteristics distinct from radicals already 
known in the organic chemistry community [8]. A decade later Wanzlick and 
co-workers started working on saturated N-heterocyclic system where they 
explored the dimers of electron rich tetraaminoethylenes to which they proposed
- 3 -
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an equilibrium existed between the free carbenes and the dimer and was named 
the ‘Wanzlick Equilibrium’ [6, 9-11] (Figurel.4). The Wanzlick equilibrium 
was recently confirmed following observation of equilibrium mixtures between 
free carbenes and tetraaminoethylenes for some benzimidazolin-2-ylidenes [11, 
12, and 14].
PhPh
PhPh
Ph
I
NON
I
Ph
Figure 1.4: The Wanzlick equilibrium.
Wanzlick proposed that the dimer dissociated into two carbenes [13].
Since then research on carbenes has rapidly expanded, but almost no attempts 
were made to prepare stabilised carbenes until 1980 when Tomoika started to 
study persisted triplet diarylcarbenes [14].
The first isolable carbenes were reported in 1988 by Bertrand [15] 4 and in 1991 
by Arduengo [16] 5. Phosphinocarbene 4 can be distilled at 80-85 °C/10-2 Torr 
and N-heterocyclic carbene (NHC) 5 is crystalline solid that melts at above 240- 
241 °C (Figure 1.5).
Figure 1.5: The first isolated carbenes
Chapter One: Introduction
Although NHCs have been known since the pioneering work of Wanzlick, who 
observed their dimerisation and was able to trap them to form mercury salt 
carbene complexes [17], three decades went by before the first NHC was 
isolated. When compound 5 was isolated, the stability of the compound was 
thought to be due to steric hindrance of the bulky adamantyl sudstituents 
preventing nucleophilic attack [16]. However in 1995, Arduengo proved using 
NHC carbene 2 that aromaticity was not needed for stabilisation, [18] and 
in 1996 Alder isolated acyclic NHC 6 [19]. This research area continue to 
expand with the isolation o f four -membered carbene 7 [20] by Grubbs and alkyl 
carbene 8 by Bertrand in 2004 [21]. Arduengo reported the synthesis of 1,3,4,5- 
tetramethylimidazolin-2-ylidene 9 and 1, 3-dimethylimidazolin-2-ylidene 10 
[22] which are less sterically hindered. Carbenes with only one nitrogen atom 
have also been isolated as indicated in compounds 8 and 11. This shows that the 
presence of one nitrogen atom is adequate enough to stabilise carbenes in certain 
cases provided the carbene carbon is bound to tertiary alkyl group. The 
replacements in compound 11 o f one o f the electronegative nitrogen by a strong 
o-donor alkyl group makes the ligand more electronegative than diamino NHCs 
and therefore behave as strong a  donor towards transition metal centres [21]. 
Carbenes with more than two heteroatoms (12 [22]) and those with mixture of 
heteroatoms have also appeared in the literature (13 [23] and 14 [24]). Hermann 
and co-workers reported the synthesis o f chiral 15 and bis-imidazol-2-ylidenes 
16 [25].
- 5 -
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iPr iPr
I I
-N. .N.
iPr iPr
i P \  x iPr 
iPr N Pri
/
iPr
iPr
\
N
Me Me
f = \
Me ^  N■ ■ Me
10 11
N
12 13 14
Ph
Me
H ■ ■ A
15
Ph 
Me
/ = \
Me— N ^ N
r = \
■N M —Me
16
Figure 1.6: Stable carbenes and their derivatives
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1.3 Synthesis of diaminocarbenes and pKa
Three principal methods have been used to successfully generate 
diaminocarbenes:
(i) Deprotonation o f imidazolium salt 17 or formamidinium salts 18 
with a base [16] (ii) Desulfurisation of thioureas 19 [26](iii) 
thermolysis o f methanol adducts of type 20 [22,95] (Scheme 1.0)
X
Base
X
17 18
Ri R'
R 2 ^ N  .N
K, THF
Ri /R1
R2 /N . N. R1, R 2 = alkyl
^ R2 X  R2
19
N:
Ph
80°C,0.1 mbar Ph
ph- N- N> h
Ph
OMe
20
Scheme 1.0: methods of generating NHCs.
The measured pKa value for diisopropylimidazolin-2-ylidenes on the DMSO 
scale was found to be 24 by Alder [27, 28]. For di-tert-butylimidazolin-2- 
ylidenes Streitweiser reported a pKa o f 20 on the THF scale [29]. It is therefore 
not surprising that the principal method used in the synthesis of NHCs is by 
deprotonation of the corresponding imidazolium or formamidinium salts. To 
synthesize the first NHCs Arduengo used NaH/KH in THF in the presence of 
KOtBu and DMSO [16].
Herrmann showed that milder conditions such as the use of sodium amide in 
liquid ammonia and THF at -40°C, were efficient [30]. When the pKa is
- 7 -
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increased by 2 to 6 units, formamidinium salts underwent nucleophilic addition 
o f the base rather than deprotonation [28]. Hindered alkali amide bases such as 
lithium diisopropylamide or potassium hexamethyldisilazide were used to 
overcome this drawback.
Kuhn and Kratz reported another pathway to imidazolin-2-ylidene by reduction 
of thioureas using metallic potassium [30]. Though this has been difficult to 
reproduce [28], it is an interesting discovery because the only other product, 
potassium sulphide, is insoluble in THF and therefore, can easily be removed.
In another method triazol-2-ylidene was synthesised in good yield by Enders by 
thermolysis o f the corresponding methanol adducts [22]. However, this method 
has some disadvantages due to the extreme sensitivity o f the methanol adduct.
1.5 NHC Ligand properties
N-Heterocyclic carbenes (NHCs) are ligands formed by the deprotonation of an 
N, N-disubstituted imidazolium (or other azolium) salts. Binding of a transition 
metal to the C2 carbon o f the NHC leads to the formation of a very strong bond, 
the strength deriving from the thermodynamic instability of the free NHC [31]. 
Unlike metal-carbon bonds in general, those to NHCs do not undergo fast 
insertion or reductive elimination reactions and so NHCs are generally good 
spectator ligands. The role of spectator ligand is to act as a placeholder by 
promoting a desired reaction at the metal, while avoiding dissociation or 
entering directly into the reaction. NHCs being used as spectator ligands for 
many decades have risen to prominence, having both steric and electronic 
tenability and capability to promote catalysis o f many useful reactions.
The bonding mode of metal carbene in Schrock and Fischer carbene complexes 
are both described by double a bond, though they differ by the polarity of the 
electron density. This difference arises from the difference in energy between 
the dn orbital of the metal and the p* orbital o f the carbene (Figure 1.6). If the dn 
orbital is lower in energy than the pn orbital, the metal -  carbon is polarised 8- 
and 8+ on the carbene and we would have a Fischer carbene complex. On the 
contrary, if the dn orbital is higher in energy than the pn orbital, the metal 
carbon bond is polarised 8+ on the metal and 8- on the carbene and we would
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expect a Shrock carbene complex. NHCs are firmly placed within the Fischer
carbenes, their prc orbital have high energy because multiple bonding between
the carbene atom and the two nitrogen atoms. As a result the prc orbital does not
interact well with the drc thus preventing almost any rc- back bonding from the
metal to the carbene. In NHC complexes the metal carbon bond is therefore best
represented by a single bond.
drc 
M \
5+
\ PTC
\
/ '  C
5-
drc;
I v r
5-
prc
5+
; C
drc •
M :~ + ; 5+
Schrock
nucleophilic carbene
Fischer 
electrophilic carbene
NHC carbene
Figure 1.7 Partial molecular diagrams for Schrock, Fisher and NHC carbene 
complexes.
The absence of a requirement for back bonding enable NHCs to form stable 
metal complexes with a range o f metals that do not posses occupied orbitals and 
so would not be able to participate in back-bonding. Metals such as Li [32, 33], 
and Be [34, 35] and hexavalent U [36, 37] have been reported to form stable 
metal complexes with NHCs.
The fundamental difference between a typical Schrock carbene and NHC as 
ligand is shown in the crystal structure o f  [RuCl2(NHC)2(=CHC6H4Cl)] (NHC= 
l,3-diisopropylimimidazolin-2-ylidene) where the two types o f the carbenes are 
linked together to the same metal centre [38].The ruthenium-carbon bond o f the 
Schrock carbene, generally written as a double bond, has a bond length o f  
1.821 (3)A, whereas the Ru-C bond length in NHC ( 2.107(3)A and 2 .115(3)A)
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which justifies its representation as a single bond (a- donor and virtually no n- 
backbonding).
Measurement o f IR carbonyl absorption frequencies of NHC carbonyl metal (Fe, 
Cr, Rh, Mo and Ir) and their phosphine analogues showed significantly donor 
capacity o f NHC relative to phosphines, even to trialkylphosphines [39, 40, and 
4]. Furthermore, experimental investigations [42], and calorimetric studies [43, 
44] and experimental calculations [45] agree that the ligand dissociation energy 
of NHC from Ru complexes is higher than for phosphines. Similar results were 
obtained from calculations with other metals such as Au, Cu, Ag, Pd and Pt [46,
1.6 Chelating, Pincer and Mixed donor Ligands
One of the attractive features o f NHCs is the wide variety of steric [48] and 
asymmetric environments [49] that are available through modification o f the 
substituents attached to the NHC nitrogen atoms. Furthermore, through the use 
of appropriate donor groups on the NHC substituents, it is possible to make 
multidentate NHCs [50]. Such variability makes possible the synthesis of NHC 
analogues of many traditional phosphine ligands. Through this synthetic 
modification, a wide range o f ligands containing two or more NHCs groups are 
known. In 1994 Dias and Jin isolated bis-carbene 21 and tri-NHC ligand 22 [51] 
as shown in figure 1.8.
47].
21 22
Figure 1.8: Chelating NHCs ligand
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Through the use of appropriate donor groups on the NHC substituents, the 
coordination sphere o f the metal can be tailored by chelating ligands 
incorporating a strongly bound, robust functional group, (NHC), with additional 
tethers carrying labile donors [52]. The later can temporarily dissociate during 
catalytic reactions creating electronic coordinative unsaturation, which is 
important for catalysis. Towards this end Danopoulos et al have synthesised 
NHC precursors functionalised with pyridine rings. Almost simultaneously, 
related ligand designs were reported by Cavell [53] and Crabtree [54]. 
Danopoulos stated that the a-donating pyridine rings tethered to the NHCs are 
believed to add versatility to the ligand designs for four reasons:(i)The pyridine 
function is expected to bind weakly to lower , softer oxidation states of the 
metal, (ii) This in combination with adjustment of the chelate ring size by using 
variable length linkers, can promote ligand hemilability with possible 
implications on the catalytic activity, (iii) The electronic asymmetric of the 
chelating N-functionalised NHC ligands renders the corresponding trans-sites 
electronically inequivalent, due to large difference in the trans effect o f the 
chelating ends, (iv) The donor and steric characteristic o f the pyridine and NHC 
functional groups are easily tunable by a variety o f substituents [55]. It was 
along these lines that a number o f research groups were able to prepare 
hemilabile pyridine functionalised ligands [53, 56, and 57]. A number of 
examples are depicted in Figure 1.8.
In order to test the hypothesis advanced for the choice of the pyridine 
functionalised ligands, the ligands shown below were used to prepare some 
carbene complexes and complexes tested in some catalysis. The reaction of the 
corresponding silver carbene Ag(I)NHC o f 23 with PdMeCl(cod) gave PdMeCl 
(NHC). The catalytic activity o f the palladium carbene was tested in Heck 
coupling reaction of 4-bromoacetophenone/4-chlorobenzaldehyde with n-butyl 
acrylate and the catalyst was found to have good activity and high stability. The 
Suzuki coupling of 4-bromoacetophenone with C6H5B (OH) 2 gave good to 
satisfactory result as well [53]. Danopoulos reported the synthesis of 
PdMeCl(NHC) from salts analogous to 23 which gave good activities in Heck 
and animation reactions [55]. Ligand 28 which is an example pyridinyl carbene 
(denoted as pyNAC-R) was used to prepare iridium (1) carbene complexes as
- 11 -
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well as catalytic activities towards the hydrogen transfer reduction of nitroarenes 
under mild conditions [58].
/ = \Gr^'O r'b^'ny^
x
23 24 25 R= iPr
Me3Si v. .NL
tBu
Me
26: R = iPr 27 28
Figure 1.9 Pyridyl functionalised Ligands
The reaction of the corresponding silver carbene 30 with [Ir(COD)Cl] 2 gave 
the unchelated compound 31. Chelation o f the pyNAC-R toward the iridium 
centre was achieved by the treatment o f 31 with an equimolar amount of AgBF4, 
leading to the ligand substitution o f chloride by the pyridine nitrogen to give 
compound 32 as shown in Scheme 2.
- 1 2 -
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Ar
N
29
R = Me 
mes
31
30
BF,
32
Scheme 2: Reagents and condition (i) Ag20, Nal, r.t. 24 hrs. (ii) [Ir (COD) Cl] 2, 
r.t. 3 hrs. (iii) AgBF4
The catalytic activities towards reduction o f benzophenone and nitroarenes 
showed that the ligand binding in a monodentate fashion compound 31 has 
higher catalytic activity compared to their respective chelation complexes 32. 
However, in all the NHC iridium complexes described showed higher catalytic 
activities relative to when [Ir (COD) Cl] 2 were used as catalyst towards 
reduction of benzophenone and nitroarenes.
The research interest in metal N- Heterocyclic carbene (NHC) is now expanding 
to the study of new versatile ligand topologies, which have shown promising 
spectator characteristics with classical functional groups [59]. One of these is 
the pincer architecture which in the case o f pyridyl carbene ligands are mostly 
tridentate in nature. The pincer ligands provide a preorganised backbone capable 
of blocking pseudo-meridional coordination sites of metal, leaving the 
remaining available for catalysis [60]. In line with above principles Crabtree 
reported the CNC ligand 33 and its corresponding pincer complex of Pd (II) 34 
through reaction with Pd (II)(OAc)2. Complex 34 proved to be a robust catalyst 
for the Heck reaction at 165°C, showing the resistance of the complex to
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thermal decomposition and in air [61].The planar complex showed low 
solubility but using R= n-Bu wingtip gave sufficient solubility for convenient 
study. Introduction o f methylene linker result in loss of planarity and greatly 
improved the solubility. The Ru pincer complexes of the mode CNC have also 
been reported by the same group (35, 36). Catalytic tests showed 35 to be active 
in both hydrogen transfer and oxidation o f olefins while 36 was inactive in both 
cases [62]. The same group reported CCC pincer ligand 37 and its conversion to 
Pd (II) complex 38 by using Pd (0) through oxidative addition cyclometallation. 
The CCC complex was more rigid than CNC pincer but still fluxional enough to 
give coalescence at elevated temperature. All the species however appeared to 
be catalytically active in the usual coupling reactions. The Crabtree pincer 
ligands and complexes are depicted in Scheme 3.
Pd(OAc)2
DMSO N N
Br
R
Br
R R R
33 34
nBU
35 36
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Br N
N+ Br + N
^  / /
CCC ligand 2J 38
Scheme 3: Synthesis and example of some Crabtree pincer complexes
The Cavell group has also looked at related Pd (II) complexes (39, 40, and 41) 
[63 and 64]. Compound 39 which is a Pd-hydrocarbyl pincer complex was 
prepared using a one pot transmetallation technique via the Ag'(NHC) 
complexes [64]. The complexes reported have shown good activity in a model 
Heck coupling reaction using activated aryl bromides with the complexes 
bearing bulkier N- substituents outperforming the N-Me substituent in the case 
of complexes 40 analogues.
,N 'PM  1
Figure 1.20: Cavell pincer complexes reported.
The Danopoulos group has also reported analogous carbene complexes as part 
of his contribution to the investigation o f the behaviour of these noble metal 
complexes. Compounds (42, 43 and 44) are Pd (II) carbene complexes and their 
tests in catalysis have showed good stability and activity in the Heck reaction 
[65].The same group also reported the synthesis of complexes 45 and 46. 
Complex 45 was accessed by the reaction o f the corresponding imidazolium salt 
with [Fe(N(SiMe3)2]. Complex 46 is the first reported dinitrogen complex
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stabilised by NHC [66]. The same synthetic methodology was applied for the 
synthesis o f complex 47 by the reaction of Co[N(SiMe3)2]2 with a bis 
imidazolium salt which on further reaction with Na(Hg) and MeLi gave 
complexes 48 and 49. Also reported in the literature by the same group is 
complex 50 which was prepared by the reaction of 2,6-[(o- 
dialkyl)phenylimidazolylidene]pyridine with RuCl2(PPh3)3 in THF. Catalytic 
tests of complex 50 in hydrogenation o f C =0 and C=N groups by hydrogen 
transfer from isopropyl alcohol in the presence of KOBu* or KOPr' showed 
remarkable activity [67], though the reactions are slow at room temperature but 
proceed at good rates at 55°C or 80°C.
42: Ar = mesityl
F e
45: Ar = 2, 6-iPr2C6H3
/  \
Na(Hg) or MeLi
X = B r , Me
47 48 /49
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RuCI2(PPh3)3
Ar
\
N
THF
RuCI2(P P h3)L
L: Ar = 2, 6 -iPrC6H3 50
Figure 1.21 Examples of some Danopoulos Pincer carbene complexes
In 2006 Zeng and Yu reported the synthesis of pyridyl-supported pyrazolyl- N- 
Heterocyclic carbene ligands (51, 52) and their corresponding palladium 
complexes (53, 54) and tested in Suzuki-Muyaura reactions [68]. A methylene 
linker was introduced in ligand 52 to release the steric strain encountered on 51. 
All the palladium complexes exhibited good to excellent catalytic activity in 
Suzuki-Miyaura reaction o f phenyl or p-tolylboric acid with aryl halide 
including iodobenzene, aryl bromides, and activated aryl chlorides under mild 
conditions, revealing that the new ligands are promising for the construction of 
highly active transition metal catalysts. The ligands and the complexes are 
depicted in figure 1.22 .
M e
Me R
Me
Me R
51 52
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Me
N Pi
Me X = BF4, PF6,
Me
RMe
53 54
Figure 1.22 Pyridyl Supported pyrazolyl NHC Ligands
A series o f other pyridyl functionalised pincer carbene complexes were reported 
by Gibson and tested in oligomerisation and polymerisation of ethylene [69] as 
shown in Scheme 4 below. However, o f all the reported complexes (Fe, V, Cr,
Ti, Co), only Fe complexes showed evidence of alkyl carbene coupling 
signifying the importance o f the early transition metal complexes in this 
chemistry[ 69, 70].
TiCI3L2 
VCI3L2 
CrCI3L1 
CrCI3L2 
CrCI3L3 
CoCI2 L2 
[ FeL12][FeBr4 j 
FeBr2L2 
FeCI3L2
Scheme 4: Examples o f Gibson pincer NHCs
o—  MN
Xn
R = 'Pr, L1
R = 2, 6-di'Prphenyl, L2 
R = 1-adamantyl, L3
Pincer PCP complex 55 [71] and tetradentate pyridine functional ligand 56 and 
its corresponding Pd(II) 57 and Ni(II) 58 [72] have also appeared in the 
literature. Compound 55 as can be seen contains three strong o- donors and its 
use in Heck and Suzuki reaction was found to be effective. In contrast to 
carbene complexes with mono, bi-, and tridentate ligands widely used in C-C 
coupling reactions, tetradentate ligands are rarely employed because of 
restriction on the available coordination sites for the incoming substrates, though 
the more robust nature o f metal complexes with tetradentate ligands can
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provide extra stability to the catalytic species. Few reports exist on the use of 
NHC nickel as catalyst in Suzuki coupling [73]. However preliminary 
application of the tetradentate nickel complex [NiL]2+.2Br‘ 58 in Suzuki 
coupling of aryl halides with phenylboronic acid has shown effective catalytic 
activities including aryl chlorides as substrates. This is particularly important as 
nickel is cheaper than palladium, thus the use nickel catalyst will give access to 
large-scale of inexpensive compounds.
2+
/ = \  
N. .N
Ph' r 'dvi pi / \
Ph u Ph Ph
2Br
55 56
DMSO M(OAc).
2+
2Br
N =
57: M = Pd 
58: M = Ni
Scheme 5: Examples of PCP and Tetradentate complexes
1.8 Carbene complexes
Carbene was first introduced into organometallics chemistry in 1964 [74] by 
Fischer. Fischer complexes exhibited a- donor/ p7c-acceptor behaviour for the 
bound carbene, and the metal to carbon bonds were shorter than the usual single 
bond [75]. Following this discovery it became evidently clear that there were
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two distinct types of carbene complexes at that time. Fisher carbene complexes 
combine weakly donating singlet carbene, which accepts back bonding from 
low-valent metal [1, 75, 76,], while the already known Schrock carbene 
complexes combine a covalent triplet carbene and triplet metal fragment. In 
contrast to NHCs, these carbenes generally contain alkyl substituents and 
therefore are nucleophilic and coordinate to high oxidation state metals.
With the isolation o f free carbene by Arduengo, there were renewed interests in 
the study o f nucleophilic carbene complexes. It was initially thought that 
Arduengo NHCs carbene would yield Fisher type carbene complexes upon 
coordination to a metal centre, but the bonding properties showed different 
characteristics. Due to the back donation from the adjacent nitrogen heteroatoms 
and their strong capacity as o-donors to metals, NHCs form only a single o-bond 
to metals with negligible 7i-back donation [1, 76], and therefore these complexes 
exhibit different reaction chemistry to either Fischer or Schrock carbene 
complexes.
N-heterocyclic carbenes (NHCs) have attracted much attention because their 
transition metal complexes display rich coordination chemistry and have wide 
applicability in catalysis [1].Recently research efforts have been devoted to the 
synthesis of polydentate ligands containing NHC moieties. The combination of 
pyridine and NHC functionalities leads to diverse polydentate ligands, some of 
which have shown interesting coordination chemistry [54, 77,78, 79], efficient 
catalytic applications [53,80,81,] and biological activities [82].The basis of this 
study was to develop new ligand structure, by substituting pyridine with 
quinoline substituents, which are expected to provide greater rigidity and hence 
stability, though these rigid structures also lead to significant steric over 
crowding. Hopefully, this controlled flexibility/steric crowding parameters will 
lead to improved catalytic performance in a range o f reactions.
- 2 0 -
C hapter One: Introduction
1.8.1 Synthesis of N- heterocyclic carbene transition metal 
complex
What is to be done with the transition metal carbene complexes is probably 
more important than the complexes themselves and since carbene complexes 
have found utilization in many industries, scientists have been working to find 
simple methods to access these very important compounds. A number of routes 
have been developed, allowing the preparation o f complexes bearing carbene 
ligands with a large variety o f electronic and steric properties [83]. This has 
mainly been achieved as a result o f the straight forward methods of synthesis of 
a range of imidazolium salts thereby allowing for the design of carbene ligands 
with a variety of electronic and steric properties, ideal for tailoring the properties 
of the desired complex as catalyst. O f the many synthetic methodologies 
available in the literature for the preparation o f NHC metal complexes, four are 
more prominent :( i) In- situ deprotonation o f azolium salts (ii) complexes via 
free carbenes (iii) Ligand transfer reactions (iv) Oxidative addition reactions.
1.8.1.1 In- situ deprotonation of azolium salts
This is the most widely used method o f accessing carbene complexes. In this 
method, the isolation o f the free carbene is not necessary. In his original work, 
Ofele formed NHCs by in situ deprotonation o f the corresponding imidazolium 
salts. The basic metalate ion [HCr(CO)s] ' serves as base as well as ligand 
acceptor [84].
R
fi \  xI /)  + HCr(CO)5
N +
\
R
Scheme 6 : Carbene complexes through basic metalate anion deprotonation
120°C
-Cr(CO),
-H2 'N
2 \
R
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Basic counter ions o f the metal precursors can also act as deprotonating agents. 
For example, a convenient method to synthesise NHC-Pd (II) is by mixing Pd 
(O A c)2 with the corresponding imidazolium salt. In a similar way, p-alkoxo 
complexes of (qQ-cod) rhodium(I) or iridium(I), formed in situ by adding p- 
chloro bridged analogues to a solution o f sodium alkoxide in the corresponding 
alcohol, will deprotonate an imidazolium salt to form the corresponding NHC 
complex[85]. Despite being relatively simple method, the imidazolium 
counterion is generally incorporated into the nascent carbene complexes unless 
non-coordinating anions are used. Good yields require the use of a solvent, such 
as THF or DMSO, however solvent free reactions have been reported [26, 86].
R
N
M
N
N +
\
R
21 Pd(OAc).
heat
-2HOAc
/ = \
/ — N N - R
-N
I
R
> Pd
Scheme 7: Carbene complexes by basic ligand deprotonation 
The use of an external base to generate NHCs in the presence of the metal 
precursor is also an efficient way o f accessing carbene complexes. Popular 
external bases include potassium and lithium tert-butoxide [87, 88], sodium 
hydride [89], butyl lithium [90, 91], triethylamine [92, 93] and KN(SiMe3)2 [94]
+ N ^  A  + [R h (C °d )C I]2 -------------------   N N
LiO-tBu
R ^  ™ F R I *
Rh— Cl
/ \
Scheme 8: Synthesis of Carbene Complexes via external base deprotonation
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Another method that allows the synthesis of carbene complexes is through the 
elimination o f molecules o f methanol and chloroform from the diazaortho-ester 
[95, 96] and trichloromethyl-substituted relatives of imidazolium salts [97, 
98].Thermal elimination o f these two substituents gives free carbene which upon 
reaction by a suitable metal precursor form the appropriate carbene complex.
1.8.1.2 Carbene Complexes through free carbenes
Following the isolation o f 1, 3-diadamantylimidazol-2-ylidene by Arduengo, a 
wide range of new carbene complexes could be synthesised by carefully using 
the appropriate metal precursor complex. The most popular methods of 
synthesising free carbenes is by the use o f strong bases such as sodium hydride 
and potassium tert-butoxide in THF [16, 99], or mixture of THF and liquid 
ammonia [26],
/>
N +
\
R
Cl
NaH
THF/NH,
-Ho, -NaCI
Scheme 9: Synthesis of free carbene
R
[Rh(cod)CI]2 +
Kl
N
M R
N
\
R
R
I
-N\
N
P ‘
Rh
C k
Cl
P^R 2 
Ru =
P R 0
Ph
/ = \  
R— N— R
-PR,
PR,
Ru:
C k ,
C l ^
R — N N — R
\ = /
Ph
Scheme 10: Carbene complex formation from free carbenes and dimeric 
cleavage and phosphines exchange
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NHCs are very strong a  donors and show dissociation energies higher than 
phosphines for a large number metals. Therefore, when their free carbene can be 
isolated, their complexation is achieved in high yield. Free NHCs have been 
found to be able to cleave dimeric species such as [(i\4-cod)RhCl]2 [26] and 
exchange phosphines [38] and pyridine [100] ligands as depicted above in 
Scheme 10
1.8.1.3 Carbene complexes through transmetallation
Some NHCs are difficult or not possible to synthesise via the free routes 
especially in a situation where the NHC precursor contains acidic proton in its 
linker chain. Gratifyingly it was discovered that Chromium, molybdenum and 
tungsten complexes could be used for carbene transfer to a variety of metals 
including rhodium(I), Palladium(II), copper(I), Platinum(II), Silver(I) and 
gold(I) [101-103]. Recently it has been found that transmetallation reactions 
using silver carbene have been reported for a wide variety of transition metals: 
Au(I), Cu(I), Cu(II), Ni(II), Pd(II), Pt(II), Rh(I), Rh(III), Ir(I), Ir(III), Ru(II), 
Ru(III), and Ru(IV) [104]. The Ag(I) NHC complexes are simply prepared by 
deprotonation of the imidazolium salt with Ag2 0  in a suitable solvent and 
transmetallation reaction is usually conducted in DMSO or DCM [64].
rTN\ /A g B r
V s.aX J ]
i) AgBF4;ii) PdCIMe(cod) 
DMSO, r.temp.
dipp dipp
N
' Me dipp
Scheme 11: Carbene complex through silver transfer reactions
1.8.1.4 Carbene complexes through oxidative addition reactions
C-H oxidative addition of an imidazolium salt is another effective alternative 
method to obtain carbene complexes. The group of Lappert [105] and Stone et al
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used oxidative addition method in the 1970’s for creating thiazol-2-ylidene 
complexes from 2-chlorothiazolium salts [106,107]. Cavell group [108, 109] 
used a similar method to carry out oxidative addition of imidazolium salts to 
Ni°, Pd° and Pt° and recently the method was utilised by Peris et al [110] to 
synthesize Ir(III) carbene complexes through direct reaction of pyridyl 
functionalised imidazolium salt with [IrCl(cod)]2 as shown in Scheme 11 below.
f = \
M
X = H, halogen, CH3 M = Pt, Pd, Ni, Rh, Ir
r = \
+ nBu-N^ N
CHXN
heat
PFe
r - n Y n " r
R—  M— R 
X
L = NHC, PR
nBu
PFfi
Scheme 12: carbene complexes through oxidative addition
Though accessing carbene complexes via this method is generally restricted to 
nickel, palladium, platinum, rhodium and iridium, these are the commonly used 
metal in catalysis.
1.9 Abnormal carbene complexes
So far all the carbene complexes reported are those in which the coordination 
took place at the C(2) position o f the NHCs. However, in 2001, Crabtree 
discovered an expected binding mode o f NHCs. Instead of having coordination 
at the usual C(2) position o f the NHC, the metal was attached at C(4) or C(5) 
[111] as shown in figure 1.23.
After this discovery a lot o f other publications o f NHC have appeared in the 
literature [112-114].
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Normal binding at C(2) Abnormal binding at C(4) or C(5)
Figure 1.23 C(2) and C(4) or C(5) binding mode o f the NHCs.
The abnormal carbene complex was initially observed by mixing pyridine- 
substituted imidazolium salts with [IrHs(PPh3)2] in refluxing benzene. From 
theoretical calculation [115], binding through C(4) or C(5) positions is less 
favoured. It was therefore reasoned that steric effects of the bidentate pyridine- 
NHC around the metal centre and selection o f imidazolium salt counter ion 
controlled the reaction [115]. With many catalytic reactions involving carbene 
being prepared in situ, care should be taken when designing reactions as slight 
changes in reaction condition can affect the properties o f the catalyst and the 
overall reaction. The study of the abnormal carbene complexes is still going on.
b f 4
L = PPh3
1.2.0 Catalysis involving NHCs
1.2.1 Ruthenium metathesis
The trial of Schrock and Fischer type carbene complexes in catalytic reactions 
showed that they had the tendency to suffer from M-C cleavage thereby making 
them catalytically inactive [75]. However, NHCs form stable bond with metals 
and can accommodate a wide range o f oxidation states, making them suitable for
N
N
BF,
lrH5L2
-H, r — H+
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many catalytic transformations. Because o f o-donor ability and their strong 
metal-carbon bond, NHC ligands have been applied as directing ligands in 
various catalytic transformations [59]. It is however in ruthenium catalysed 
olefin metathesis type reactions that NHC ligands have proved their efficiency 
giving access to unprecedented successful catalytic systems.
Figure 1.24 NHCs in ruthenium metathesis
In his catalysis investigations Herrmann showed that having one imidazolin-2- 
ylidene in place of a phosphine 60 favours the dissociative substitution of the 
phosphine ligand with olefinic substrate, giving rise to a more active species 
[42, 116]. Catalyst 60 was found to have good activities in ring opening 
metathesis of 1, 5-cyclooctadiene. In a similar fashion Grubbs [117] synthesised 
and tested catalyst 61 containing more basic NHC and results showed excellent 
activity in ring opening metathesis. The use o f imidazolidin-2-ylidene allowed 
access to more catalysts by introducing chirality at the C(4) and C(5) positions 
of the NHC. Towards this end complex 62 was made and its application in 
desymmetrisation of triolefins yielded the ring closing metathesis products in 
high enantioselevtivities [118]
1.2.2 Asymmetric catalysis
Following the success of the use o f chiral carbenes in asymmetric catalysis 
in i996/1997 by Enders [119] and Herrmann [129], chemists have pursued this 
area leading to many publications on the use of NHCs for asymmetric 
homogeneous catalysis [121]. Enders applied the NHC and their derivatives in 
catalysed asymmetric nucleophilic acylation processes with remarkable success.
Ru = C H P hR u = C H P h Ru = C H P h Ru = C H P h
59 60 61 62
- 2 7 -
C hapter One: Introduction
Chiral NHC ligands have found applications in the following catalytic 
processes: Rh-hydrosilation o f ketones [120, 122, 123], olefin metathesis [118, 
124], Rh(I) and Ir(I)-transfer hydrogenation of ketones [125] .
1.2.3 Hydrogenation
In his pioneering work Nolan used achiral monodentate NHC iridium complex 
63 for the hydrogenation of cyclohexene and 1-methyl cyclohexene (Figure 
1.24). Catalyst 63 and Crabtree’s catalyst 64 were found to have comparable 
activity at room temperature [126]. However, catalyst 63 was found to be more 
robust and efficient at higher temperature probably due to the stability of metal- 
carbene bond relative to metal -phosphine bond.
Figure 1.25 Achiral monodentate NHC ligand and Crabtree’s catalyst 
In another investigation, Buriak discovered that combining NHC with phosphine 
ligands led to efficient systems for the hydrogenation o f simple olefins [127]. 
Comparing complex 65 with its analogue 66  in hydrogenation of 1- 
methylcylohexene and 2 , 3-dimethyl-2 -butene showed the superiority of catalyst 
65 in activity. While complex 65 fully hydrogenated 2, 3-dimethyl-2-butene in 
less than an hour at 1 bar H2 at room temperature, complex 66 gave 19% 
conversion in 4 hours under the same conditions.
63 64
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65 66
Figure 1.26 Achiral monodentate NHC phosphine and NHC pyridine iridium 
complexes
There also exist in the literature some reports on the use of chiral NHCs carbene 
complexes in asymmetric iridium- catalysed hydrogenation. In particular 
Burgess chiral bidentate oxazoline-NHC ligand 67 gave high 
enantioselevtivities for a range o f olefins with best results obtained using 
phosphine-oxazoline (PHOX) 68  and its derivatives 69 [128, 129].
Figure 1.27 Burgess’s bidentate oxazoline-NHC ligand, PHOX ligands and its 
derivatives
NHC carbene complexes are also known to catalyse a wide range of reactions 
such as hydroformylation [129], hydrosilylation [26, 42, 88 , 115, 132,], olefin 
metathesis [38, 44,130,133-135,136], and polymerisation of alkynes [137 and C- 
C coupling reactions including Suzuki, Stille and Heck reactions [53, 80, 139, 
140].
67 68 69
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1.2.4 Catalyst decomposition
NHCs complexes show remarkable stability in many catalytic reactions are 
often stable to heat, moisture and oxygen. However, McGuiness et al discovered 
that the carbene catalyst decomposed during the catalytic reaction giving 
unsatisfactory results [115]. Further investigation indicated that the 
decomposition was as a result o f reductive elimination of cis located carbene 
and alkyl or acyl ligands [141, 142] (Figure 1.28)
Figure 1.28 Decomposition pathways in carbon monoxide ethylene 
copo 1 y meri sation
It is believed that the reaction is assisted by twist o f the carbene with respect to 
the square planar Pd(II) centre by approximately 60° so that the empty p orbital 
on the carbene centre is directed towards the alkyl/ acyl group adjacent to it on 
the metal centre. Since the acyl/ carbene intermediates are necessary 
intermediates in the CO/ ethylene catalytic cycle, the discovery o f the 
decomposition was quite disturbing, and no reports of success has appeared in 
the literature of carbene complex catalysis o f this reaction since then.
1.2.5 Aims and overview of the thesis
Carbene based ligand systems with functionalised pyridine groups have proved 
very effective as ligands for catalysis and there has been considerable work on 
these types of system. The task o f this thesis was to develop a new variation on 
this ligand structure, involving quinoline substituents, which are expected to 
provide greater rigidity and stability to the complexes. Also as part of this work, 
the catalytic applications o f interesting reactions was explored, primarily the 
iridium complexes. Ligands o f this nature were largely unknown and this opens 
up an opportunity to develop a whole range of systems with a cross section of 
properties.
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This thesis is composed o f chapters which contains introductions, and reviews 
of relevant literatures to date.
Chapter 2 describes the preparation and characterisation of a range of quinoline 
functionalised imidazolium salts and a tetrahdropyrimidium salt that were 
required as precursors to the respective NHC ligands.
Chapter 3 deals with the synthesis and characterisation of a range Ag'CNHC) 
complexes and few Pdll(NHC) complexes accessed by transmetallation of the 
corresponding silver carbenes. Some o f the Ag1 (NHC) complexes were found to 
be biscarbenes and the nature o f the functional group was found to be of no 
influence to the type o f complexes formed.
Chapter 4 presents the synthesis and characterisation o f a range Rh1 (NHC) and 
Ir1 (NHC) complexes by transmetallation o f Ag*(NHC) complexes, with Rh1 
(NHC) complexes giving higher yields. Attempt to prepare the chelated version 
was not successful as the complexes were found to insoluble in less polar 
solvents and decomposed in high polar solvent like DMSO. It also covers the 
catalytic testing of some the Ir1 (NHC) complexes prepare in reduction of 4- 
bromoacetophenone by hydrogen transfer reactions. The results show that all the 
complexes were very active giving a conversion o f up to 100% with as little as 
0.01 mole % of the catalysts.
Chapter 5 deals with conclusions and further work to be carried out as there a lot 
of research opportunities in this area.
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CHAPTER TWO 
Quinoline functionalised imidazolium and pyrimidinium salts
2.1 Introduction
Imidazolium salts can be defined as planar 5 five membered heterocycle with 
nitrogens at the 1 and 3 positions and a substituents (H, R, Ar, or X) at each 
position of the ring. The ring members are sp2 hybridized and the ring bears a 
single positive charge that is delocalised around the ring [1]. In most cases the 
imidazole 2a which does not have substituents on one o f the nitrogens serves as 
a precursor to the many imidazolium salts possible.
/ = \
2a
r 4
Ri R,
w
K  , N -
R1
IA2
2b 2c
r ^ \
R3 N /  ^ R ,
2d 2e  2f
The numbering presented in 2b is used throughout this research work with R2 = 
R4 = R5 = H in all the imidazolium salts. The structures are named according to 
the degree of saturation in the heterocycle o f the parent compound. As presented 
above the imidazole 2a has two double bonds. The imidazolin-2-ylidene 2c is 
derived from 2b by loss o f a proton. In contrast to 2b, 2d is a 
dihydroimidazolium salt and is fully saturated and this does not allow 
delocalisation of the charge beyond the NCN region, therefore, it has the effect 
of increasing the donor ability o f the derived imidazolidin-2-ylidenes, 2e [2]. All
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but one o f the imidazolium salts described in this thesis are those based on type 
2b. One type 2d based imidazolium salt is also presented.
Structure 2f is a typical example o f pyrimidinium salt which is a six membered 
ring with nitrogens at positions 1 and 3. The two nitrogens and C-2 carbon are 
sp hybridized while C4, C5 and C6 are sp hybridized. The NHC derived from 
pyrimidinium would be expected to be more basic with high donor capability 
due to the absence of delocalisation o f charge in the NCN region. Though as 
stated above the NHCs with an unsaturated backbone are generally more stable 
as free carbenes, since the normally empty pz orbital is part of an aromatic 
system, conjugated with the C-C double bond in the backbone. There is however 
little evidence that the aromaticity o f an NHC has much bearing on its properties 
as a ligand for transition metals [3].
The ease o f synthesis o f imidazolium salts is one o f the chief reasons for the 
popularity of NHCs. Other attractive features o f imidazolium based NHCs are 
the wide variety of steric and asymmetric environments that are available 
through modification o f the substituents on the nitrogen o f the heterocycle. 
Furthermore, through the use o f appropriate donor groups on the nitrogen 
substituents, it is possible to make multidentate NHC ligands [4]. Such 
variability makes possible the synthesis o f numerous ligands. Along these lines 
Cavell [5], Crabtree [6] and Danopoulos groups [7] have reported wide variety 
of multidentate pyridyl functionalised ligands. Multidentate ligands especially 
those that can behave as a chelating ligand having both strong and weak donors 
(hemilabile ligands) are particularly important in catalysis. The weak hemilabile 
part of the ligand is capable of reversible dissociation from metal centre, thereby 
creating vacant coordinating sites during catalytic cycles and stabilising the 
metal centre by recoordinating when it is catalytically inactive. In addition to the 
works so far reported on pyridyl ligands, we envisioned the synthesis of an 
analogue of the quinoline framework. It was our hope that replacing the 
relatively small pyridine with large quinoline substituents will provide greater 
rigidity and hence stability to the complexes, though, the rigid structures also 
lead to steric crowding. Bearing these in mind methylene linker was introduced 
in some of the imidazolium salts between the imidazole and the quinoline 
moiety to reduce the steric strain and improve solubility.
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2.1.1 Ligand synthesis
Our initial intention was to synthesize a wide range of quinoline based 
imidazolium salts. However, while we were successful in the synthesis of 
symmetrically substituted saturated imidazolium salt, the unsymmetrical 
substituted analogues could not be accessed via traditional approaches [8].
+ HC(OEt)
B
R N . N R  2 / v  /kii jp
RHN
a rv [pdl / ' \ / ' N H A r+ ArX  ► ArHN
Scheme 2.1: Traditional approach to the synthesis o f symmetrical saturated 
imidazolium salts
Unsymmetrical substituted imidazolium salts have been successfully 
synthesized via nucleophilic attack o f 1-alkylimidazole or 1-aryl imidazole on 
an alkyl halide [9-12] (Scheme 2.2).Through this direct quartinization, a lot of 
functional groups have been attached to the imidazolium moiety. Such 
functional groups include: hydroxyl group [13], carboxylic groups [14], thiol 
groups [15], alkyne and alkene groups [16, 17].
I m + r 1x  ___________^  /  \  + :
r " n \ ^ n \ r 1
Scheme 2.2: Synthesis o f unsymmetrical imidazolium via nucleophilic attack of 
imidazole on alkyl halide
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However nucleophilic attack on an aryl ring by an imidazole is difficult, 
making N, N-diaryl substitution unattainable by this approach.
This is a set back because one o f our aims was to create as much as possible 
some steric environment in our target NHCs precursors. Therefore, N, N ’-diaryl 
substituted imidazolium salt with quinoline as one of the substituents was 
considered an ideal candidate. Fortunately, flexible approaches allowing for the 
synthesis of bulky N-substituted imidazoles are available in the literature [18, 
19] (Scheme 2.3). Synthetic routes to organohalide compounds with donor 
functionalised groups are also available, though in most cases they can be 
obtained from commercial sources. Once the N- substituted imidazole is made, a 
wide range of imidazolium salts can be prepared by reaction with the 
appropriate alkyl halides as shown in Scheme 2.2 above.
o  o
NH3 H2N R Acid catalyst ^ / = \
^ R
OHAh
Scheme 2.3: Synthesis of bulky N- substituted imidazoles
In summary, this chapter reports the syntheses o f a wide variety o f quinoline 
functionalised imidazolium salts giving access to bidentate and in some cases 
tridentate ligands. All the reported imidazolium salts were fully characterised by 
]H and 13C NMR spectroscopy, mass spectroscopy, micro analysis and in most 
cases were structurally characterised using single crystal X-ray crystallography.
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2.2 Results and Discussion
2.2.1 Synthesis and characterisation of symmetrical saturated 
imidazolium imidazolium salt
Prior to that the start o f this work there was no reported synthesis of 
symmetrical quinoline substituted imidazolium salts and several attempts 
towards accessing this compound were not successful by the established 
procedure [20]. However, in 2006 Michon et al almost at the same we 
synthesised our quinoline based salts reported the synthesis of analogue chiral 
tetradentate diamine and chiral dihydroimidazolium salts, [21]. In their reaction 
they utilised Buchwald-Hartwig Palladium -catalysed animation [22] involving
2.1 equivalents of 8-bromoquinoline, 3 equivalents of sodium t-butoxide, 5 
mol% of Pd2(dba)3 and 10mol% o f rac-BINAP in toluene at 80 °C under argon 
affording the chiral amine in 90% (Scheme 2.4). Ring cyclisation of the chiral 
diamine with triethylortho formate solution at 135°C afforded the desired 
dihydroimidazolium salts in 60-90% yield.
Previously this type of diamine was synthesised using a Bucherer reaction by 
refluxing 8-hydroxy quinoline, the desired diamine and sodium pyrosulfite in 
water for two weeks[ 23,24], but the yield obtained via this method was low by 
almost 50% compare to that reported by Michon [21]. This method was also 
used by T. Okada to make N,N-Di quinolyl-l,3-propanediamine [25].
In our study, we formed our diamine from the considerably cheaper 8- 
hydroxyquinoline material [23] and the achiral dihydroimidazolium 2 was 
prepared in 95% yield by reaction with triethyl orthoformate and ammonium 
tetraflouroborate salt at 120°C in 2 hours as depicted in (Scheme 2.4) above.
| n
Compound 1 was characterised by H and C NMR spectroscopy while
1 13imidazolium salt 2a was characterised by H, C NMR, mass spectroscopy and 
microanalysis. The salt is soluble only in high polar solvents such as DMSO or 
DMF. O f particular importance is the identification of CH unit between the N 
atoms which appeared at 5 value o f 11.4 which is higher than the figure reported 
by Michon [21]. The signal for the C2- carbon in 13C NMR occurs at a 8 of 
159.21 which is typical o f such group [21] (161.90).
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OH
sodium pyrosulfite
H20 , 120°C, 10 days
HC(OEt)3, 120°C
s. X
N
r "
NH
.NL
f  \
NH4BF4t 2hrs. 95% yield
2a : X = BF4 
2b : X = Barf
In order to carryout any further investigations with the salt there was a need to 
improve the solubility of the dihydroimidazolium salt. This was achieved by 
replacing the counter ion tetrafluoroborate with Barf giving access to the 
imidazolium salt 2b that is soluble in almost all organic solvents with the 
exception of petroleum ether and hexane. The characteristic features of 2b as 
observed in the *H and 13C NMR spectra did not changed significantly in 
relation to what was observed in 2a. Diffusion o f hexane into the DCM solution 
of compound 2b gave crystals suitable for X- ray crystallographic 
determination, figure 2 .1.
C12 C11
C14
C15
”  \  N 3 ^  \ , N 2  C7
f  ,  c^ f  N  ^  ^  ^  C6
A  4  c,° C8C> ' C5
ci7 \  r? / /
,  '  -  N  -  
C 18\ ^  C1 4
^  C20
C19 C2
Figure 2.1: ORTEP projection o f the cation of 2b.Barf, excluding hydrogen 
atoms for clarity, showing labelling of atoms.
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Table 2.1: Selected bond lengths (A) and bond angles (°) of 2b
N2 -C8 1.428 N 3-C13 1.476 N2-C10-N3 113.4
N2-C10 1.315 N4-C21 1.369 N1-C9- C8 119.9
N2-C11 1.481 C8- C9 1.480 N2 -C8- C7 119.3
N3-C10 1.316 C13-C21 1.420 C10-N2 -C8 127.5
N3-C12 1.476 NI-C9 1.363 C10-N3 -C l3 126.4
The planes of the quinoline and imidazolium rings make angle of approximately 
36.71° with imC2-H and the nitrogen on the quinoline rings on the same side. 
Some selected bond angles and bond length are presented in table 2.1 above. 
The N2-C10-N3 bond angle o f 113.4° obtained is higher than that generally 
reported for imidazolium salts (108°) [31, 32], but there is no significant 
difference in bond lengths.
2.2.2 Synthesis and characterisation of bis quinoline pyrimidium 
salt
Reports on the synthesis o f 1, 3- dimesityl and 1, 3-dialkyl tetra 
hydropyrimidinium salts have appeared in the literature [26]. However, 
pyrimidium salt 4 is the first six membered ring that is functionalised with 
quinoline giving a tridentate ligand that may behave as a pincer ligand. The 
method of Okada was employed to prepare N, N-Di quinolyl-1, 3- 
propanediamine 3 by refluxing 1, 3 -diaminopropane, 8-hydroxyquinoline and 
sodium pyrosulfite in water for two weeks [23, 24],
The pyrimidium salt 4 was prepared by the reaction of the corresponding 
diamine 3 with triethyl orthoformate and ammonium hexafluorophosphate salt at 
120°C in 3 hours as depicted in (Scheme 2 .5 ), giving a white powder in good 
yield. The synthesis of the salt was confirmed from the NMR data. The *H NMR 
showed a signal at 9.3ppm corresponding to C2-H proton and C2 carbon was 
appeared at 5 value o f 156.72 from the 13C NMR spectrum. The data from the 
mass spectrum and micro analysis were consistent with the proposed structure.
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N
+ H2N NH.
Na2S 20 5
OH
N
PF,
N.
reflux, one week
NH4PF6,HC(OEt)3
120 0C, 3Hrs.
NH
NH
N.
Scheme 2.5: Synthesis of quinoline functionalised pyrimidium salt
Diffusion of Et20  into a MeCN of solution o f 4 yielded crystals suitable for a 
single X-ray crystallographic determination, Figure 2.1
Table 2.2: Selected bond lengths (A) and bond angles (°) of 4
Cl -N1 1.317(3) N4-C22 1.372(3) N1-C1-N2 124.2(3)
Cl -N2 1.317(3) C5-C6 1.365(3) C1-N1-C5 120.71(3)
N1 -C5 1.439(3) C14-C15 1.371(3) C1-N2-C14 120.32(3)
N2 -C14 1.429(3) N4-C21 1.323(3) N1-C5-C15 118.33(3)
C13-N3 1.370(3) N1-C2-C3 109.90(3)
The molecular structure of the tetrahydropyrimidium salt 4 in the solid state is 
depicted in Fig 2.2 being the first structure o f a tetrahydropyrimidium salt with 
nitrogens of the quinoline substituents on the same side with the imC2-H. The 
quinoline and imidazolium rings o f 4 make an angle of approximately 53.69 
which shows a clear divergence from co-planarity. Search of the available 
literature revealed that X-ray structures of 1,3-disubstituted 3,4,5,6- 
tetrahydropyrimidinium salts have been reported only for a few symmetrical:
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diisopropyl[33], diethyl [34] and dimesityl [35]. The data obtained for 
compound 4 is very similar to that of the corresponding 
diisopropyltetrahydropyrimidinium salt reported by Alder [33]. The N1-C1-N2 
angle of 124.2(3)° and C 1-N2 distance o f 1.317(3) A are nearly identical to the 
ones published by Alder[33] and Herrmann[35] who reported 124.72(15)° and 
1.3147(14)A respectively.
C17
{
C 16 Cl
C 15
C 19 ~ C18 \
C 22 t C 1 4
\
C1
C 20 V
*N4 J
C21 C 4
C8
C6
C9
'C5
C 13
N1
N3
C1
C 10
C11
C 3
Figure 2.2: ORTEP projection o f the cation o f 4.PF6 excluding hydrogen atoms 
for clarity, showing labelling o f atoms.
2.2.3 Unsymmetrical substituted Quinoline imidazolium salt
Two quinoline based imidazolium salts are herein reported. 8-imidazol-l-yl- 
quinoline was synthesised following the Zhang modified procedure for the 
synthesis of 1-arylimidazole [27].The yield obtained is low (~ 20%) which is a 
known problem in the literature with most 1 -aromatic substituted imidazoles.
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35% CH20(aq)
O 25% NH3-H20 , MeOH [=\ 
-----------------------------   l\U ,N
O 70 °C, 16 hours
Mel or PhCH2Br / = \
/ /  --------------- - r - n+^ / n
THF, r.t.
6a, R= PhCH2, X= B r'  
6b, R= PhCH2, X= Bf'A 
6c, R= Me, X= f
Scheme 2.6; Synthesis o f quinoline imidazolium salt
The low yield may be connected with the generation of large amounts of 
unknown by-product during neutralisation. The use o f large volume of diethyl 
ether and vigorous agitation during extraction slightly increased the yield. The 
use of small scale synthesis is generally more efficient, though the overall yields 
were not constant. The imidazolium salts were prepared following the standard 
N-alkylation using methyl iodide or benzyl bromide. The alkylatiom of the 
quinoline imidazole follows Sn2 behaviour and is difficult to achieve with 
nucleophile less reactive than a secondary alkyl bromide precluding access to 
desired bulky N-lBu, N- Mes and N-dipp substituents on the resulting 
imidazolium salt via this route [2]. The quinoline imidazole was reacted with 
either methyl iodide or benzyl bromide in THF overnight to give the desired 
imidazolium salts (6a, and 6c) as light brown solid in good yield. While 
imidazolium 6c is stable towards air and moisture, compound 6a is hygroscopic 
and the anion (bromide) was exchanged for tetrafluoroborate anion to obtain 
compound 6b. The anion exchange was accomplished by mixing a solution of 
the halide salt in acetonitrile with a solution o f an excess of sodium 
tetraflouroborate in water which on work gave the BF4 salt in good yield. The 
imidazolium salts were fully characterised. The characteristic peak in the *H 
NMR is the C2-H imidazolium proton appearing as singlet between 10.15- 
10.75ppm. In the 13C NMR the C2 appeared at a 8 value of 150.70ppm. Quality 
crystals for X-ray crystallography were obtained for the BF4 version of the 
imidazolium salt 6b by vapour diffusion o f Et20  into DCM solution. In the *H 
NMR spectra of the BF4 salt (CDCI3 solvent) the C2-H imidazolium proton was 
observed to move upfield while only little o f such change could be observed in 
13C NMR.
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Table 2.3: Selected bond lengths (A) and bond angles (°) of 6b
N6-C7 1.391(2) N9-C8 1.381(2) N6-C10-N9 108.38(14)
N6-C10 1.3405(19) C7-C8 1.349(2) C10-N6-C18 127.40(13)
N6-C18 1.4411(19) C12-C13 1.389(3) N9-C11-C12 111.31(14)
N9-C10 1.324(2) C19-N20 1.367(2) C18-C19-N20 119.85(14)
N9-C11 1.4846(19) N20-C21 1.315(2) N6-C18-C27 118.31(14)
C 22
^ 2 3
\
C 2-T -
w
C 25
\
C21
N
C 26
N 20 
^ 2 1 9  
\  C 18
/
C 27
C 1 0
C11 C 17
f  l\  C 8
>
C 12  \
C 13
C 16
*
C 14
C 7
Figure 2.3: ORTEP projection o f the cation of 6b.BF4 excluding hydrogen 
atoms for clarity showing atom labelling scheme.
The quinoline and imidazolium rings make an angle of approximately 36.16° 
and both the nitrogen of the quinoline ring and imC2-H are directed on the same 
sides of the molecules. The crystal structure of 6b reveals N6-C10-N9 bond 
angle of 108.38° and N6-C10, N9-C10 bond lengths of 1.3405(19) A and
1.324( 19) A respectively which is within the expected values of imidazolium 
salts reported [31, 32].Crystals suitable for X- ray chromatography was obtained 
for compound 6c by diffusion o f diethyl ether into the DCM solution of the 
compound and the crystal structure is depicted in figure 2.4. 'H and 13 NMR, 
MS, and micro analysis data correspond to the proposed structure.
C 15
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Table 2.4: Selected bond lengths (A) and bond singles (°) of 6c
CI-C2 1.367(4) CIO- N2 1.340(4) N2-C10-N3 108.9(2)
CI-C9 1.442(4) C10-N3 1.319(4) C1-N2-C10 127.4(3)
C1-N2 1.439(4) C13-N3 1.461(4) C1-C9-N1 119.5(2)
C5-C9 1.423(4) C9-N1-C8 116.8(2)
C9-NI 1.365(4) C10-N3-C13 125.3(3)
The planes of the quinoline and imidazolium rings o f 6c make an angle of 
approximately 37.34° and gave N2-C10-N3 bond angle o f 108.9°(2) and N2- 
C 10, N3-C10 bond lengths of 1.340(4) and 1.319(4) A respectively which is 
consistent with the values reported in the literature [31, 32].
/ C13
v5N2 
C1 N1
02 S *  \
• A J  rX  ^ c s \  /  CT
C4 C6
Figure 2.4: ORTEP projection of the cation of 6c.I excluding hydrogen atoms 
for clarity showing atom labelling scheme.
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2.2.4 Synthesis and characterisation of methylene-bridged 
quinoline functionalised imidazolium salts
Synthesis of imidazolium salts with the quinoline methylene bridge was 
desired, as apart from reducing the steric strain, it also improves solubility. The 
methylene bridged quinoline imidazole was prepared in good yield following 
the procedure reported in the literature [28] by refluxing a mixture of imidazole, 
2-chromethylquinoline monohydrochloride and KOH in THF for 2 days. The 
direct quartemization of the methylene bridged quinoline imidazole with 
appropriate alkyl halides gave the desired salts in good yield.
f = \
N ^ N H
/ = \
V ' R
RX
8a: R = Mes 
8b: R = PhCOMe2
THF
r = \reflux, 2 days
RX
7
9a : R = Me, X= Cl 
9b : R = Mes. X = Cl 
9c : R = ipp, X = I 
9d : R = n-Bu, X = I 
9e : R = PhCOMe2, X = Cl 
9f : R = QiunCH2, X = Cl
Scheme 2.7: Synthesis of methylene-bridged imidazolium salts
However two of the imidazolium salts reported in this work could not be 
obtained via this method because of the difficulty associated with synthesising 
imidazolium salts by alkylating imidazoles with aryl halides or tertiary alkyl 
halides. Therefore 2-methypropiophenone imidazole and mesityl imidazole were 
prepared according to the reported literature methods [29] and [30] respectively, 
which upon alkylation with 2- chromethylquinoline monohydrochloride in the 
presence o f a base gave the desired imidazolium salts.
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Imidazolium salts 9b, 9c and 9d are stable to moisture and air while compounds 
9a, 9e and 9f are hygroscopic salts. The characteristic features confirming the 
synthesis of the salts are appearances o f a singlet in fH NMR between 10.20-
11.60 corresponding to the C2-H proton between the two nitrogens and the 13C 
NMR spectra showed the value o f the C2 carbon between 152.25-153.60 ppm 
with the highest value of 153.60ppm being observed in compound 9b and
152.25 ppm in 9c. Crystals o f compounds 9b and 9c suitable for X-ray 
structures were obtained by diffusion o f Et2 0  into the acetonitrile solutions of 
the salts. Crystals of compound 9f suitable for X-ray crystallography were 
grown by layering hexane onto a DCM solution o f the salt. In order to 
investigate the effect of counter ion on the crystal structure, the counter ion 
chloride in salt 9b was exchanged for tetraflouroborate and crystals suitable for 
X- ray crystallography of the corresponding salt were obtained by vapour 
diffusion of Et20  into the DCM solution of the salt Figure 2.5. The nature o f the 
counter ion, i.e coordinating and non-coordinating, may have little influence on 
the structure o f the cation as the X-ray revealed almost identical data, though 
peaks in the *H NMR spectra o f the BF4 version are shifted slightly upfield from 
the values observed in 9b. X-ray quality crystals were also obtained for salts 9c 
and 9f by diffusion of diethyl ether into the DCM solutions of the respective 
salts and the crystal structures are depicted in Figures 2.6 and 2.7 respectively.
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C11
*
Cl\
C6
C8 C12
\ C 4
C19
C 2 0 ^  ^  C18
f f  / C 17
C21 ^ C 2 ^ .  ^  C16
N3
C15
C10
\
C2
C1
\ N 2
m /
C3
C14
C13
Figure 2.5: ORTEP projection of the cation of 9b.BF4 excluding hydrogen 
atoms for clarity showing atom labelling scheme.
Table 2.5: Selected bond lengths (A) and bond angles (°) of 9.BF4
CI-N1 1.340(3) C4-C9 1.402(3) N1-C1-N2 108.2(2)
C1-N2 1.323(3) C9-C12 1.500(3) C1-N1-C4 126.2(2)
C2-N1 1.374(3) C13-N2 1.463(3) C1-N2-C13 125.3(2)
C3-N2 1.370(3) C13-C14 1.506(3) N1-C4-C9 117.5(2)
C4-N1 1.446(3) C14-N3 1.306(3) N2-C13-C14 112.9(2)
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C14
C15
C16
\
C11 i
C10
C13
IC12
N3
C8
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N2 /  ^ / C 2  
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C9 C7
Figure 2.6: ORTEP projection o f the cation of 9c.I excluding hydrogen atoms 
for clarity showing atom labelling scheme.
Table 2 .6 : Selected bond lengths (A) and bond angles (°) of 9c.I
C l-N l 1.30(2) C7-C8 1.4888 N1-C1-N2 105.9(12)
C1-N2 1.369(2) N3-C8 1.3899 C1-N2-C7 129,5(13)
C7-N2 1.515(15) C8-C9 1.3888 C1-N1-C4 124.4(11)
C4-N1 1.50(2) C6-C4-C5 109.7(14)
C4-C5 1.53(2) N2-C7-C8 111.2(5) N3-C8-C7 119.2
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C4 C3
C15
Figure 2.7: ORTEP projection of the cation of 9f.Cl excluding hydrogen atoms 
for clarity showing atom labelling scheme.
Table 2.7: Selected bond lengths (A) and bond angles (°) of 9f.Cl
N2- C6 1.335(3) C8-N9 1.316(3) N2-C6-N5 108.3(2)
N2-C18 1.467(3) C19-N20 1.323(3) C6-N5-C7 125.0(2)
N5-C6 1.327(3) N9-C10 1.371(3) C6-N2-C18 124.7(2)
N5-C7 1.461(3) N2-C18-C19 113.0(2)
C7-C8 1.511(3) C7-C8-N9 117.6(2) N5-C7-C8 112.07(2)
The imidazolium salts 9b, 9c and 9f for which single X-ray structure 
determinations were performed show relatively consistent parameters in terms 
of bond distances and internal angles around the imidazolium rings and are all 
within the data reported in the literature [31, 32]. Important bond angles and 
bond distances are tabulated in tables 2.5, 2.6 and 2.7. In 9b the mesityl and 
imidazolium rings planes are almost perpendicular to each making an angle of 
approximately 88.69° and the imC2-H and the nitrogen on the quinoline ring are 
disposed to the same side of the molecule. The planes of the methylquinoline
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and imidazolium ring o f 9c make an angle o f approximately 61.83° while those 
of 9f are almost perpendicular to each other forming an angle of approximately 
85.65° and the imC2-H and nitrogen on the quinoline moiety are disposed on the 
side of the molecules in the both compounds (9c and 9f).
2.2.4 Synthesis and characterisation of octahydroacridine based 
imidazolium salt
In addition to the quinoline based imidazolium salts, it was decided to synthesise 
an octahydroacridine based imidazolium salt. Octahydroacridine can offer a 
secondary donor function for chelation as well as sp3 hybridized carbons which 
offers the ability to make the ligand chiral as well as addition o f extra steric 
strain if required. Octahydroacridine was synthesised following the procedures 
of Paine [29] and Bell [30]. Bell’s method offers fewer synthetic steps as well 
less forcing conditions but the yield as stated in the paper (50%) could only be 
achieved by strict adherence to conditions and deviation from the procedure led 
to the formation of large quantities o f by-products.
Although Paine’s method requires the use o f many steps and forcing reaction 
conditions, it was found to be more reliable giving access to cleaner products.
Paine’s synthetic procedure as well as steps leading to the synthesis o f the 
desired imidazolium salt is depicted in Scheme 2.8 above. To introduce the 
chlorine onto position 4 it was necessary to functionalise the octahydroacridine 
ring with hydroxyl group. Paine’s procedure involves the reaction o f 
octahydroacridine with 3-chloroperoxybenzoic to form octahydroacridine N- 
oxide which upon reaction with an excess of boiling acetic anhydride gave 4- 
hydroxyl substituted octahydroacridine 14 after work up. However, in our work 
Fontena’s method was employed [31] which requires the use triflouroacetic 
anhydride instead of large excess of acetic anhydride with the reaction being 
carried out at room temperature to form the desired 4- 
hydroxyoctahydroacridine. 4-Chlorooctahydroacridine 15 was prepared by the 
reaction of 4-hydroxyoctahydroacridine with thionyl chloride which upon work 
up gave the desired compound as a yellow solid.
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Scheme 2.8: Synthesis of octahydroacridine based imidazolium salt
Finally the acridine based salt was prepared by reaction of 4-
chlorooctahydroacridine with 1 -mesitylimidazol in THF in a pressure tube at 90 
°C for 14 days. The yield obtained in this reaction was very low because the 
reaction follows a typical SN2 pathway, and with secondary alkylchloride, the
reaction would be expected to be very slow even under the forcing conditions
used. Attempt to prepare a more reactive 4 iodooctahydroacridine was made by 
the addition of sodium iodide to an acetone solution of 4-
chlorooctahydroacridine and stirred overnight and after work up there was no 
observable effect from the NMR spectra. The imidazolium salt prepared was 
fully characterised by 'H NMR, mass spectroscopy and micro analysis with the
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'H NMR showing C2-H appearing as singlet at a 5 value of 10.15pmm. The 
imidazolium salt 16 returned satisfactory MS and elemental analysis results.
Due to low yield and time constraints large varieties of the acridine based 
imidazolium could not be prepared using the secondary alkyl chloride 14. 
However, it should be noted that, there is a lot o f research opportunities in this 
area that need to be explored. It is envisage that once a more reactive 
halooctahydroacridine such as bromo or iodooctahydroacridine can be prepared 
and following the procedure of Steiner et al [29] 1-acridine imidazole can be 
obtained thereby opening the way to a range of acridine based imidazolium 
ligands. Some of the interesting acridine based ligands that can possibly be 
prepared are presented in figure 1.8 below. It will be interesting to compare 
these potential pincer ligands with the pincer ligands reported by Gibson, 
Cavell, Danopoulos and Crabtree.
17a 17b 17c
17d
Figure 1.8: Proposed acridine based pincer ligands
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2.3 Conclusions
A range of quinoline based imidazolium salts have been synthesised and 
characterised as precursors to the corresponding NHC ligands. A range of N- 
substituents give variable steric bulk to the imidazolium rings. The summary of 
all the imidazolium salts synthesized in this work are presented below in Table 
2 .8 .
Table 2.8: Ligands synthesized in this project
S.
NO
Ligand Structure
1 2b
o  oN--- ' Barf ^ J
2 4
\  V  - \ \  /)\ = /  pf 6
3 6a t= \ f = \
O  Br
4 6c r= \ r = \
5 9a != \
Cl ^_f j
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N) \
10 9f r=\
ft XN Cl‘ N \
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The previously unreported bis 1, 3-(quinoline) tetrahdropyrimidium salt 4 is the 
first reported quinoline based salt o f this nature. Though in 2006 Michon et al 
reported chiral bis 1,3-quinolinedihydroimidazolium salts [21], salt 2b is an 
achiral analogue and therefore is a new compound. Compounds 6a, 6c and 16 
have earlier been prepared by Cavell group while all the other ligands are new.
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Similar ligands functionalised with pyridine have been reported in the literatures 
[7, 31, 32, and 40]. However in this study, the pyridine moiety has been 
replaced by quinoline and this change is expected to increase the steric strain of 
the ligands as well as rigidity which may have important implications in the 
synthesis of the metal complexes. The acridine based imidazolium salt offers the 
possibility of accessing chiral ligand as well as varying the steric strain. 
Synthesis of the acridine based imidazolium salt also open up the opportunity to 
look into the possibility o f synthesising the ligands presented in figure 1.8 
above.
2.4 Experimental
2.4.1 General comments
Unless otherwise stated all manipulations were carried out using standard 
Schlenk techniques under an atmosphere o f dry argon or in an MBRAUN M72 
glove box (N2 atmosphere with > lppm  O2 and H2O). Glassware were dried 
overnight in an oven at 120°C or flame dried prior to use. Tetrahydrofuran 
(THF), diethyl ether (Et2 0 ), and hexane were dried and freshly distilled before 
used. Dichloromethane (DCM), methanol (MeOH) and acetonitrile (MeCN) 
were dried over calcium hydride. All other anhydrous solvents were obtained by 
distillation from the appropriate drying agent under dinitrogen. Deoxygenation 
of solvents and reagents was carried out by freeze- thaw- degassing.
All NMR solvents were purchased from Aldrich and Goss, dried over 3A 
molecular sieves and freeze-thaw degassed three times. All reagents were 
purchased from commercial sources and used without purification, unless 
otherwise stated.
All NMR data are quoted 8/ppm. 'H and 13C spectra were recorded on a Bruker 
400 MHz DPX Avance, unless otherwise stated, and referenced to SiMe4. 
Electrospray mass spectrometry (ESMS) was performed on a VG Fisons 
Platform II instrument by the department o f Chemistry, Cardiff University. 
Micro analysis was performed by Warwick Analytical Service.
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2.4.2 N-Substituted imidazoles
The following imidazoles were prepared by established literature methods. l-(- 
2-methylpropiophenone)imidazole [29], mesitylimidazole [19], imidazole-1-yl- 
quinoline [27] and l-(2methylquinoline) imidazole [28]. 
Imidazol-l-yl-quinoline (5):
8-aminoquinoline (2.27 g, 8.8 mmol) was mixed with 40% glyoxal (1.22 g, 8.8 
mmol) in 30 mL MeOH and stirred overnight at room temperature to give a 
yellow mixture. NH4CI (0.94 g, 17,6 mmol) and 37% aq formaldehyde (1.42 g, 
17.6 mmol) were then added to the mixture which was then diluted by further 
addition of 150 ml MeOH. This was refluxed for an hour and H3PO4 (1.6 mL.85 
%) was slowly added to the mixture before heating to reflux for 12 hours. After 
removal of the solvent the dark residue was poured on to ice (lOOg) and 
neutralised with aqueous 40% KOH until pH 9. The resulting mixture was then 
extracted with diethyl ether (4 x 100 mL). The ethereal phase was then washed 
with water, brine and dried with Na2S0 4 . The solvent was then removed to give 
a light brown solid product, 0.19 g (10%). JH NMR (CDCI3 400 MHz 298K) : 
8.90 (s, 1H, NCHN-H ), 8.2 (m, 1H, J = 6.7 Hz, quin-H), 8,05(s, 1H, CHHC),
7.8 (m,lH, J = 7.9 Hz, quin-H), 7.6 (m, 1H, J = 1.3 Hz, quin-H), 7.5 (m, 1H, J =
7.9 Hz,), 7.4( m, 2H, J = 4.2 Hz, quin-H), 7.2(s, IH, HCCH-H). 13C NMR 
(CDCI3 100.61MHz 298K): 159.0, 140.5, 138.5, 136.0, 135.5, 128.5,127.0, 
126.8, 125.0,123.0,122.5,120.5.
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l-(-2-methylpropiophenone) imidazole (8b).
A round bottomed flask was charged with imidazole (1.70g, 25mmol), 2- 
bromo-2-methylpropiophenone (2mL, 11.9mmol) and 40mL of ethanol. The 
yellow solution was refluxed for 3 days. Aqueous work up yielded yellow oil 
which crystallized in the freezer. Recystallization from from dichloromethane/n- 
hexane (1:2) afforded pure colourless product (1.56g. 7.25mmol, 61%).!H NMR 
(CDC13 400 MHz R.T.): 7.60(s, 1H, NCHN), 7.4(m, 1H, J = 2.5 Hz, arom-H), 
7.2(m, J = 1.1 Hz, 4H, arom-H), 7.05(s, 1H, CHHC), 6.85(s, 1H, CHHC), 1.8(s, 
6H, CH3). I3C NMR (CDCI3 72.5MHz R.T): 198.45(PhCOC), 134.78,134.48, 
130.17, 128.60,128.50, 117.39,64.89,27.14(CH3).
1 -(2 methylquinoline)imidazole (7):
A mixture of imidazole (0.38g, 5.51mmol), 2-(chloromethyl) quinoline and 
KOH (1.24g, 0.022mol) in THF (20mL) was refluxed for 2 days. The solvent 
was removed completely under reduced pressure. DCM (20mL) and water 
(20mL) were added and shaken vigorously in a separatory funnel. The organic 
layer was extracted and washed thoroughly with 20mL of water. The organic 
layer was separated and dried with anhydrous MgSC>4. The solution was filtered 
and removal of the solvent under reduced pressure gave an orange solid as the 
desired product (0.80g, 69%). 'H NMR (CDC13 400 MHz 298K):8.1(d, 1H, J = 
8.5 Hz, quin-H), 8.0(d, 1H, J = 8.5 Hz, quin-H), 7.75(d, 1H, J = 8.2 Hz. quin- 
H), 7.65(t, 1H, J = 5.6 Hz, qiun-H, 7.6(s, 1H, NCHN), 7.45(t, 1H, J = 8.6 Hz, 
quin-H), 7.05(s, 1H, CHHC), 7.0(s, 1H, CHHC), 6.95(d, 1H, J = 10.0 Hz, quin- 
H), 5.35(s, 2H, NCH2) l3C NMR (CDC13 100.61MHz R.T): 156.13 (NCN),
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147.71, 137.80, 137.60, 130.14, 129.18, 127.64, 127.41, 126.93, 119.58, 118.66,
53.25 (NCH2)
2.4.3 Symmetrical saturated bis(13- quinoline) imidazolium salt 
N, N-Diquinolinethane -1, 2-diamine (1):
A mixture of 8-hydroxyquinoline (36.25 g, 0.25 mol), 1,2-diaminethane (9.75 g, 
0.125 mol), sodium pyrosulfite (47.5 g , 0.25 mol ) and water (250mL) was 
refluxed and stirred for one week. The solution was made strongly alkaline, 
cooled and filtered. The solid product was extracted several times with hot 0.2N 
NaOH until removal o f 8-quinolinolate was complete and the residue was 
recrystallised from ethanol to give the desired product as a light yellow solid ( 
6.00g 16 %).'H NMR (CDC13, 400MHz 298K): 8 .6(m, 2H, J = 2.6 Hz, Quin-H), 
), 8.0(m, 2H, J = 6.8 Hz, Quin-H), ), 7.3(m, 4H, J = 7.7 Hz, Quin-H), 7.0( m, 
2H, J = 7.5 Hz, Quin-H), 6.7( m, 2H, J = 8.0 Hz, Quin-H), 6.35( b, 2H,CNH), 
3.7(s,4H,NCH2), 13C NMR (CDC1, 72.5MHz R.T): 146.94, 144.68, 138.34, 
136.01,128.73,127.77,121.46, 114.23, 104.77(quin-C), 42.79(NCCN).
Synthesis of 1 ,3-diquinolin-4, 5-dihydroimidazoluim tetraflouroborate (2):
N, N ’-diquinolinethane-l, 2-diamine (0.3g 0.58mmol) and NH4BF4 (0.095g, 
0.58mmol) in triethyl orthoformate were heated at 120°C for 24 hours. The 
precipitate which was isolated was washed several times with diethyl ether and 
recrystallised from CHC^/Diethyl ether to afford the desired product 0.3g 
(85%). Anal. Calcd. for CziHn^BFzj: C, 61.19; H, 4.13; N, 13.60; F, 18.46%.
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Found: C, 59.06; H, 4.01; N, 13.48; F, 19.04%. FIRMS: Calculated for 
C21H17N4BF4: 325.1453. Found: 325.1437. ‘H NMR (DMSO-d6, 400MHz 
R.T):11.40(s, 1H, NCHN), 9.20(m, 2H, J = 2.6 Hz. Quin-H), 8.70(m, 2H, J =
1.2 Hz. Quin-H), 8.20(m, 2H, J = 8.2 Hz, Quin-H), 8.10(m, 2H, J = 8.0 Hz, 
Quin-H), 7.90(m, 2H, J = 8.0 Hz, 7.8(m, 2H, J = 4.2 Hz, Quin-H), 4.95(s, 4H, 
NCH2CH2N). I3C NMR (DMSO-d6 , 72.5MHz R.T.): 158.91(NCN),
150.95(quin-C), 139.98(quin-C), 137.35(quin-C), 132.52(quin-C), 128.97(quin- 
C), 127.87(quin-C), 126.60(quin-C), 122.81(quin-C), 49.99(im-C).
2.4.4 Bis(l,3-quinoline)pyrimidium hexaflouro phosphate salt 
N, N-diquinolinepropane-1, 3-diamine (3):
Following the procedure for preparation o f 1, 7.32g of compound 3 was 
obtained from 8-hydroxyquinoline (18.13g, 0,125moles), 1,3-diamonopropane 
(4.64g, 0.125moles), sodiumpyrosulfite (23.77g, .125moles) and 125mL of 
water as a yellow solid. 'H NMR (CDCI3, 400MHz 298K): 8.60(m, 2H, J = 2.7 
Hz, quin-H), 8.00(m, 2H, J = 6.7 Hz, quin-H), ), 7.30(m, 4H, J = 4.4 Hz, quin- 
H), 7.00( m, 2H, J = 8.3 Hz, quin-H), 6.65( m, 2H, J = 7.7 Hz, quin-H), 6.20( 
broad, 2H,CNH), 3.50(m,4H, J = 7.0 Hz, NCH2), 2.20(m, 2H, J = 6.8 Hz. 
CCH2C). 13C NMR (CDCI3 72.5MHz R.T): 146.84, 144.80, 138.25, 136.04,
128.70, 127.84, 121.41, 113.85, 104.72(quin-C), 41.30(NCC), 29.01(CCH2C).
1, 3-diquinoline-3, 4, 5, 6-tetrahydropyrimidinium hexaflouro phosphate
(4):
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Following the procedure for the synthesis o f 2, the desired pyrimidinium salt 4 
was synthesised from N,N-diquinolinepropane-l,3-diamine(3.59g,0.011 moles) 
NH4PF6(1.78g, 0.011 moles) and triethyl orthoformate(30mL) as a light brown 
solid (Yield= 5.00g, 94.34%). Anal. Calcd. for C22Hi9N4PF6: C, 54.35; H, 3.93; 
N, 11.57%. Found: 53.74; H, 3.84; N, 11.37%.HRMS: Calculated for 
C22HI9N4PF6: 339.1610. Found: 339.1618. ]H NMR (DMSO-d6 , 400MHz 
298K): 9.30 ( s, 1H, NCHN), 9.20(m, 2H, J = 4.2 Hz, quin-H), 8.70(m, 2H, J =
4.1 Hz, quin-H), 8.30(m, 2H, J = 8.3 Hz, quin-H), 8.25(m, 2H, J = 7.4 Hz, quin- 
H), 7.90(m, 2H, J = 7.8 Hz. quin-H), 7.80(m, 2H, J = 4.1 Hz, quin-H), 4.30(m, 
4H, J = 5.4 Hz, NCH2C), 2.70(m, 2H, J = 5.1 Hz. CH2C). I3C NMR (DMSO-d6 , 
72.5MHz R.T.): 156.72 (NCN), 151.57, 141.82, 138.10, 136.93, 129.64, 128.97, 
126.65, 126.51, 122.72,48.03, 19.54.
2.4.5 Unsymmetrical substituted quinoline imidazolium salts
Synthesis of l-benzyl-3-quinolinimidazolium bromide (6a):
f= \ /= \
O Bt
Benzyl bromide (1.41 g, 8.25 mmol) was added to a solution 8-imidazol-l-yl- 
quinoline (0.70 g, 3.59 mmol) in 20 mL THF.The resulting mixture was allowed 
to stir overnight at r.t. The resulting yellow/brown precipitate was filtered using 
filter stick and washed with fresh THF to afford a brown powder. This was then 
recrystallised from DCM/Hexane to give the desired imidazolium salt (light 
brown solid).‘H NMR(CDCL3:250MHz 298K):10.80( s, 1H, NCFIN), 8.90( 
m ,lH, J = 4.1 Hz, Quin-H), 8.25(m, 1H, J = 8.7 Hz, Quin-H), 8.00(m, 1H, J =
8.3 Hz. Quin-H), 7.90(s, 1H, CHHC), 7.70(m, 1H, J = 5.7 Hz, Quin-H), 7.60(m, 
2H, J = 6.2 Hz. Quin-H , CHHC), 7.50(broad 2H, Quin-H), 7.30(m, 3H, J = 7.3 
Hz, Ar-H), 5.85(s, 2H, CH2). 13C NMR (CDC13 100MHz R.T):
152.07(NCN),140.79, 137.30, 137.10,133.60, 131.40, 131.03, 129.86, 129.75,
129.70, 129.55,126.90,126.00, 124.72, 123.23, 121.95,53.76(NCH2).
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l-benzyl-3-quinolinimidazoliumtetraflouroborate (6b): The counter ion
bromide in 6a was exchanged for tetraflouroborate ion by mixing one equivalent 
of l-benzyl-3-quinolineimidazolium bromide (0.5g, 1.75 mmol ) in acetonitrile 
with 1.5equivalent o f NaBF4(0.28g, 2.63mmol) in water. The acetonitrile was 
removed under reduced pressure and product was washed twice with water. The 
residue was then dissolved in DCM and the organic and aqueous layer 
separated. The DCM solution was dried over MgSC>4 and solution concentrated 
under reduced pressure. Addition o f Et2 0  precipitates out the product which was 
filtered and dried in vacuum to give the desired product as brown solid. Crystals 
suitable for X-ray crystallography were obtained by vapour diffusion of Et20 
into DCM solution o f the product. Anal. Calcd. for C 19H 16N3BF4: C, 61.29; H, 
4.29; N, 11.27%. Found: C, 60.96; H, 4.31; N, 11.12%. *H NMR (CDC13, 
250MHz R.T.): 9.40(s, 1H, NCHN), 8.85(d, 1H, J = 4.2 Hz, quin-H), 8.35(d, 
1H, J = 7.5 Hz, quin-H), 8.20(d, 1H, J = 8.4 Hz, quin-H), 8.00(d, 1H, J = 8.3 
Hz, quin-H), 7.85(s, 1H, CHHC), 7.70(t, 1H, J = 4.2 Hz, quin-H), 7,50(m, 3H, 
arom-H), 7.60(s, 1H, CHHC), 7.50(m, 3H, J = 7.0 Hz, arom and quin-H), 5.50(s, 
2H, CH2). 13C NMR (CDCI3 72.5MHz R.T): 150.70(NCN), 139.31, 135.92, 
135.69, 131.97, 129.96, 129.68, 128.46, 128.41, 128.26, 128.16, 125.42, 124.21, 
123.35, 121.85, 120.77, 52.68(NCH2).
l-methyl-3-quinolineimidazolium iodide (6c):
Methyl iodide (lg , 7mmol) was added to a solution of 8-imidazol-l-yl-quinoline 
(0.5g, 2.7mmol) in 20M1 o f THF. The resulting mixture was stirred at room 
temperature for 48 hrs. The resulting brown precipitate was filtered using filter 
stick and washed with further amount o f THF to afford a brown powder. This 
was then recrystallised from DCM/Hexane to give the desired imidazolium salt 
(0.6g, 70%).Crystals suitable for X-ray were obtained by vapour diffusion of 
Et20 into the DCM solution o f the compound. Anal. Calcd. for C 13H 12N3I: C, 
46.30; H, 3.56; N, 12.47%. Found: C, 46.09; H, 3.60; N, 12.16%. 'H 
NMR(DMSO-d6:250MHz R.T): 9.80(s, 1H, NCHN), 8.90(d, 1H, J = 1.7 Hz, 
quin-H), 8.30(d, 2H, J = 1.6 Hz, quin-H), 8.00(d,lH, J = 7.4 Hz, quin-H), 7.80(s,
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1H, CHHC), 7.70(d, 1H, J = 7.9 Hz, quin-H), 7.50(m, 1H, J = 4.2 Hz. quin-H), 
7.40 (s, 1H, CHHC), 4.30(s, 3H, CH3). ,3C NMR (DMSO-d6 , 72.5MHz R.T.): 
152.02(NCN), 140.62, 138.48, 136.95, 131.39, 130.69, 128.77, 126.38, 126.27, 
124.41, 123.29, 123.06, 67.00(CH3)
2.4.6 methylene-bridged quinoline Functionalised imidazolium 
salts
1-methyl -3-(2-methylquinoline) imidazolium chloride 9a:
A mixture of methyl imidazole (0.58g, 7mmol), 2-chloromethyl quinoline 
monohydrochloride (1.5g, 7.00 mmol) and K2C0 3 (0.50g, 3.50 mmol) in 
acetonitrile was refluxed for 24 hours. The solvent was removed and the 
remaining residue was dissolved in dichloromethane. The solution was filtered 
to remove the KC1 formed and unreacted K2C0 3 and the filtrate were 
concentrated to few millilitres. Addition o f THF to the solution precipitated out 
the product which was repeatedly to give the product as a pale yellow solid 
(1.20g, 81%). Required: For C ,3H ,4N3C1: C, 60.12; H, 5.41; N, 15.80; Cl, 
13.68%. Found: C, 64.14; H, 5.42; N, 16.00; Cl, 13.93%.HRMS: Anal.Calcd. 
for Ci3H14N3C1: 224.1188. Found: 224.1193. ‘H NMR (CDC13. 400MHZ, R.T.) 
: 10.67 ( s,lH , NCHN ) ,  8.10 ( m, 1H, J = 8.4 Hz, Quin-H ), 7.90 ( d, 1H, J =
8.4 Hz, Quin-H ), 7.65 (m, 3H, J -  8.1 Hz Quin-H, CHHC ), 7.60 ( s, 1H, 
CHHC ), 7.40 ( t, 1H, J = 7.1 Hz, Quin-H ), 5.90 ( s, 2H, CH2 ), 4.00 ( s, 3H, 
CH3 ). 13C NMR (CDCL3, 100.61MHZ, R.T): 153.14 (NCN), 147.86, 138.32, 
138.14, 130.47, 129.06, 127.92, 127.57, 123.61, 123.25, 120.71, 54.57(NCH2), 
36.92(CH3).
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Synthesis of 1-mesityl 3-(-2-methylquinoline)imidazolium chloride 9b :
cr
A mixture of mesityl imidazole (0.87g, 4.67mmol), 2-chloromethylquinoline 
monohydrogen chloride (l.Og, 4.67mmol) and K2CO3 (0.33g, 2.39mmol) in 
acetonitrile was refluxed for 24 hours. The solvent was removed and the residue 
dissolved in dichloromethane. The solution was filtered to remove the KC1 
formed and unreacted K2CO3 and the filtrate were concentrated to few 
millilitres. Addition of THF to the solution precipitated the product which was 
repeatedly to give a white product (1.25g, 73.5%). Anal. Calcd. for C22H22N3CI: 
C, 72.63; H, 6.05; N, 11.55; Cl, 9.77%. Found: C, 69.41; H, 6.03; N, 10.98; Cl, 
9.57%. HRMS: Calculated for C22H22N3C1: 328.1814. Found: 328.1807. 'H 
NMR (CDCI3. 400MHz, R.T. ) : 10.50 ( s,lH , NCHN ) ,  8.20 ( m, 1H, J = 8.4 
Hz, Quin-H ), 8.00 ( s, 1H, aromatic-H ), 7.85 ( m,2H, J = 8.4 Hz, Quin-H ), 
7.75( d, 1H, J = 8.1 Hz, Quin-H), 7,65 (t, 1H, J = 7.0 Hz, Quin-H ) , 7.50 ( t, 
1H, J = 7.1 Hz, Quin-H ),7.05 ( S, 1H, aromatic-H ) ,  6.95 ( s,2H, CHHC ), 6.30 
(s, 2H , CH2 ), 2.30 ( s, 3H, P-CH3 ), 2.00 ( s, 6H, O-CH3 ). ,3C NMR (CDCL3, 
100MHz, 298K): 153.60, 147.77, 141.56, 139.17, 138.36, 134.71, 131.17, 
130.48, 130.14, 129.16, 128.23, 128.15, 127.53, 124.43, 123.04, 121.18, 54.57, 
21.47, 17.94.
Synthesis of 1-isopropyl -3-(2-methylquinoline) imidazolium iodide (9c)
A mixture 2-iodopropane (1.63g, 9.57mmol) and 1-(2-methylquinolin) 
imidazole (lg, 4.8mmol) in 50ml o f ethyl acetate was refluxed for 3 days. The 
reaction solution was allowed to cool to room temperature, after which the 
crystals were filtered off and washed with ethyl acetate and dried in vacuum to 
give the desired product, (1.25g, 6 8 .68% ). Anal. Calcd. for C16H18N3I: C, 
50.67; H, 4.75; N, 11.08; I, 33.49%. Found: C, 50.17; H, 4.64; N, 10.89; I, 
33.13%. HRMS: Calculated for C |6H |8N3I: 252.1501. Found: 252.1491. 'H
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NMR (CDCL3, 400MHz, R.T): 10.35 (s, 1H, NCHN), 8.15 (d, 1H, J = 8.4 Hz, 
quin-H), 7.90 (d, 1H, J = 3.5 Hz, quin-H), 7.90 (t, 2H, J = 8.4 Hz, quin-H), 7.80 
(m, 2H, quin-H), 7.70 ( m,2H, J = 6.5 Hz, CHHC, Quin-H), 7.50 (m, 2H, J = 9.0 
Hz. quin-H, CHHC), 6.90 ( s, 2H, NCH2C), 4.80 ( m, 1H, J = 7.8 Hz, NCHC2,
1.60 ( d, 6H, J = 7.0 Hz, CH3). I3C NMR (CDCL3. 100MHZ, 298K):152.25 ( 
NCN), 147.93, 138.43, 136.07, 130.63, 129.45, 128.25, 128.15, 127.74, 123.63, 
121.28, 120.29,54.72,23.59.
l-n-butyl-3-(-2-methylquinolin) imidazolium iodide (9d):
A mixture of 1-(2-methylquinoline) imidazole (l.OOg, 4.80mmol) and 1- 
iodobutane (1.76g, 9.60mmol) was refluxed in 50mL o f ethyl acetate for two 
days. The reaction solution was allowed to cool to room temperature and the 
ethyl acetate decanted off. The residue was dissolved in minimum amount of 
DCM and the product precipitated out by the addition o f hexane. The desired 
product was filtered and dried in vacuum. (1.20g, 63.83%). MS (ESMS, Da): 
M/Z 266.16 [M-I]+ (100%). Anal. Calcd. for C 17H2oN3I: C, 51.92; H, 5.09; N, 
10.69; I, 32.30%. Found: C, 52.58; H, 4.99; N, 10.57; I, 31.94%. 'H NMR 
(CDCL3, 400MHz, R.T):10.2(s, 1H, NCHN), 8.15(d,lH, J = 8.4 Hz, quin-H), 
7.90(d,lH, J = 6.6  HZ. quin-H), 7.85(m, 2H, J = 8.3 Hz. quin-H, CHHC), 
7.65(t,2H, J = 5.9 Hz, quin-H), 7.50(t, 1H, J = 7.4 Hz, quin-H),7.40(s,lH, 
CHHC), 5.90(s,2H, NCH2), 4.20(t, 2H, J = 7.2 Hz, NCH ), 1.85(m, 2H, J = 7.5 
Hz, CH2), 1.30(m, 2H, J = 7.4 Hz, CH2), 0.90(t, 3H, J = 7.1 Hz, CH3). 13C 
NMR (CDCL3, 1 0 0 M H z , 298K): 152.78(NCN), 147.92, 138.29, 137.02, 130.58, 
129.44, 128.21, 128.07, 127.68, 123.64, 122.36, 120.93, 54.65(NCC), 50.43, 
32.41,19.79,13.88(CH3).
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l-(-2-methylpropiophenone)-3-(-2-methylquinolin) imidazolium chloride 
(9e)
f=\
+N^ N
2(chloromethylquinoline)monohydrochloride( 1.50g,7.0mmol), 1 (2methylpropio 
phenone) imidazole (1.50g, 7.0mmol) and K2CO3 (0.55g, 3.98mmol) in 30mL 
of acetonitrile was refluxed for 2 days. The solvent was removed and the residue 
dissolved in dichloromethane. The solution was then filtered to remove KC1 and 
unreacted K2CO3 and the dichloromethane completely removed. The residue 
was repeatedly was washed with diethyl ether and dried in a vacuum to afford 
the desired product. MS (ESMS): M/Z 366.16 [M-C1]+ (100%). 'H NMR 
(CDCLj, 400MHz, 298K): 11.60(s, 1H, NCHN), 8.10(d, 1H, J = 8.40 Hz, quin- 
H),7.90(m, 2H, J = 3.6 Hz, quin-H, aromatic-H), 7.80(d, 1H, J = 8.3 Hz, quin- 
H), 7.65(t, 1H, J = 1.5 Hz, Quin-H), 7.60(s,lH, CHHC), 7.50 -7.40(m, 4H, J = 
7.7 Hz, arom-H), 7.20(m, 2H, J = 1.8 Hz, quin-H),7.25(s,lH, CHHC), 7.00(s, 
1H, CHHC). 13C NMR (CDCL3, 100MHZ, R.T):197.30(CO), 153.45(NCN), 
147.91, 138.33, 134.06, 133.75, 130.44, 129.43, 129.26129.08, 128.83, 128.22, 
128.13, 127.62, 123.78, 121.40, 120.87, 70.08, 54.79, 27.31(CH3).
Bis-1,3- (2-methylquinolin) imidazolium chloride (9f)
A mixture of 1-(2-methylquinolin) imidazole (l.OOg, 4.79mmol), 2- 
(chloromethylquinoline) monohydrogen chloride (1.02g, 4.79mmol) and K2C 0 3 
(0.50g, 3.62mmol) in 50mL acetonitrile was refluxed for 24 hours. The solvent 
was removed and the residue dissolved in dichloromethane. The solution was 
filtered to remove the KC1 formed and unreacted K2C 0 3 and the filtrates were 
concentrated to few millilitres. Addition o f THF to the solution precipitated the 
product which was washed repeatedly with THF to give a pale yellow product. 
(Yield, 0.98g; 72%). Anal. Calcd. for C23Hi9N4C1: C, 71.41; H, 4.92; N, 
14.48%. Found: C, 71.08; H, 5.00; N, 14.07%. HRMS: Calculated for
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C23H 19N4CI: 351.1610. Found: 351.1606. ‘H NMR (CDCL3, 400MHz, 298K):
11.20(NCHN), 8 .10(d, 2H, J = 8.4 Hz. quin-H), 7.85(d, 2H, J = 8.4 Hz, quin- 
H), 7.70(m, 4H, J = 8.3 Hz quin-H,), 7.65(m, 4H, quin-H, CHHC), 7.45(t, 2H, J 
= 6.7 Hz, quin-H), 5.80(s, 4H, NCH2C). 13C NMR (CDCL3, 100MHZ, 
R.T): 152.79, 147.58, 138. 44, 137.98, 130.12, 129.13, 127.76, 127.69, 127.57, 
120.67, 54.57.
2.4.7 Acridine based imidazolium salt
To prepare the desired imidazolium salt, 4-chlorooctahydroacridine was 
prepared following Paine multi step synthesis [29] and then coupled with 
mesitylimidazole.
2-I)imethylaminomethylcyclohexanone (10):
o
A mixture of cyclohexanone (22.30g, 0.23 mol), dimethylamine hydrochloride 
(9.9 g, 0.12 mol), and formaldehyde (36.90 g o f 37% solution in water) was 
refluxed (oil bath at 130 °C, 30 min) and then cooled to room temperature. 
Sodium chloride (4.25g) was added, and the mixture was stirred at 23 °C (20 
min). The mixture was transferred to a separatory funnel, and the organic and 
aqueous phases were separated. The aqueous phase was extracted with Et20  (4 
X 10 mL) to further remove unreacted cyclohexanone, and adjusted to pH= 13.5 
by addition of 9.50 g of KOH in 22.5 mL of water. The mannich base was 
separated as yellow oil, which exhibited a strong amine odour. The aqueous 
phase was extracted with Et2 0  (3 x 20 mL), and the yellow oil and the ether 
extracts were combined and then dried over anhydrous sodium sulphate. After 
removal of the ether at 23 °C under reduced pressure, the remaining oil was 
distilled under vacuum (42-43 °C/100 mTorr): yield 16.00 g (90%).1H NMR 
(CDCL3-d3:400 MHz 298K): 5 = 2.65(m, 1H, J = 6.0 Hz), 2.40-2.20(m,3H, J =
3.4 Hz), 2.10(m, 8H, J = 6.2 Hz), 1.9(m, 1H, J = 2.7 Hz, ), L8(m, 1H, J = 4.8 Hz, 
), 1.6(m, 2H. J = 3.0 Hz ), 1.3(m, 1H, J = 11.1 Hz, ) 13C NMR (DCM, 400MHz 
R.T.): 24.30,27, 80, 32.23, 41.69, 45.57, 48.73, 58.80, 212.27.
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2, 2’-Dicyclohexanoylmethaiie (11):
2-Dimethylaminomethylcyclohexanone (19.5 g, 0.125 mol) and cyclohexanone 
(37 g, 0.38 mol) were mixed and refluxed (oil bath at 205 °C, 1.5 h), and the 
resulting mixture was distilled under vacuum. The fraction collected at 90-100 
° C /100 mToor was colourless oil (20.75g). Hexane (25mL) was added to the oil 
and mixture was cooled to -30 °C overnight. A white solid was collected and 
washed with cold hexane (3 x 15 mL). The colourless solid product was 
obtained: yield 14.63 (56.2%).'H NMR (CDCL3:400 MHz 209K): 8 = 1.0- 
2.4(m, 20H): l3C NMR (DCM, 400MHz R.T.): 24.37, 24.60, 27.56, 29.11, 
29.88, 33.88,34.68,41.44,41.77,47.18,48.33, 212.33,212.83.
Sym-Octahydroacridine (12):
Hydroxylamine hydrochloride (7.63 g, 0.11 mol) was added with stirring to a 
boiling solution of 2, 2-Dicyclomethane (14.13g, 0.068mol) in EtOH (100 Ml). 
The mixture was refluxed (20 min), after cooling, the ethanol was removed 
under reduced pressure, and 25 mL o f water was added to dissolve the residue. 
A solution of NaOH (5.00g) in water (25mL) was added at 0 °C to bring the pH 
of the solution to 13.5. The solid that appeared was collected, washed with water 
and dried. Yield 11.7 g (92. 2%).‘H NMR (CDCL3-d3:400 MHz R.T): 5 = 7.00 
(s 1H, aromatic-H), 2.80(m, 4H, J = 6.2 Hz), 2.6(m, 4H, J = 6.3 Hz), 1.8(m, 4H 
J = 6.2 H z ), 1.6(m, J = 6.2 Hz), 13C NMR (DCM, 400MHz R.T.): 22.53, 22.95, 
27.98, 31.75, 128.85, 137.14, 153.51.
Sym-Octahydroacridine N-Oxide (13):
o
A mixture of sym-Octahydroacridine (11.50 g, 0.062 mol) and 3- 
chloroperoxybenzoic acid (17.75 g, 77% max) in CHCI3 (100ml) was stirred 
(17h) at 23 °C. The resulting reaction mixture was extracted with NaHC03 
(32.50 g) and Na2C 03 (15 g) in water (350 mL). The aqueous phase (pH = 8.5)
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was washed with CH2CI2 (2 x 75 mL), and the chloroform and dichloromethane 
solutions were combined and dried with anhydrous sodium sulphate. After 
removal of the solvent at 23 °C under reduced pressure, the product sym- 
octahydroacridine N-oxide was obtained as a light yellow solid: yield 12.0 g 
(96.3%).'H NMR (CDCL3-d3: 400 MHz R.T): 6.7(s, 1H), 2.80(m 4H, J = 6.5 
Hz ), 2.6(m, 4H, J = 6.2 Hz), 1,8 (m, 4H, J = 6.4 Hz), 1,6 (m, 4H, J = 2.4 Hz,): l3C 
NMR(CDC13, 100MHzR.T.): 21.19,21.44,24.11,27.58,125.58,131.10.
1 ,2 ,3 ,4 ,5 ,6 ,  7 ,8-octahydroacridin-4-ol (14):
OH
Triflouroacetic anhydride (10.2mL, 0.072mol, 2.5 equivalent) was slowly added 
to a stirred solution of octahydroacridine N-oxide (5.85g, 0.029mol) in dry 
DCM (50M1) causing a slight increase in temperature o f the solution. The 
solution was allowed to stir for a further hour at room temperature. The volatiles 
were then removed under reduced pressure to leave a yellow viscous residue, 
which was taken up in 20ml DCM. This was then saponified by the addition of a 
2M solution of sodium carbonate, the biphasic mixture being vigorously stirred 
for 3 hours. The organic phase was then separated and the aqueous phase 
washed twice with DCM. The combined organic extract extracts were then 
washed with water and brine and then dried over magnesium sulphate. The 
solvent was removed to give octahydroacridine-4-ol (4.98g, 85%). *H NMR 
(CDC13, 400MMHZ, 8): 7.05(s, IH, ArH), 4.55(m, 1H, J = 5.5 Hz CHOH), 
4.05(broad, 1H, CHOH), 2.8(m, 2H, J = 6.3 Hz CH2), 2.7(m, 4H, J = 5.9 Hz 
CH2), 2.2(m, 1H, J = 3.2 Hz CH2), 1,6-2.0(m,7H, J = 4.8 Hz CH2). 13CNMR 
(CDC13, 100MHz, 8): 154.86, 154.35, 137.5, 130.97, 128.55, 68.36, 31.88, 
31.15,28.42,27.99,23.16,22.79, 19.39.
4-chlorooctahydroacridine (15):
Cl
Thionyl chloride (15mL) in CHCI3 (15mL) was added to a solution of 
octahydroacrin-4-ol (7g, 0.0345mol) in 25mL DCM. The mixture was stirred at
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room temperature for 10 minutes, and then refluxed for an hour at 80 °C. The 
excess thionyl chloride and volatile by-products were then removed under 
reduced pressure and the residue dissolved in DCM (75mL). The solution was 
then extracted with Na2CC>3 (7.5g) in water (125mL) and the aqueous phase (pH 
8.5) was washed with DCM (2xl00m L). The DCM extract was then dried with 
Na2CC>3 and the solvent removed under reduced pressure to give a yellow solid 
of 4-chlorooctahydroacridine (4.90g, 64%). !H NMR (CDCI3, 400MMHz, 
298K): 7.05 (s, 1H, ArH), 5.20 (m, 1H, J = 2.8 Hz CHC1), 2.55-2.95(m, 6H, J =
4.7 Hz, CH2), 2.05-2.35(m, 3H, J = 2.9 Hz CH2), 1.65-1.85 (m, 5H, J = 4.3 Hz 
CH2). I3CNMR (CDCI3, 100MHz, 5): 155.53, 151.22, 137.96, 132.35, 128.97, 
59.44, 32.65, 32.24, 28.60, 27.54, 23.15, 22.65, 17.42.
l-mesityl-3-octahydroacridinimidazoliiim chloride (16):
4-chlorooctahydroacridine (l.OOg, 4.5mmol) and mesityl imidazole (0.84g, 
4.5mmol) were placed in an ACE pressure tube with 10 mL THF. The mixture 
was refluxed at 90 °C for 10 days as a dark precipitate formed. The precipitate 
was filtered and washed with Et2 0  (4x1 OmL) to give the imidazolium salt as an 
off-white solid (0.15g, 8%). The filtrate was placed back under reflux where it 
continued to react further over time. Anal. Calcd. for C25H29N3CI: C, 73.80; H, 
7.13; N, 10.33%. Found: C, 65.65; H, 7.11; N, 8.98%. 'H NMR (CDC13, 
400MMHZ, 298K): 10.15 (s, 1H, NCHN), 8.18(s, 1H, CHHC), 7.65(s, 1H, 
CHHC), 7.20(s, 1H, ArH), 6.95 (s, 2H, ArH), 6.55 (d, 1H, J = 9.7 Hz CHN), 
1.80-3.40 (m, 23H, CH2, CH3). M S (ES) m/z (%): 372.3(29) [M-C1]+; MS (ESI) 
m/z (%): found 372.3424 [M-C1]+; expected: 372.5333.
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2.4.8 Crystal structure solution
All single crystal X-ray chromatographic determinations presented in this study 
were kindly performed by Dr. Dirk Beetstra and Dr. Benson Kariuki at the 
Cardiff University.
X-ray data collection was carried out at 150K on a Bruker/Nonius Kappa CCD 
diffractometer using graphite monochromated Mo-Ka radiation, equipped with 
an Oxford Cryostream cooling apparatus. The data was corrected for Lorentz 
and polarization effects and for absorption using SORTAV [36]. Structure 
solution was achieved by direct methods [37] and refined by full matrix least -  
square on F2 with all non- hydrogen atoms assigned anisotropic displacement 
parameters. Hydrogen atoms attached to carbon atoms were placed in idealised 
positions and allowed to ride on the relevant carbon atom. In the final cycles of 
refinement a weighting scheme that gave a relatively flat analysis o f variance 
was introduced and refinement continued until convergence was reached. 
Structure refinement and final geometrical calculations were carried out with the 
SHELXL-97 [38] program implemented in the WinGX and the diagrams were 
generated using the ORTEP-3 for windows [39] program.
Table 2.9: Crystal data and structure refinement for 4
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated) 
Absorption coefficient
C 2 2 H 1 9 F 6 N 4 P  
484.38 
150(2) K 
0.71073 A 
Triclinic 
P - l
a = 7.8550(3) A 
b = 8.300(3) A 
c =  16.4760(8) A 
1022.59(7) A3
2
1.573Mg/m3 
0.208mm-1]
a  =75.6640(10)° 
P = 82.7570(10)° 
y = 80.586(2)°
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F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness of theta = 35.01° 
Absorption correction 
Max and min. transmission 
Refinement method 
Data/restraints/parameters 
Goodness of fit on F 
Final R indices [I>2 sigma(I)]
R indices (all data)
Largest diff. peak hole
Table 2.10: Crystal data and
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
Z
Density (calculated) 
Absorption coefficient 
F000
Crystal size
496
0.30 x 0.10 x 0.10 mm3 
2.56 to 35.01 o
- 12<=h<= 12, -13<=k<=13, -26<=1<=26 
12823
8815 [Rint = 0.745]
97.7%
Semi-empirical from equivalents 
.9795 and 0.9403 
Full matrix least square on F 
8815/0/298
1.029
R1 = 0.0802, wR2 = 0.1579 
R1 =0.1888, wR2 = 0.1992 
0.364 and-0.573e A’3 
structure refinement for 6b
C 1 9 H 1 6 B N 3 F 4
373.16 
150(2) K 
0.71073 A 
Triclinic 
P - l
a = 7.1833(2) A a =82.4233(9)°
b = 7.9742(2) A p = 79.9094(10)°
c = 16.0924(4) A y = 76.9424( 11)°
879.97(4) A3 
2
1.408Mg/m3 
0.114m m -1 
384
0.08 x 0.25 x 0.35 mm3
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Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness of theta = 26.13° 
Absorption correction 
Max and min. transmission 
Refinement method 
Data/restraints/parameters 
Goodness of fit on F 
Final R indices [1>2 sigma(I)]
R indices (all data)
Largest diff. peak hole
2.945 to 27.506 0
-9<=h<=9, -10<=k<=10, -20<=1<=20 
14794
3998 [Rint = 0.120]
99.50%
Semi-empirical from equivalents 
0.9900 and 0.9700 
Full matrix least square on F 
3998/0/245 
1.2019
R1 = 0.0793, wR2 = 0.1677 
R1 = 0.0578, wR2 = 0.1560 
0.400 and-0.370e A '3
Table 2.11: Crystal data and structure refinement for 6C
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated) 
Absorption coefficient 
F000
Crystal size
Theta range for data collection
C 1 3 H 1 2 I N 3
337.16 
150(2) K 
0.71073 A 
Monoclinic 
P 21/C
a = 7.2140(10) A 
b =  19.3630(3) A 
c =  11.5400(2) A 
1290.16(3) A3 
4
1.736Mg/m3 
2.464mm-1 
656
0.68 x 0.25 x 0.25 mm
3.01 to 27.50°
a  =90.00°
P =  126.8350(10)° 
y = 90.00°
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Index ranges 
Reflections collected 
Independent reflection 
Completeness of theta = 27.50° 
Absorption correction 
Max and min. transmission 
Refinement method 
Data/restraints/parameters 
Goodness of fit on F 
Final R indices [I>2 sigma(I)]
R indices (all data)
Largest diff. peak hole
-9<=h<=9, -25<=k<=25, -14<=1<=14 
18959
2943 [Rint = 0.1107]
99.50%
Semi-empirical from equivalents 
0.5779 and 0.2851 
Full matrix least square on F 
2943/0/153 
1.071
R1 = 0.0360, wR2 = 0.0737 
R1 = 0.0305, wR2 = 0.0702 
0.643 and-1.089e A '3
Table 2.12: Crystal data and
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated) 
Absorption coefficient 
F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected
structure refinement for 9b
C22H22BF4N3
415.24 
150(2) K 
0.71073 A 
Monoclinic 
P 21/C
a = 9.8460(4) A 
b =  12.5190(6) A 
c =  17.2380(7) A
2120.81(16) A3
4
1.300Mg/m3 
0.01 mm-1 
864
0.30 x 0.30 x 0.20 mm3 
2.663 to 27.47 0
-12<=h<=12, -14<=k<=16, -22<=1<=22 
8027
a =90.00° 
p = 93.507(3)° 
y = 90.00°
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Independent reflection 
Completeness of theta = 27.47° 
Absorption correction 
Max and min. transmission 
Refinement method 
Data/restraints/parameters 
Goodness of fit on F 
Final R indices [I>2 sigma(I)]
R indices (all data)
Largest diff. peak hole
4825 [Rint = 0.559]
99.30%
Semi-empirical from equivalents 
0.9800 and 0.9702 
Full matrix least square on F 
4825/267/302 
1.028
R1 = 0.1366, wR2 = 0.1814 
R1 =0.0650, wR2 = 0.1476 
0.263 and-0.320e A’3
Table 2.13: Crystal data and
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness of theta = 27.42° 
Absorption correction
structure refinement for 9c
c , 6h 18i n 3
379.23 
150(2) K 
0.71073 A 
Monoclinic 
P C
a =  11.2770(4) A a  =90.00°
b = 12.300(5) A p = 90.100(5)° 
c =  11.5370(4) A y = 90.00°
1600.26(10) A3
4
1.574Mg/m3 
1.996mm-1 
752
0.30 x 0.22 x 0.15 mm3 
3.02 to 27.42°
-14<=h<= 11, -10<=k<=15, -14<=1<=14 
8017
5779 [R^t = 0.287]
92.30%
Semi-empirical from equivalents
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Max and min. transmission 
Refinement method 
Data/restraints/parameters 
Goodness of fit on F2 
Final R indices [I>2 sigma(I)] 
R indices (all data)
Largest diff. peak hole
0.7339 and 0.5859 
Full matrix least square on F2 
5779/50/306 
1.055
R1 = 0.0627, wR2 = 0.1040 
R1 = 0.0434, wR2 = 0.0939 
1.046 and-0.934e A'3
Table 2.14: Crystal data and
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness of theta = 27.442° 
Absorption correction 
Max and min. transmission 
Refinement method
structure refinement for 9f
C23H,oC1N4 
386.86 
150(2) K 
0.71073 A 
Monoclinic 
P 1 21/n 1
a = 8.34480(10) A a =90.00°
b = 20.0690(4) A p = 95.5741(8)° 
c =  11.4953(2) A 7 = 90.00°
1916.04(6) A3 
4
1.341 Mg/m3 
0.216mm-1 
808
0.20 x 0.25 x 0.25 mm3
2.030 to 27.422 0 
-10<=h<=10, -24<=k<=26, -14<=1<=14 
30860
4358 [Rint = 0.189]
99.70%
Semi-empirical from equivalents 
0.9600 and 0.9500 
Full matrix least square on F2
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Data/restraints/parameters 
Goodness of fit on F2 
Final R indices [I>2 sigma(I)] 
R indices (all data)
Largest diff. peak hole
2307/0/254
0.9465
R1 =0.0422, wR2 = 0.1019 
R1 =0.0792, wR2 = 0.1145
0.29 and-0.29e A'3
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CHAPTER THREE 
Siver(I) and Palladium(II) complexes of quinoline functionalised 
Heterocyclic Carbene ligands. 
3.1 Silver(I) (NHC) complexes
3.1.1 Introduction
The synthesis of Ag‘(NHC) was first reported by Arduengo in 1993 using the 
free carbene route [1]. This was accomplished by deprotonation of the 
imidazolium salt 3.01 to make the free carbene (1, 3-dimesitylimidazolin-2- 
ylidene) 3.02 and subsequent reaction o f 3.02 with silver triflate to yield the 
desired homoleptic A g’(NHC) 3.03. Several other Ag'CNHCs) have been 
synthesised using this method [1, 2, 3,4,5, ]. However, this method has been 
applied to the synthesis o f only a limited number Ag'(NHC) due to the difficulty 
of generating most free carbenes , which have other acidic protons especially 
azolium salts with methylene linkers [6 ].
Mes Mes
N KH or KOtBu
N
\
Mes
r-'N
D - -N
Ag(OTf)
Mes
MesMes
Mes Mes
3.01 3.02 3.03
Scheme 3.0: Synthesis of Arduengo homoleptic Ag carbene complex
Ag’(NHC) can also be accessed by transmetallation. Transmetallation of the 
NHC ligands to AgPF6 yielding homoleptic imidazolindin-2-ylidene complexes 
3.04-3.06 was also reported [7].
The in situ deprotonation o f imidazolium salts with basic silver precursors is the 
most commonly used method to synthesise Ag’^ H C )  complexes. In their 
reaction Bertrand et al demonstrated that Ag(OAc) reacts with 1,2,4-triazolium
+
OTf
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salts producing polymeric A g!( l,2,4-triazolin-3,5-diylidene) complexes with 
alternating Ag1 and l,2,4-triazolin-3,5-diylidene units [8]. The use of Ag(OAc) 
protocol has not been widely utilised with the reports of A g ^ H C )  complexes 
being restricted to a few examples with symmetrically alkyl substituted NHCs.
Kl
Cr—(CO)5
AgPF e
N
R
R
\
R R
PFe
3.04: R = Et 
3.05: R -  allyl 
3.06: R = benzyl
Scheme 3.2: Synthesis of Ag'(NHC) via transmetallation
The most commonly used base is silver (I) oxide, pioneered by Lin and Wang 
[9]. These workers reported that stirring 1, 3-diethylbenzimidazolium bromide 
with Ag20  in DCM, or with AgBr and NaOH under phase transfer conditions 
gave the Ag1(benzimidazollin-2 -ylidene)2 complexes 3.07 and 3.08 in high 
yield, Scheme 3.3.
(X>
Br'
\
Et
Ag2Q
DCM
3.07: X = AgBr2"
3.08: X = PF6-
Scheme 3.3: Wang and Lin’s preparation o f Ag1(benzimidazolin-2-ylidene)2 
complexes via silver(I) oxide.
The principle advantage of the Ag2 0  protocol is its tolerance to oxygen and 
moisture, indeed water is the by-product o f the reaction. There are in fact reports
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of the reactions being carried out at ambient temperature, in a variety of solvents 
including water [10-12]. The formation of silver complexes in water suggests 
that the deprotonation o f the imidazolium salt and coordination to metal centre 
is a concerted process because free carbenes are water sensitive [13]. Several 
groups have successfully prepared a variety A g!(NHC) complexes through the 
application of the Ag2 0  method o f Wang and Lin with different kinds of 
imidazolium salts [14-21]. Modification o f Wang and Lin’s original method 
used dichloroethane as solvent [17], thereby allowing the reaction to be carried 
out at elevated temperatures for less reactive imidazolium salts.
In the cases where the imidazolium salts are insoluble in DCM, the use of 
solvent mixtures such as DCM-MeCN [22] and DCM -  EtOH [23] has been 
found to be useful. The reaction can also be performed in DMSO at 55°C as 
reported recently [24]. Furthermore, addition o f molecular sieves to the reaction 
has also been reported to facilitate the formation of Ag’(NHC) complexes by 
removing the water generated in the reaction as shown in Scheme 3 above [17]. 
Silver(I) carbonate was also reported to have been used in the synthesis of 
A g ^ H C ), though less effective than the Ag2 0  protocol as a longer reaction 
time is required for the reaction to reach completion [17]
McGuinness and Cavell reported the synthesis o f a series of mono donor- 
functionalised Pdn(NHC) by the use o f Ag2 0  protocol via the transmetallation 
Ag’(NHC) complexes 3.09 -  3.10 with appropriate palladium precursors [16].
Me'
/= \  5N. „N / V , / = \
Ag  AgBr2
MeN N
w
M e ^  X / " -------- " 'N '
Ag ..... i / a9'2
I
N ^ N " Me
w
3.09 3.10
Figure 3.10: Cavell carbonyl and pyridyl functionalised Ag (NHC) used to 
prepare Pd"(NHC) complexes
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The Cavell group also reported the application of the Ag20  protocol to 
synthesise phenoxy- functionalised [25], pyridyl-functionalised [26] and 
thiophene and furan-functionalised [27)Ag,(NHC) complexes. A range of 
imidazolium salts bearing a diverse variety o f functionalised groups have been 
shown to be compatible with the formation o f A g!(NHC) complexes via Ag2 0 . 
Thus, Ag!(NHC) complexes with amine [18], ferrocenyl [15], imines[17], amide 
[17] and alkoxy functionalised bis-NHC have been prepared through the Ag20 
route. Other Ag’(NHC) prepared were not isolated but used directly as 
transmetallation reagents [18].
The wide applicability and ease o f preparation o f stable A g ^ H C )  complexes 
via the Ag20  route and the good transmetallation properties of these complexes 
promised ready access to donor-functionalised NHC complexes of catalytically 
interesting transition metals [28]. The ability to obtain Ag](NHC) complexes 
from the reaction of Ag2 0  with imidazolium, saturated imidazolidinium and 
benzimidazolium salts indicates that their formation is relatively unaffected by 
the electronics of the heterocyclic ring [28].The reaction is also tolerant of steric 
group and a wide range functional groups on the NHC N-substituents.
Halogen exchange reactions have been found to occur when NHC complexes 
are synthesised in chlorinated solvents. Danopoulos and co-workers reported 
halide exchange reactions when synthesising A g!(NHC) in 1,2-dichloroethane 
or dichloromethane [17]. An example o f the halide exchange is depicted in 
Scheme3. 4. Similarly Lin and co-workers reported the salt metathesis of 
imidazolium iodide salts with chloride from methylene chloride during the 
synthesis of Ag'(NHC) complexes [22].
2Br
N+
Ag2Q
CICH2CH2CI
reflux
f = \
Scheme 3.4: Halide exchange in Ag (NHC) complex synthesis
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Mixtures o f halogeno and halide anions o f silver NHCs have been reported [18, 
29]. To reduce the complications due to inorganic halogeno complexes and 
cluster formation, anion exchange o f the imidazolium halide salt for a 
noncoordinating anion has been widely employed. After the anion exchange, the 
synthesis of the Ag'(NHC) proceeds cleanly to one product. Anion exchange of 
the halide after the synthesis o f the A g1(NHC) has also been performed using 
reagents such as AgBF4, to obtain clean products without the complexities of the 
halide [26,29,30,31].
Theoretical calculations o f group 11 NHC carbenes showed that the metal- 
carbene bond strengths follow the pattern Au > Cu > Ag [13]. While the bond 
strength of Ag'(NHC) complexes were shown to be relatively the weakest, the 
overall strength of 56. 5 Kcal/mol was considered strong enough to stabilise the 
Ag'(NHC) [32],
3.1.2 Structural diversity in Ag^NHC) complexes
The structural characterisation o f N-heterocyclic carbene complexes of silver 
has led to very complex bonding motifs in the solid state, especially in 
complexes with halide anions. The ability o f silver to form complex anions of 
the formula [AgX2]" (X = halogen), coordinate to either one or two NHC 
moieties and engage in Ag(I)....Ag(I) interactions in the solid state appear to 
account for most of this structural diversity. The interactions between Ag(I) and 
functional groups present on the NHC ligand are weak compared to most of the 
Ag(I)....Ag(I) interactions observed in Ag(I)NHCs.
Ag'(NHC) complexes with non coordinating anions exist as biscarbene salts 
with the cationic silver bound by two carbene moieties and the noncoordinating 
anion balancing out the charge (C2- Ag).
Studying the crystal structure o f their non functionalised Ag*(NHC) complex
3.07 Wang and Lin [9 ] reported a mononuclear complex with two NHC ligands 
coordinated to Ag(I) and the counter ion [AgBr2] coordinating through a
Ag(I) Ag(2) interaction above the plane of the cation. The Ag(I) Ag(2)
distance of 2. 954 A was found to be significantly shorter than the van Waals 
contact distance of 3. 44 A. and relatively short for an unsupported 
Ag(I) Ag(I) interaction [9].
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Another study o f non functionalised Ag*(NHC) complex 3.11 revealed a linear 
NHC-Ag(I)-NHC m otif with coordinated [AgBr2]- counterion almost 
perpendicularly aligned [22]. Other structural studies of Ag*(NHC) complexes 
revealed mono NHC complexes with coordination anions or uncoordination 
anions. For example, in 3.12 the C2-Ag-X strings deviate from linearity [5, 21].
3. 13 [19] and 3.14 [22] may therefore be considered to be aggregated 3.12 
motifs formed due to A g...X  and weak A g...A g interactions between adjacent 
molecules. As a result o f alternating Ag-Br and Br-Ag units in the solid state, 
the bond length around Ag2Br2 rhomboids in 3.14 are unequal.
Ag'(NHC) complexes that have donor functionalised group feature most of the 
structural diversities observed in the non functionalised counter parts. In 3.15 
the [AgBr2]- counter ion is coordinated to the pyridine functionality of one of 
the NHC ligands that make up the linear NHC-Ag(I)-NHC unit [17]. Other 
reported examples are shown in structures 3.16 and 3.17 where they exhibited 
rhomboid Ag^B^ and linear NHC-Ag(I)-X geometries respectively [17]. Also 
reported is a dinuclear A g!(NHC) complex 3.16 with Ag2L2 formulation [3]. 
The structure of 3.18 is that o f double helical unit with the C2-Ag-C2 strings 
distorted by 14.5° from the linear orientation because of relatively rigid ligands 
Ag...Ag’ bonding interaction is present and brings the these atoms to within 
3.158A.The pyridyl group o f each ligand is equidistant to Ag, Ag’ at a distance 
o f 3.02A. Structure 3.19 is a trinuclear pyridyl functionalised Ag*(NHC) 
complex obtained by the reaction o f 3 -methyl-1-picolylimidazolium iodide with 
2.5 eq mole of Ag20  in DCM[33]. The geometry at the silver centre is planar, 
with every Ag coordinated by two carbene atom and one triply bridging iodine. 
The three Ag(I) cations are linked by the bridging 1(1) anion symmetrically with 
an A g(l)-I(l) distance o f 3.04 A which is more longer than those o f the Ag- 
I(bridging) bonds 2.83 and 2.78 A [37], and the net charge of 2+ is balanced by 
two non interacting iodide ions [33].
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Ag' \B z  
✓Bz Me
M e-N
Me
N —
3.18 3.19
Figure 3.11: Bonding motifs in A g’(NHC) complexes
Ag...Ag interactions have not been observed in A g‘(NHC) complexes that have 
been prepared in the absence o f coordinating halide anions. In Ag’^NHC) 
complexes with triflate [1,3,8], barf[15], nitrate[22], and carborane [4] anions, 
homoleptic [Ag'(NHC)2]X complexes are formed with quasi-linear C2-Ag-C2 
strings.
3.1.3 Ag^NHC) complexes as transmetallation reagents
The use of Ag*(NHC) in homogenous catalysis has recently appeared in the 
literature: such as in the preparation o f 1,2-bis(borane) esters [34], ring opening 
polymerization of lactides [ 35 , 36 ] and olefin polymerization [37]. However, 
the increased interest in the chemistry o f A g’CNHC) complexes has been mainly 
due to their role as transfer agents in the development o f many important metal- 
NHCs.The fact that active hydrogen atoms other than C2-H can be protected 
effectively by this method solved difficulties encountered in the synthesis of 
metal- NHCs by other methods [16,18, 26,38]. NHC ligands have thus been 
transferred from Ag'(NHC) complexes to a variety o f metals including Cr111, 
Fem, Co", Ni" [38], Cu1 [1], Cu" [39], Pd" [9,14, 16,18,39,40,], Au1 [9,23],Rh' 
and Ir1 [41].
Transmetallation may be carried out using isolated A g ^ H C )  complexes or 
conveniently performed in a one pot protocol where the Ag'(NHC) complex is
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generated from an imidazolium salt and Ag20  and then reacted in situ with a 
precursor of the desired metal. The transfer o f NHC depends on the nature of
3.2.0 Palladium (II) complexes of quinoline functionalised 
heterocyclic carbene ligands
Pd"(NHC) carbene complexes were first reported in 1995 by Herrmann [42] by 
the reaction of Pd(OAC)2 with 1,3,-dimethylimidazolium iodide to give 3.20 and 
3, 3-dimethyl-1,1-methylenediimidazolium diiodide to give 3.21 as shown in 
scheme 3.5. It was discovered that these new palladium complexes were stable 
to heat, air and moisture. In addition to this, these complexes were found to be 
excellent catalysts in Heck reactions.
As enumerated in chapter 1 NHCs exhibit properties that are complimentary to 
their application as ligands in catalysis. They are more strongly bonded to 
transition metals such as Pd than the widely used phosphine ligands [42, 43], 
and thus required only in stoichiometric amounts, and in general Pdn(NHC) 
complexes are less toxic, easier to handle and exhibit better thermal stability 
than typical phosphine ligands.
Ag'(NHC), the receiving metal precursors and the reaction conditions.
/
2
N +
Pd(O Ac)
\ -2 AcOH
+ Pd(O Ac)
3.20
-2 AcOH
3.21
Scheme 3.5: Herrmann’s synthesis o f 3.20 and 3.21.
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Following the discovery o f the qualities of complexes 3.20 and 3.21, there was 
renewed interest to explore catalytic applications of the Pdn(NHC) system 
through modification o f the NHC ligands. Among the important ligand design 
was the combination o f the strongly bound NHC moiety with more weakly 
nucleophilic functional groups allowing access to ligands with hemilabile donor 
groups, as these can increase catalytic activities by stabilising the low- valent 
metal centres formed during catalysis. Along this line several Pdn(NHC) 
complexes were reported bearing one or two functionalised substituents with 
carbamoyl ( 3.22 [44,45]), ester (3.23[46] and 3.24[47]), ethers (3.25[48]), 
hydroxyl(3.26 [42], 3.27 [48]), oxazoline(3.28[49]), picolyl(3.29 [50]), pyridyl 
(3.30 and 3.31 [51], 3.32 [52] ),imine 3.33 [53] groups Figure 3.12.
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I— Pd— | |— Pd----
3.28
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Me— P d -NI
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Figure 3.12: Structurally characterised examples of some reported Pd(II) 
complexes bearing functionalised NHC ligands.
Many synthetic routes have been employed to synthesise Pdn(NHC) complexes 
and these have been outlined in chapter one. The routes to be used depend on 
the nature of available imidazolium salts. The Pd(OAc)2 route is among the 
many routes available and is suitably for simple mono and bis imidazolium salts 
as shown by Herrmann in Scheme 3.5 above but does not give access to 
catalytically important Pd- hydrocarbyl species. Pdn(NHC) complexes can also 
be prepared via the free carbene route by the use of strong bases such as NaH 
with catalytic amounts o f KOtBu and amides ( K[N(SiMe3)2] ). Once the free 
carbene is formed, it can be reacted with appropriate metal source such as 
PdCbCCOD) to produce the desired Pdn(NHC) complexes. However free 
carbenes are known to be unstable especially in the absence of bulky aryl or 
alkyl groups on the 1 and 3 positions o f the ring thereby making the route 
unsuitable in the synthesis o f some Pdn(NHC) complexes. The use of strong 
bases have been found to be unsuitable in accessing functionalised carbenes 
because of acidic protons commonly associated with functional group and any 
methylene linkers.
The chapter also reports the synthesis and characterisation of quinoline 
functionalised Ag‘(NHC) complexes. X- ray crystallographic studies have been
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earned on two o f the A g ^ H C )  complexes prepared in this work and the data 
obtained compared with the published examples. The reported A g ^ H C )  
complexes were synthesised primarily as transmetallation reagents to access the 
catalytically important quinoline functionalised Pdn(NHC) complexes and Ir1 
and Rh'(NHC) complexes.
Also described in this chapter are the Pd“(NHC) complexes synthesised via 
transmetallation o f the desired Ag'fNHC) complexes and the complexes were 
characterised spectroscopically and by micro analysis.
3.3 Results and Discussion
3.3.1 Silver (I) complexes of quinoline functionalised NHC
ligands
General comments
Quinoline functionalised imidazolium salts described in chapter two were 
reacted with Ag20  to give stable complexes with the general formula 
[Ag1(NHC)2][AgX2] or A g1(NHC)X based on the two x-ray structures of the 
complexes obtained. No attempt was made to abstract halide to isolate the 
Ag’(NHC) complexes as salts o f non coordinating anions such as 
tetraflouroborate, hexaflourophophate or triflate to improve solubility or purity 
of the complexes. For the purpose o f clarity the quinoline based A g ^ H C )  
complexes described below are divided into two: the methylene bridged and the 
rigid quinoline Ag'CNHC) complexes.
3.3.1.1 Silver(I) complexes of rigid quinoline functionalised NHC 
ligands
Two quinoline functionalised imidazolium salts (6b and 6c) were reacted with 
Ag20  to give the corresponding A g!(NHC) complexes. Two equivalent o f the 
imidazolium salt 6b was reacted in DCM with one equivalent of Ag20  overnight 
at room temperature until the black suspension o f Ag20  disappeared. The 
reaction was performed free o f light as most Ag1(NHC) complexes are light 
sensitive . After work up , the A g’CNHC) complex 3.34 was obtained as a light 
brown powder. The room temperature *H NMR of complex 3.34 was consistent 
with the proposed structure with no evidence o f residual imC2-H resonance.
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N.x  N
+ Ag2Q
DCM
room temp.
6b: R = PhCH2, X = Br 
6c: R = Me, X = I
R'
Ag N
3.34:R = PhCH2, X = Br 
3.35: R = Me, X = I
Scheme 3.6: Synthesis o f rigid quinoline functionalised Ag*(NHC) complexes
The proton peak of the methylene linker o f the benzyl moiety was shifted 
upfield (5.35 ppm) relative to those o f the corresponding imidazolium salt (5.85 
ppm). The carbenic carbon could not be observed in the 13 NMR spectra and this 
is consistent with some o f the reports that appeared in the literature as a 
significant number o f silver^ NHC) complexes were reported with no 
observable carbene resonances [8], Elemental analysis returned a satisfactory 
result for complex 3.34. Crystals suitable for X-ray chromatography were not 
obtained but the analytical data as well spectroscopic data are consistent with 
the proposed structure. Complex 3.35 was characterised by *H NMR, mass 
spectroscopy and micro analysis. The characteristic feature confirming the 
formation of the silver^ NHC) complex is the disappearance o f C2-H in the 1 H 
NMR spectra.
3.3.1.2 Silver(I) complexes of methylene-bridged quinoline 
functionalised NHC ligands
The methylene-bridged quinoline functionalised Ag'(NHC) complexes were 
prepared following the method reported by Wang and Lin [9], i.e. by interaction 
of the imidazolium salts with Ag2<3 as shown in scheme 3.7.
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+ Ag20 DCM
9a : R = Me, X = Cl 
9b : R = Mes, X = Cl 
9c : R = ipp, X = I 
9d : R = n-Bu, X = I
3.36 : R = Me, X = Cl
3.37 : R = Mes, X = Cl
3.38 : R = ipp, X = I
3.39 : R = n-Bu, X = I
9e : R = PhCOC(Me)2, X = Cl
3.40 : R = PhCOC(Me)2, X = Cl
3.41 : R = QuinCH2, X = Cl
9f : R = QuinCH2, X = Cl
Scheme 3.7: Synthesis o f methylene bridged quinoline functionalised 
A g ^ H C )  complexes
It was found that: (i) with the relatively unreactive sterically hindered 
imidazolium salts (9e and 9f ) the reaction was carried out in refluxing 
dichloromethane, whereas for all other imidazolium salts the reaction occurred 
at room temperature ; (ii) synthesis in refluxing dichloromethane increases the 
formation of by-product (iii) the purity o f the product is improved by addition of 
activated molecular sieves to the reaction medium.
Compound 3.36 was characterised by NMR, 13 NMR, microanalysis and X- 
ray crystallography. The room temperature *H NMR of Complex 3.36 was 
consistent with the proposed structure showing complete disappearance o f imC2- 
H resonance and the protons o f the methylene linker was observed to move up 
field. In the 13C NMR there was sharp singlet peak at 181.18 ppm which is 
assignable to the carbene carbon o f the A g1(NHC) complex. Microanalysis 
returned satisfactory results for complex 3.36.
Crystals suitable for X- ray structural determination were obtained by diffusing 
Et20  into a DCM solution o f the complex. The crystal structure is depicted in 
figure 3.13 below.
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C13
C14
Figure 3.13: ORTEP projection o f complex 3.36 excluding hydrogen atoms for 
clarity showing atom labelling scheme.
Complex 3.36 as shown in the above figure consists o f a linear [Ag(NHC)2]+ 
cation and a linear [AgC^]" with the two ions associating through Ag1- Ag1 
interaction. The Ag-C bond distance (A g(l)-C (l) = 2.106(12) are comparable to 
those reported by Wang and Lin (2.073 A) [8]. The geometry o f C (l)-A g(l)- 
C(l_2) is close to linear (170.8°(8) though it is lower than what was obtained by 
Wang and Lin (175.6°) [8]. The Ag(l)-Ag(2) separation o f 3.201 A is smaller 
than the contact van de Waals distance o f 3.44A and is at upper range o f the 
ligand-unsupported Ag-Ag bond lengths (range 2.80-3.30 A) [54]. The Cl(l)- 
Ag-Cl(l) angle o f 176.6° deviates only slightly from that of the coordinated 
linear species. Some selected bond lengths (A) and angles (o) are presented in 
table 3.1 below.
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Table 3.1: Selected bond lengths (A) and bond angles (°) of 3.36
Agl- Ag2 3.201(4) N2-C5 1.48(2) Cl-Agl-Ag2 94.6(4)
Ag2-Cll 2.290(5) N2-C1-N1 104.0(10) Cl-Agl-Ag2 85.4(4)
A gl-Cl 2.106(12) N 2-C l-A gl 130.6(8) Cl 1-Agl-Cl 1 176.6(11)
C l-N l 1.353(16) N l-C l-A g l 125.2(9) C3-C2-N1 107.8(11)
C1-N2 1.351(14) C l-A g l-C l 170.8(8) C1-N2-C5 119.3(10)
The !H NMR spectrum o f complex 3.37 shows the disappearance of C2-H signal 
with other signals consistent with the proposed structure. The 13C NMR 
spectrum reveals the absence o f Ccarbene resonance and the elemental analysis 
returned satisfactory results. A ES-MS showed a peak corresponding to cation 
[ M+-C1 =328.15] with intensity o f 100% similar to that o f the corresponding 
imidazolium salt indicating that under these conditions the silver complex 
undergoes decomposition .This decomposition o f silver(NHC) complexes and 
the observation of the corresponding o f the corresponding salts has been 
reported using ES-MS [55]. Crystals suitable for X-ray chromatography were 
obtained by diffusion of Et20  into a saturated DCM solution of the complex and 
the crystal structure is depicted in Figure 3.14 below. The geometry o f the silver 
in the carbene complex is that o f distorted linear with Cl 3- Agl-C12 bond angle 
of 169.03° (10) which is similar to the silver carbene complex reported by Cesar 
and Gade
(169.4° (1)) [56] and lower than those reported by Danopoulos et al (176.1°(2)) 
[17], Pytkowicz etal (175.2°(5» [39] and Paas et al (173.5°(2)) [57]. All other 
bond lengths and bond angles are consistent with the reported values [17,39, 56, 
57]. Some selected bond length and bond angles are presented in table 3.2 
below.
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C18 /  
C1(}X "y
C21 S*c2:
S  Cl 
C19
Figure 3.14: ORTEP projection o f complex 3.37 excluding hydrogen atoms for 
clarity showing atom labelling scheme.
Table 3.2: Selected bond lengths (A) and bond angles (°) of 3.37
Agl-C12 2.350(9) N5-C14 1.320(5) Agl-C13-Nl 1 123.7(3)
Agl-C13 2.090(3) C4-C16 1.344(5) N3-C13-N11 104.9(3)
N3-C13 1.342(5) C4-N3 1.384(4) N3-C6-C14 111.6(3)
N11-C13 1.354(4) C13-Agl-C12 169.03(10) C13-N11-C22 122.6(3)
N3-C6 1.474(4) Agl-C13-N3 131.4(2) C6-C14-N5 116.2(3)
The formation of complexes 3.38, 3.39 3.40 and 3.41 were confirmed by *H 
NMR and 13C NMR spectroscopy. The NMR revealed complete 
disappearance of the C2-H protons while the Ccart>ene of complexes 3.38, 3.39 and
3.41 appeared at 184.10, 183.23 and 180.37 ppm respectively, that of complex
3.40 was not observed. High resolution mass spectroscopy of complex 3.41 
indicated only the decomposition o f the complexes as only the its corresponding 
imidazolium salt ions was observed at M/z = 351.16 (100% intensity) equivalent
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to [(NHC)+H]+. !H NMR and 13C NMR spectra o f complex 3.38 are consistent 
with the bis carbene formulation with the Ccarbene o f the complex appearing at 
184.10 ppm. HRMS showed cluster at M/z = 609.1886 (100% intensity) 
attributable to [Ag(NHC)2]+ o f the bis carbene. The lH NMR and 13C NMR data 
of complexes 3. 36-3.41 is presented in Table 3.3 below.
Table 3.3: *H and 13 NMR data o f complexes 3.36-3.41
Compound 'H NMR at 298K 13C NMR(Ag- 
C)
[Ag(NHC)2]+[AgCl2]-
3.36
H, 3.55; N, 11.46; Cl, 9.67%. Found: 
C, 45.71; H, 3.45; N, 11.33; Cl, 
9.60%. 'H  NMR (CDCI3. 400MHZ, 
298K): 8.10 ( d, 2H, J = 8.5 Hz, 
Quin-H ), 8.00 ( d,2H, J = 8.4 Hz, 
Quin-H ), 7.80 ( d, 2H, J = 8.1 Hz, 
CHHC ), 7.5 ( d, 2H, J = 8.4 Hz, 
Quin-H ), 7.35 (d, 2H, J = 1.7 Hz, 
Quin-H ) 7.15 ( d, 2H, J = 1.8 Hz, 
Quin-H ), 6.95 ( s ,lH , Quin-H), 5.50 
( s, 4H CH2 ), 3,85 ( s, 6 H, CH3).
181.18
[Ag(NHC)Cl] 3.37
'H NMR (CDC13. 400MHZ, 298K) : 
8.10 ( d, 1H, J = 8.4 Hz, Quin-H), 
8.00 ( d, 1H, J = 8.5 Hz, Quin-H ), 
7.80 ( d, 2H, J = 8.1 Hz, CHHC ), 
7.70 ( t, 1H, J = 1.4 Hz, Quin-H ), 
7.50 ( t, 1H, J = 7.0 Hz, Quin-H ), 
7.35 ( t, 2H, J = 8.7 Hz, Quin-H ), 
6.90 ( s, 3H, Aromatic-H ), 5.60 ( s, 
2H, CH2 ), 2.25 ( s, 3H,
m-CH3 ), 1.95 ( s, 6 H, o-CH3 ).
N.A.
[Ag(NHC)Cl] 3.38 'H NMR (CDC13. 400MHz, 298K):
-
184.10
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8.05(d, 2H, J = 8.5 Hz, quin-H), 
7.65(t, 2H, J = 7.0 Hz, quin-H), 
7.50(d, 2H, J =5.2 Hz, quin-H), 
7.10(s, 1H, CHHC), 6.90(s, 1H, 
CHHC), 5.60(s, 2H, NCH2C), 
4.85(m, 1H, NCHC), 1.35(d, 6H, J = 
6.8  Hz, CH3).
[Ag(NHC)Cl] 3.39 'H NMR (CDCI3. 400MHZ, 298K): 
8.00(d, 1H, J = 8.5 Hz quin-H), 
7.90(d, 1H, J = 8.5 Hz, quin-H), 
7.60( m, 2H, J = 8.1 Hz, quin-H), 
7.55(d, 1H, J = 8.5 Hz, quin-H), 7.40( 
t, 1H, J = 7.2 Hz? quin-H), 7.00(s, 
1H, CHHC), 6.80(s, 1H, CHHC), 
5.60(s, 2H, methylene linker-H), 
4.10(t, 2H, NCH2), 1.70(m, 2H, J = 
7.5 Hz, CH2), 1.20(m, 2H, J = 7.0 Hz, 
CH2), 0.80(t, 3H, J = 7.3 Hz, CH3).
183.23
[Ag(NHC)Cl] 3.40 'H NMR (CDCI3. 400MHz, 298K): 
8.00(d, 2H, J = 10.7 Hz, quin-H), 
7.75(d, 1H, J = 7.1 Hz, quin-H), 
7.60(d,lH , J = 7.5 Hz, arom-H), 
7.50(t, 1H, J = 7.3 Hz, arom-H), 
7.35(s,2H, arom-H), 7.25(s, 2H, 
CHHC), 7.20(d, IH, J = 6.8 Hz, quin- 
H), 7.10(t, 2H, J = 8.4 Hz, quin-H), 
6.90(d, 1H, J = 11.8 Hz, arom-H), 
5.50(s,2H,NCH2qiun), 2.00(s, 6H, 
CH3).
N.A.
[Ag(NHC)Cl] 3.41
'H NMR (CDC13. 400MHz, 298K): 
8.10(d, 2H, J = 8.4 Hz, quin-H), 
8.00(d, 2H, J = 8.5 Hz, quin-H), 
7.75(d,2H, J =
180.37
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8.1 Hz, quin-H), 7.65(t, 2H, J = 5.6
Hz, quin-H), 7.5(t, 2H, J = 7.1 Hz,
quin-H), 7.35(d, 2H, J = 8.5 Hz,
quin-H), 7.15(s, 2H, HHC), 5.5(s, 4H,
NCH2C).
A look at the data presented in Table 3.3 indicate that there is no significant 
difference between complexes 3.36 -3.41 in terms of the chemical shift of 
quinoline protons and that o f the methylene linkers and the C- Ag carbene 
resonances were observed between 180.37 -184.10 which are within the range 
reported in the literature (180-243 ppm) [13]. Elemental analysis o f complex
3.38 returned a satisfactory results consistent with the proposed structure as 
suitable crystal for X-ray crystallography could not be obtained. Complex 3.39 
revealed a cluster at M/z = 637.2189 Da (100% intensity) attributable to the 
cation of biscarbene [Ag(NHC)2]+. The NMR and 13C NMR spectra as well 
as the elemental analysis o f complex 3.40 are consistent with the proposed silver 
carbene complex. MS analysis revealed a cluster at M/z = 356.1642 Da (100% 
intensity) and 817.2445 Da (36%) attributable to the cation o f the corresponding 
salt [(NHC)+H]+ and biscarbene ion [Ag(NHC)2]+ respectively. The observation 
of the peak attributable to the bis carbene ion may not necessarily indicate that 
the complex is indeed a biscarbene. Danopoulos and colleagues reported that 
silver NHCs with solid-state motifs o f C-Ag-X and C-Ag-X2 formed 
biscarbenes (C2-Ag) in the gas phase [17].
3.3.2 Pd(II) Quinoline functionalised (NHC) carbene complexes
Two quinoline based Pd(II) (NHC) complexes were prepared according to steps 
in Scheme 3.8 by the reaction o f quinoline functionalised Ag(I)(NHC) complex 
with one equivalent o f PdCl2(COD) in DCM, over night, the PdCl2(COD) being 
synthesised by standard procedures.
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^ //
3.34
DCM, r.t.
r = \
+ COD + AgBr
3.42
N
Ag
3.39
PdCI2(COD) 
DCM, r.t.
+ COD +Agl
Cl—  Pd -
3.43
Scheme 3.8: Synthesis of quinoline functionalised Pd(II)(NHC) complexes
Complex 3.42 was characterised by and 13C NMR. Relative to the silver (I) 
(NHC) complex from which the Pd complex was prepared, the protons where 
observed to have moved considerably down field indicating that chelation has 
indeed taken place. Crystal suitable for X-ray crystallography was not obtained 
but elemental analysis gave satisfactory results in conformity with the proposed 
structure. Complex 3.43 was characterised by *H NMR and elemental analysis. 
The solubility of the complex in CDCI3 was not good enough to get a
1 3satisfactory C NMR spectrum. Elemental analysis returned unsatisfactory 
results.
3.4 Conclusions
Ag'(NHC) complexes have been valuable intermediates in the preparation of 
functionalised Pdn(NHC) complexes that are difficult to be accessed via other 
methodologies. Thus a range o f imidazolium salts synthesised in chapter two 
was reacted with Ag20  to form the corresponding silver (I) carbene complexes. 
The syntheses of the silver complexes were confirmed by the absence of C2-H in 
the *H NMR spectrum, and other analytical techniques.
Compounds 3.36 and 3.37 are the first examples of quinoline functionalised 
Agl (NHC) complexes and were structurally characterised by X-ray
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crystallography and formulated as [Ag(NHC)2]+[AgCl2]‘ and [Ag(NHC)Cl] 
respectively. Results o f MS data indicated that complexes 3.38, 3.39 and 3.40 
may have a similar formulation to that o f 3.36 because o f the presence o f cluster 
attributable to [Ag(NHC)2]. However the MS is not enough to formulate the 
formula of Ag,(NHC) complexes as Danopoulos and colleagues reported that 
silver NHCs with solid-state motifs o f C-Ag-X and C-Ag-X2 formed 
biscarbenes (C2-Ag) in the gas phase [17]. All the Ag](NHC) complexes 
showed stability to air and moisture and were not exposed to light.
In order the extend the synthetic applicability o f Ag'CNHC) complexes as 
transmetallation agents complexes 3.34 and 3.39 were reacted with PdCl2COD 
in DCM to obtain quinoline functionalised Pd(II)(NHC) complexes (3.42 and 
3.43) respectively. The formation o f the Pd(II)(NHC) complexes was confirmed 
by *H NMR spectrum as relative to the corresponding Ag*(NHC) complexes , 
the protons signals of the quinoline moiety o f the Pd complexes were observed 
to have moved down field indication the chelation between the nitrogen o f the 
quinoline moiety and Pd metal. Attempts were made to synthesise the Pd 
complexes of by reacting the other described quinoline functionalised 
Ag'(NHC) complexes in this work with PdCl2COD but a lot o f difficulties were 
encountered in separating the complexes formed from the silver halides .
3.5 Experimental 
3.5.1 General comments
All reactions were performed under the atmosphere o f dry dinitrogen or argon 
using standard Schlenk techniques, and solvents were purified and dried by 
usual means [58], unless otherwise indicated. Imidazolium salts were prepared 
as detailed in Chapter 2, and all other reagents were used as received. All NMR 
data are quoted 5/ppm. *H and 13C (proton decoupled) spectra NMR were 
recorded on a Bruker DPX Advance 400 ( !H at 400MHz, 13C at 100.61 MHz) 
at ambient temperature, unless otherwise stated, and referenced to SiMe4. 
Electrospray mass spectrometry (ESMS) was performed on a VG Fisons 
Platform II instrument by the department of Chemistry, Cardiff University. 
Micro analysis was performed by Warwick Analytical Service. All reactions 
involving silver compounds were performed with the exclusion of light.
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3.5.2 The silver (I) complexes of rigid quinoline functionalised 
mono -NH C ligands
[ Ag(l-benzyl-3- quinolineimidazolin-2-ylidene)Br] 3.34:
A mixture of 1 .benzyl-3-quinolineimidazolium bromide (0.7g, 2mmols) and 
silver (I) oxide (0.222g, lmmol in 10ml o f DCM was stirred over night at 40Oc. 
The resulting solution was filtered through celite and the solvent removed under 
reduced pressure to leave a brown coloured solid. The solid was recrystallised 
from DCM / Hexane to give the desired Ag complex. 0.55g (60.84%). Anal. 
Calcd. for C,9H ,i5N3AgBr: C, 48.23; H, 3.17; N, 8 .88%. Found: C, 49.45; H, 
3.22; N, 8.96%. 'H NMR (CDCI3. 400MHZ, 298K): 8.85 ( d, 1H, J = 1.7 Hz, 
quin-H), 8.25 (d, 1H, J = 6.7 Hz, quin-H), 7.90(d, 2H, J = 7.7 Hz. quin-H,) 7.55 
(t, 1H, J = 7.8 Hz. quin-H),7.45 (m, 2H, J = 3.0 Hz, CHHC), 7.25-7.35 (m, 5H, 
J = 5.4 Hz, Ar-H), 7.10 (s, 1H, quin-H), 5.35 (s, 2H, CH2-Ph). 13C NMR 
(CDCL3, 100 MHZ, 298K): 151.75, 142.86, 136.99, 135.60, 130.04, 129.68, 
129.60, 129.19, 128.59, 127.54, 126.72, 125.74, 122.77, 120.64, 56.49(CH2).
[Ag(l-methyl-3-quinolineimidazolin-2-ylidene)I] 3.35:
A mixture of 1-methyl-3 -quinolineimidazolium iodide (0.44g, 1.3lmmol) and 
silver (I) oxide (0.15g, 0.66mmol) in 10ml of CH3CN was stirred over night at 
40°C. The resulting solution was filtered to remove silver halide through celite 
and the solvent removed under reduced pressure to leave a tan coloured solid. 
The solid was then recrystallised from DCM/Hexane to give the desired Ag
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complex (0.26g. 63%). lH NMR (CDC13. 400MHZ, 298K): 8.85 (d, 1H, J = 2.7 
Hz, Quin-H), 8.25(d, 1H, J = 7.3 Hz, quin-H), 7.95 (d, 1H, J = 8.2 Hz, quin-H), 
7.80( d, 1H, J = 7.4 Hz, quin-H), 7.5 (t, 1H, J = 7.6 Hz, quin-H), 7.4 (d, 1H, J =
4.2 Hz, quin-H), 7.35 (s, 2H, CHHC). 3.90 (s, 3H, CH3). 13C NMR (d2-DCM, 
100 MHZ, 298K): 163.00, 151.3, 147.6,145.2, 139.4, 138.5, 136.9, 134.7, 133.2, 
131.8,44 .0(CH3).
3.5.3: Silver (I) complexes of methylene bridged quinoline functionalised 
NHC ligands
[Ag (l-methy-3-(-2-methylquinoline) imidazolin-2-ylidine) 2][AgCl2 ] 3.36
^ //
A mixture of 1-methyl-3-(2-methylquinoline) imidazolium chloride (0.30g, 
1.16mmol) and Ag20  (0.14g, 0.59mmol) in dichloromethane was stirred for 12 
hours. The solution was filtered through celite and the filtrate concentrated. 
Diethyl ether was added to precipitate the carbene complex which was 
repeatedly washed with diethyl ether and dried under vacuum to give the desired 
silver carbene complex. Crystals suitable for X- ray structure were grown by 
layering diethyl ether on dichloromethane. Anal. Calcd. for Ci4H i3N3AgCl: C, 
45.86; H, 3.55; N, 11.46; Cl, 9.67%. Found: C, 45.71; H, 3.45; N, 11.33; Cl, 
9.60%. *H NMR (CDC13. 400MHz, 298K): 8.10 ( d, 2H, J = 8.5 Hz, Quin-H ),
8.00 ( d,2H, J = 8.4 Hz, Quin-H ), 7.80 ( d, 2H, J = 8.1 Hz, CHHC ), 7.5 ( d, 
2H, J = 8.4 Hz, Quin-H ), 7.35 (d, 2H, J = 1.7 Hz, Quin-H ) 7.15 ( d, 2H, J = 1.8 
Hz, Quin-H ), 6.95 ( s,lH , Quin-H), 5.50 ( s, 4H CH2), 3,85 ( s, 6H, CH3). 13C 
NMR (CDC13, 100MHz, 298K): 181.18 (C-Ag), 155. 45, 148.09, 138. 12, 
130.55, 129.62, 128.11, 127.92, 127.50, 123.01, 122.31, 120.20, 58.14, 39.27. 
MS (HRMS, Da): M/z (224.09) [(NHC)+H]+ (100%).
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Synthesis of [Ag (l-mesityl-3-(-2-methylquinolme) imidazolin-2-ylidine) Cl] 
3.37
r = \
A mixture of 1-mesityl 3-(2-methylquinoline) imidazolium chloride 4 (0.50g, 
1.38mmol) and Ag2 0  in dichloromethane was stirred at room temperature for 12 
hours. The solution was filtered through celite and the filtrate concentrated. 
Diethyl ether was added to precipitate the carbene complex which was 
repeatedly washed with diethyl ether and dried under vacuum to give the desired 
silver carbene complex. Crystals suitable for X- ray structure were grown by 
layering diethyl ether on dichloromethane. Anal. Calcd. for C22H2iN3AgCl: C, 
56.13; H, 4.46; N, 8.93; Cl, 7.55%. Found: C, 56.23; H, 4.53; N, 8.77; Cl, 
7.55%. fH NMR (CDCI3. 400MHZ, 298K) : 8.10 ( d, 1H, J = 8.4 Hz, Quin-H),
8.00 ( d, 1H, J = 8.5 Hz, Quin-H ), 7.80 ( d, 2H, J = 8.1 Hz, CHHC ), 7.70 ( t, 
1H, J = 1.4 Hz, Quin-H ), 7.50 ( t, 1H, J = 7.0 Hz, Quin-H ), 7.35 ( t, 2H, J =
8.7 Hz, Quin-H ), 6.90 ( s, 3H, Aromatic-H ), 5.60 ( s, 2H, CH2 ), 2.25 ( s, 3H, 
m -C H s), 1.95 ( s, 6H, 0 -CH3 ). I3C NMR (CDCL3, 100 MHZ, R.T.): 155.40, 
148.0, 139.20, 138.18, 135.08, 130.59, 129.84, 129.64, 128.16, 127.95, 127.50, 
123.57, 122.29, 119.74, 58.16, 21.47, 18.11. MS( HRMS, Da): M/z (328.15) 
[(NHC)+H]+ (100%).
[Ag (1-isopropyl- 3-(2-methylquinolin) imidazolin-2-ylidine) I] 3.38
f= \
Following the method for the synthesis o f 3.37, compound 3.38 was synthesized 
from 1-isopropyl-3-(2 -methylquinoline) imidazolium iodide (0.1 Og, 0.26mmol) 
and Ag20(32mg, 0.14mmol) in dichloromethane.(Yield =0.12g, 73.00% ). 
Anal. Calcd. for C ,6H 17N3AgI: C, 39.52; H, 3.50; N, 8.65; I, 7.55%. Found: C, 
39.70; H, 3.42; N, 8.57; I, 25.92%. *H NMR (CDC13. 400MHZ, 298K): 8.05(d,
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2H, J = 8.5 Hz, quin-H), 7.65(t, 2H, J = 7.0 Hz, quin-H), 7.50(d, 2H, J =5.2 Hz, 
quin-H), 7.10(s, 1H, CHHC), 6.90(s, 1H, CHHC), 5.60(s, 2H, NCH2C), 4.85(m, 
1H, NCHC), 1.35(d, 6H, J = 6.8  Hz, CH3). 13C NMR (CDCL3, 100 MHZ, R.T.): 
184.10(C-Ag), 156.55, 137.91, 130.18, 129.47, 128.12,127.91,121.71, 121. MS 
(HRMS, Da): M/z = 609.1886 [Ag(NHC)2]+ (100%).
[Ag(l-n-butyl-3-(-2-methylquinolin)imidazolin-2-ylidine)I] 3.39
f=\
Following the method for the synthesis o f 3.38, compound 3.39 was synthesized 
from l-nbutyl-3-(2-methylquinoline)imidazoliumiodide (0.50g, 1.27mmol) and 
Ag2O(0.15g, 0.64mmol) in dichloromethane.(Yield = 0.40g, 62.50% ). Required 
for C ,7H 19N3AgI: C, 40.82; H, 3.80; N, 8.40%. Found: C, 39.90; H, 3.67; N, 
7.79%.*H NMR (CDC13. 400MHz, 298K): 8.00(d, 1H, J = 8.5 Hz, quin-H), 
7.90(d, 1H, J = 8.5 Hz, quin-H), 7.60( m, 2H, J = 8.1 Hz, quin-H), 7.55(d, 1H, J 
= 8.5 Hz, quin-H), 7.40( t, 1H, J = 7.2 Hz, quin-H), 7.00(s, 1H, CHHC), 6.80(s, 
1H, CHHC), 5.60(s, 2H, methylene linker-H), 4.10(t, 2H, NCH2), 1.70(m, 2H, J 
= 7.5 Hz, CH2), 1.20(m, 2H, J = 7.0 Hz, CH2), 0.80(t, 3H, J = 7.3 Hz, CH3). I3C 
NMR(CDCL3, 100 MHZ, R.T.): 183.23(C-Ag), 155.02,146.52,136.50,128.80,
128.07, 126.70, 126.50, 126.14, 125.76, 120.30, 119.96, 64.84, 56.56, 50.68, 
32.50,18.75. MS( HRMS, Da): M/z (637.2189) [Ag(NHC)2]+ (100%)
[Ag (l-(-2-methylpropiophenone)-3-(-2-methylquinoIin) imidazolin-2- 
ylidine) Cl] 3.40.
Following the method for the synthesis o f 3.39, compound 3.40 was synthesized 
from 1 -(2-methylpropiophenone)-3 -(-2 -methylquinolin) imidazolium chloride 
(0.30g, 0.77mmol) and Ag20  (90mg, 0.39mmol) in dichloromethane. (Yield = 
0.32g, 90.00%). Anal. Calcd. for C23H2iN3OAgCl: C, 55.38; H, 4.14; N, 8.43%. 
Found: C, 55.78; H, 4.18; N, 8.22%. *H NMR (CDC13. 400MHZ, 298K): 8.00(d,
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2H, J = 10.7 Hz. quin-H), 7.75(d, 1H, J = 7.1 Hz, quin-H), 7.60(d,lH, J = 7.5 
Hz, arom-H), 7.50(t, 1H, J = 7.3 Hz, arom-H), 7.35(s,2H, arom-H), 7.25(s, 2H, 
CHHC), 7.20(d, IH, J = 6 .8  Hz, quin-H), 7.10(t, 2H, J = 8.4 Hz, quin-H), 
6.90(d, 1H, J = 11.8 Hz, arom-H), 5.50(s,2H,NCH2qiun), 2.00(s, 6H, CH3). I3C 
NMR (CDCL3, 100MHz, 298K):196.71(PhCOC), 153.72, 146.53, 136.77,
136.59, 131.72, 129.18, 129.12, 128.17, 127.94, 127.60, 126.72,126.66, 126.46, 
126.12, 120.91, 118.72, 118.43, 118.38, 66.99, 57.61, 27.56. MS( HRMS, Da): 
M/z (356.1642) [(NHC)+H]+ ( 100%), 817.2445 [Ag(NHC)2]+ (36%).
[Ag (bis-1,3(2-methylquinolin) imidazolin-2-ylidine) Cl] 3.41
\ J
Following the method for the synthesis o f 3.40, compound 3.41 was 
synthesized from bis-1, 3-(2-methylquinoline) imidazolium chloride (0.30g, 
,78mmol) and Ag20  (93mg, 0.40mmol) in 20 ml o f dichloromethane. (Yield 
= 0.12g, 40%). Anal. Calcd. for C23H ,8N 4AgCl: C, 55.94; H, 3.65; N, 11.35%. 
Found: C, 56.39; H, 3.61; N, 11.21%. lH NMR (CDC13. 400MHZ, 298K): 
8.10(d, 2H, J = 8.4 Hz, quin-H), 8.00(d, 2H, J = 8.5 Hz, quin-H), 7.75(d,2H, J =
8.1 Hz, quin-H), 7.65(t, 2H, J = 5.6 Hz, quin-H), 7.5(t, 2H, J = 7.1 Hz, quin-H), 
7.35(d, 2H, J = 8.5 Hz, quin-H), 7.15(s, 2H, HHC), 5.5(s, 4H, NCH2C). 13C 
NMR (CDCL3, 100 MHZ, 298K): 180.37(C-Ag), 154.09, 146.58, 136.71,
129.08, 128.09, 126.70, 126.47, 126.01, 121.31, 118.75, 56.74. MS (HRMS, 
Da): M/z (351.16) [(NHC)+H]+ (100%).
3.5.4: Pd(II) quinoline functionalised NHC complexes 
[Pd(l-benzyl-3 -quinoline-im idazolin-2 -ylidene)Cl2] 3.42
/= \ / = \
Cl
A solution of PdCl2(COD) (0.092g, 0.32 mmol) in 10ml DCM was added to 
solution [ Ag(l-benzyl-3- quinolineimidazolin-2-ylidene)Br] ( 0.30g, 0.32mmol) 
in lOmL DCM and stirred at room temperature for 2 hours. The solution was
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then filtered through celite to remove the silver bromide formed and the solvent 
was concentrated to 5ml. Hexane was added to precipitate the Pd carbene 
complex which was repeatedly washed with hexane to any 1,5-cyclooctadiene. 
Anal. Calcd. for Ci9H 15N3PdCl2: C, 49.31; H, 3.24; N, 9.08%. Found: C, 46.08; 
H, 3.30; N, 7.78%. 'H  NMR (CDCI3. 400MHZ, 298K): 9.70(d, 1H, quin-H), 
8.40(d, 1H, J = 1,4 Hz, quin-H), 8.00(d, 1H, J = 6.7 Hz, quin-H), 7.90 (d, 1H, J 
= 7.2 Hz, quin-H), 7.70 ( t, 1H, J = 7.9.5 Hz, quin-H), 7.50(t, 1H, J = 6.3 Hz, 
quin-H), 7.40(d, 2H, J = 6.1 Hz, Ar-H), 7.35(s, 1H, CHHC), 7.30 (m, 3H, J =
7.7 Hz, Ar-H), 6.95( s ,lH , CHHC), 5.25(s, 2H, Ph-CH2)
[Pd(l-nbutyl-3- (2-methylquinoline)imidazolin-2-ylidene)Cl2) 3.43
Pd —  N
l-nbutyl-3-(2-methylquinoline)imidazolium (0.15g, 0.38mmol) and Ag2 0  ( 
44mg, 0.2mmol) in 15mL o f DCM were stirred over night and the reaction 
mixture was filtered via cannula to a solution PdC^COD ( 0.1 lg, 0.38mmol ) 
in 15mL DCM and the reaction mixture stirred overnight. The reaction mixture 
was filtered through celite and the filtrate was concentrated over vacuum.
Hexane was added to precipitate the desired Pd complex which repeated 
recrystallised from hot CH3CN and diethyl ether. Anal. Calcd. for 
CnHigNsPdCb: C, 46.21; H, 4.30; N, 9.51%. Found: C, 43.92; H, 4.05; N, 
6.72%. *H NMR (DMSO. 400MHZ, R.T): 9.20(d, 1H, J = 8.8 Hz quin-H), 
8.70(d, 1H, J = 8.2 Hz quin-H), 8.10(d, 1H, J = 8.0 Hz , quin-H), 7.90(t, 2H, J =
5.2 Hz, Quin-H ), 7.70(t, 1H, J = 7.5 Hz quin-H), 7.60(s, 1H, CHHC), 6.35(s, 
1H, CHHC), 6.10(d,lH, J = 15.6 Hz methylene linker-H), 5.80(d, methylene J =
15.7 Hz linker-H),4.60(m, 1H, J = 6.6  Hz NCH2), 4.10(m, 1H, J = 6.6  Hz 
NCH2), 2.90(m, 2H, J = 7.0 Hz CH2), 1.15(m, 2H, J = 8.5 Hz , CH2), 0.80(t, 3H, 
J = 7.3 Hz, CH3 ).
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3.5.4 X-Ray crystallography
Standard conditions as outlined in section 2.4.7.
Table 3.4: Crystal data and
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated) 
Absorption coefficient 
F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness of theta = 27.4° 
Absorption correction 
Max and min. transmission 
Refinement method 
Data/restraints/parameters 
Goodness of fit on F 
Final R indices [I>2 sigma(I)] 
R indices (all data)
Largest diff. peak hole
a  = 90.00°
(3= 111.937(8)° 
y = 90.00°
structure refinement for 3.36
C,4Hi3AgN3Cl 
366.59 
150(2) K 
0.71073 A 
Monoclinic 
C2
a = 15.9530(14) A 
b = 6.5010(8) A 
c =  13.8760(13) A 
1334.90(2) A3 
4
1.8424Mg/m3
1.698mm-l
728
0.30 x 0.15 x 0.01 mm3 
2.61 to 27.40 °
-19<=h<=20, -8<=k<=7, -17<=1<=16 
2473
2473 [Rint = 0.0714]
93.20%
Semi-empirical from equivalents 
0.6299 and 0.9832 
Full matrix least square on F2 
2473/144/133 
1.094
R1 =0.1141, wR2 = 0.2350 
R1 =0.1015, wR2 = 0.2261 
1.763 and-1.552e A'3
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Table 3.5: Crystal data and structure refinement for 3.37
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness of theta = 25.18° 
Absorption correction 
Max and min. transmission 
Refinement method 
Data/restraints/parameters 
Goodness of fit on F2 
Final R indices [I>2 sigma(I)] 
R indices (all data)
Largest diff. peak hole
C22H2,AgN3Cl 
470.75 
150(2) K 
0.71073 A 
Triclinic 
P - l
a = 8.9956(3) A a  = 79.2749(17)°
b = 9.3915(3) A p = 81.9409(16)°
c = 12.4646(4) A 7 = 74.7489(16)°
993.57(6) A3 
2
1.573Mg/m3 
1.160mm-1 
476
0.20  x 0.20  x 0.20  mm3 
1 to 27 0
- 10<=h<= 11, -12<=k<=12, -16<=1<= 16 
24373
4440 [Rint = 0.145]
99.30%
Semi-empirical from equivalents 
0.7900 and 0.7900 
Full matrix least square on F2 
3644/0/244
1.0042
R1 =0.0418, wR2 = 0.11129 
R1 =0.0505, wR2 = 0.1206
0.69 and-1.07e A’3
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CHAPTER FOUR 
Rhodium(I) and Iridium(I) complexes of quinoline 
functionalised Heterocyclic Carbene ligands
4.1 Introduction
Prior to the isolation o f the first stable crystalline NHC 4.5 in 1991 by 
Arduengo et al [1], metal complexes o f N-heterocyclic carbenes (NHCs) were 
reported concurrently in i968 by Ofele 4.1 [2] and by Wanzlick and Shonherr
4.2 [3] both being prepared directly from imidazolium salts. In his contribution 
Lappert prepared a wide range o f  transition metal- NHC compounds including
4.3 and 4.4 from electron rich olefins in 1970 [4] and complex 4.3 was found to 
be an active catalyst for hydrosilylation.
MeI
-N
NI
Me
Cr(CO)5
PhIKl
INI
Ph
PhI
N'I
Ph
Me
\
Rh; N
Cl Me
4.1 4.2 4.3
Et3P
Pd:
Cl Ph
N^ _ y N'
4.4 4.5
Figure 5.1: Early metal complexes o f NHCs 4.1- 4.4 and first crystalline free 
Carbene 4.5
Encouraged by the promise o f these early applications utilising Rh(I) 
complexes of simple monodentate NHC ligands, there was a natural evolution 
to expand the catalytic applications o f Rh and Ir NHC complexes systems
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through modification o f the NHC ligands. The desired qualities of modified 
NHC ligands include the incorporation o f functional groups leading to easily 
recoverable catalyst, water or methanol soluble catalyst, and catalyst containing 
flexible steric bulk as well as chiral and bidentate and pincer ligands [5] and 
combination o f the strongly bound NHC moiety with more weakly nucleophilic 
functional groups to furnish ligands with hemilabile donor groups as these can 
increase catalytic activities by stabilising the low valent centres formed during 
catalysis. These functional groups may be incorporated at one or both of the ring 
nitrogens to give access to bidentate or tridentate NHC ligands.
Examples o f Rh(I) and Ir(I) complexes o f functionalised NHC ligands are 
limited but have increased considerably in the past few years. Functionalised 
Rh(I) and Ir(I) (NHC) complexes have appeared in the literature with picolyl 
(4.5 and 4.6) [6 ], 4.17 and 4.18[11], ether, ester, amide and ketone( 4.7, 4.8, 4.9 
and 4.10) [7], amino (4.11 , 4.12) [8], pyridyl (4.13, 4.14, 4.15, 4.16 [9], imino 
4.19 [10] Figure 4.2. As this thesis was nearing completion a publication by 
Webster et al reported quinoline functionalised NHC complexes o f rhodium and 
iridium.
r = \ + f = \ / = \
Rh-Br Rh-CI
4.6: M = Ir
4.5: M = Rh 4.7: R 1, R2 = ether 
4.8: R 1, R2 = ester 
4.9: R 1, R2 = amide
4.10: R 1, R2 = ketone
DIPP DIPP
4.12 4.13: M = Rh 4.15: M = Rh
4.14: M = Ir 4.16: M = Ir
- 121 -
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r = \
Mes
Ir—<
Ar
f = \
IsL ^N- Mes
+
BF.
r = \ BF,
Mes
Rh.
4.17 4.18 4.19
Figure 5.2: Some o f the published Rh(I) and Ir(I) NHC complexes
Other Rh(I) and Ir(I) NHC complexes have also been reported: Crabtree et al 
[12] reported the effect o f linker length and counterion on the formation of 
chelated complexes o f rhodium(I) NHC complexes where they observed that 
short linker length and non coordinating counter ion favoured chelated 
rhodium(I) NHC complexes while long linker length and coordinating 
counterion disfavoured the formation o f chelated complexes.
Different approaches are normally employed to prepare Rh and Ir NHC 
complexes. O f the many coordination strategies available, three are more 
prominent: oxidative addition o f the imidazolium ring, deprotonation o f the 
imidazolium salts with suitable base and transmetallation o f the previously 
obtained silver carbene.
One of the potentially very mild ways to make transition metal NHC complexes 
is by oxidative addition o f the azolium C-H bond to an appropriate low-valent 
metal centre.Thoertical and experimental work by Cavell et al [13] has shown 
that this is a viable synthetic route. However, this method will not the desired 
rhodium(I) and iridium(I) NHC complexes as it always rhodium(III) or iridium 
(III) NHC complexes that are formed.
The best synthetic method o f obtaining Rh(I) and Ir(I) NHC complexes is via 
deprotonation of the imidazolium precursor with suitable base. However, a 
strong base such as potassium tert-butoxide or potassium hydride is usually 
employed to prepare the free carbene. This sometimes causes problems because 
the acidic protons or electrophilic sites may be attacked by the base.
Gratifyingly, the important work o f Wang and Lin [14] demonstrated that silver 
complexes o f NHCs could be synthesized directly from imidazolium salts and 
Ag20  or Ag2C 0 3 and silver(I) NHC complexes are capable o f transferring the
- 1 2 2 -
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carbene ligands to other metals such Pd [14, 15], Au [16] including Rh and Ir [6 , 
7, 8, 9, 10, 11, 16]. Realising the simple way o f obtaining our desired Rh(I) and 
Ir(I) through transmetallation o f silver carbene, all the Rh(I) and Ir(I) 
presented herein were prepared using the silver carbene protocol. However it is 
worth noting that the reaction yield via silver carbene is depended on the 
imidazolium salt/ metal ratio and the starting metal complex used. Mas-Marza et 
al [6] reported that Rh(III) and Ir(III) NHC can also be prepared by the 
transmetallation, as the silver carbene can play dual role (i) in NHC transfer and 
(i) as oxidizing agent.
In summary, this chapter presents work pertaining to Rh(I) and Ir(I) NHC 
complexes of quinoline functionalised imidazolin-2 -ylidene ligands and includes 
a review of literature pertaining to this work.
The synthesis and characterisation o f  a series o f [Rh(COD)Cl] NHC and 
[Ir(COD)Cl] NHC complexes o f  quinoline functionalised via Ag'(NHC) is 
outlined. The ligands have range o f steric bulk at their 1, 3 positions. Also 
described are chelated complexes o f the corresponding [Rh(COD)Cl] NHC and 
[Ir(COD)Cl]NHC complexes obtained by treatment o f the neutral complexes 
with AgBF4 , although only one such o f  complexes is presented because of 
solubility problems encountered in the characterisation of other complexes. All 
the Rh (I) and Ir NHC complexes obtained are found to be stable to moisture 
and air.
4.2 Results and Discussions
4.2.1: Synthesis and characterisation o f quinoline functionalised Rh(I) NHC 
complexes.
The use of free carbene route by deprotonation o f the imidazolium salts with 
strong base, which was expected to produce the corresponding free carbene, was 
not successful presumably because o f  interference from deprotonation of 
benzylic methylene protons [17]. Therefore,A all the Rh(I) NHC complexes 
presented in this work were prepared from the A g1(NHC) complexes presented 
in chapter 3 . Treatment o f [Rh(COD)Cl]2 with the methylene bridged quinoline 
functionalised Ag*(NHC) complexes in dichloromethane at ambient temperature
- 1 2 3 -
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gave the desired rhodium carbene complexes as yellow solids in good yield after 
work up as shown in Scheme 4.1 below. All the prepared rhodium complexes 
were characterised by 'H  NMR, 13C NMR and mass spectroscopy, elemental 
analysis and X- ray crystallography. The 13C NMR data for the coordinating 
carbene carbons for complexes 4.20, 4.22, 4.23 and 4.24 appear at 5 values of
181.60, 180.38, 178.66 and 183.45ppm respectively, suggesting the formation of 
the Rh-C bond which are in the usual range for other Rh(I)-NHC complexes [18, 
19, 20-22]. The carbenic carbon in complex 4.21 was not observed in the 13C 
NMR spectrum. The !H NM R shifts corresponding to the protons o f the 
quinoline ring are essentially similar to those o f the silver complexes from 
which they were made, indicating that the quinoline nitrogen donor remains 
uncoordinated. Furthermore, lH NM R spectra show diasterotopic protons for the 
CH2 linker ( 5 = 6.5 and 5.6 for complex 4.20, 6.5 and 6.1 for complex 4.21, 6.5 
and 5.75 for complex 4.22, 6.5 and 5.6 for complex 4.23 and 6.5 and 5.8 for 
complex 4.24) which suggests that this group is out o f the coordination plane of 
the molecule thus reducing its symmetry.
R
[Rh(COD)CI].
DCM, r. temp.
3.36: R = Me, X = Cl 4.20: R = Me
3.37: R = Mes, X = Cl 4.21: R = Mes
3.38: R = iPr, X = I 4.22: R = iPr
3.39: R = n-Bu, X = I 4.23: R = n-
Bu
3.41: R =QuinCH2, X = Cl 4.24: R -
QuinCH2
Scheme 4.1: Synthesis o f quinoline functionalised Rh(I) NHC complexes.
-  1 2 4 -
Chapter Four: Rh(I) and Ir(I) complexes of quinoline functionalised ligands
Elemental analysis results for complex 4.20 were satisfactory but no reasonable 
data could be obtained from the mass spectrum. Suitable crystals for X-ray 
single crystal diffraction were obtained from a DCM/ n-pentane solution at 
ambient temperature. The detailed solid state coordination sphere around the 
rhodium centre of complex 4.20 is confirmed by the X- ray crystal structural 
analysis. The complete molecular structure of complex 4.20 is depicted in 
Figure 4. 3 below. Selected bond distances and bond angles are listed in table
4.1
C 22 C21
V
\
C 15
Rh1
I  C 10 C11
\ f  c ®____C 9^>  ——■
H iF 1 ^  — -  v \
&  —  ^  
<  \  ✓''ce*—  N3 C14 cis
C5
ci:
C 14 C 13
Figure 4.3: ORTEP projection of complex 4.20 excluding hydrogen atoms for 
clarity,showing atom labelling scheme.
Table 4.1: Selected bond lengths (A) and bond angles (°) of 4.20
Cl - N1 1.356(6) C 16 - Rh 1 2.126(5) N l- C l- Rhl 131.4 (4)
C l-R hl 2.028(5) C 19 - Rh 1 2.206(5) C l-R hl-C ll 87.99(14)
Cl -N2 1.362(7) R h l-C ll 2.386(13) N2- C5- C6 113.90(4)
N 2-C3 1.394(9) C20- Rhl 2.233(6) Cl-Rhl-C15 92.00(2)
C15 -Rhl 2.123(5) N 1-C1-N 2 103.8(4) C1-N2- C3 111.00(4)
The structural arrangement of complex 4.20 shows that the molecular geometry 
around the rhodium ion is a square planar arrangement with two coordination
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sites occupied by carbene and chloride in a cis fashion. The distances of Rh- 
C(COD) trans to the carbene donor appear to be longer than those in the cis 
arrangement, suggesting that the a-donor nature of the diaminocarbene is 
stronger than that of the chloride. No major deviations were observed in the 
bond lengths and bond angles o f complex 4.20 compared with those reported in 
the literature [23-25].
The *H NMR shifts for complex 4.21 corresponding to the protons of the 
quinoline ring are essentially similar to those of the silver complexes from 
which they were made, indicating that the quinoline nitrogen donor remains 
uncoordinated with the carbenic carbon not observed in the ,3C NMR spectrum. 
The high resolution MS measurement were consistent with the proposed 
formulation with [M- Cl]+ observed at M/z = 538.18 Da (100% intensity). 
Crystals suitable for X-ray crystallography were obtained for complex 4.21 by 
diffusion of n- pentane into the DCM solution of the compound enabling 
elucidation of the solid state structure as depicted in Figure 4.4. Selected bond 
distances and bond angles are listed in table 4.2
Figure 4.4: ORTEP projection of complex 4.21 excluding hydrogen atoms for 
clarity showing atom labelling scheme.
C30
c i y / '  o n  
4
C6
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Table 4.2: Selected bond lengths (A) and bond angles (°) of 4.21.
Cl - N1 1.355(5) C24 - Rhl 2.179(4) Nl-Cl-Rhl 130.8(4)
Cl - Rhl 2.045(5) C27- Rhl 2.123(4) Cl-Rhl- Cll 87.67(11)
Cl- N2 1.355(5) R h l-C ll 2.3865(9) C1-N1-C4 124.3(3)
N 2-C3 1.379(9) C 28- Rhl 2.112(4) Cl - Rhl-C28 94.63(2)
C23 -Rhl 2.202(4) N1-C1-N2 103.7(3) C24-Rhl-Cll 90.55(14)
Elemental analysis of complex 4.21 returned satisfactory results. There are no 
significant deviations in terms of the bond lengths and bond angles of complex 
4.21 with complex 4.20 and all are within the range reported in the literature 
[ 20-22, 23,].
Complex 4.22 was characterised by spectroscopic analysis, elemental analysis 
and X- ray crystallography. The lH NMR spectrum for complex 4.22 displays 
similar pattern with that of complexes 4.20 and 4.21. The synthesis of complex 
was confirmed by l3C NMR, which reveals Rh-C resonance at a a  value of
180.38 ppm. The high resolution MS measurement was consistent with the 
proposed formulation with [M- Cl]+ observed at M/z = 462.14 Da (100% 
intensity) and elemental analysis results were in agreement with the proposed 
formulation. Crystals suitable for X-ray structural determination were obtained 
by diffusion of n-pentane into the saturated DCM solution of the compound and 
Ortep crystal structure is as depicted in Figure 4.5. Selected bond distances and 
bond angles are listed in table 4.3.
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I
*—  C14
C 13
Figure 4.5: ORTEP projection of complex 4.22 excluding hydrogen atoms for 
clarity showing atom labelling scheme.
The geometry of rhodium in complex 4.22 is square planar and the parameters 
in terms of bond distances and internal angles in the complex are consistent the 
reported values [23].
Table 4.3: Selected bond lengths (A) and bond angles (°) o f 4.22.
C l-N l 1.343(6) C l9 -Rhl 2.127(5) N l-C l-R hl 129.7(4)
C l-R hl 2.037(5) C22- Rhl 2.213(5) Cl-Rhl-C ll 89.2467(13)
C1-N2 1.345(6) Rhl-Cll 2.3755(13) C1-N1-C4 125.0(4)
N2-C3 1.369(7) C3- Rhl 2.226(5) Cl-Rhl-C19 93.10(2)
C18- Rhl 2.113(5) N1-C1-N2 104.7(4) C23-Rhl-Cll 94.52(17)
High resolution MS of complex 4.23 displays a cluster of peak M/z = 476.16 Da 
(100% intensity) assignable to the [M-C1]+ and the elemental analysis gave 
results consistent with the formulation of the complex.
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C21
Figure 4.6: ORTEP projection of complex 4.23 excluding hydrogen atoms for 
clarity, showing atom labelling scheme.
Table 4.4: Selected bond lengths (A) and bond angles (°) of 4.23.
C l-N l 1.355(5) C l9 -Rhl 2.114(4) N 1-C l -Rhl 126.4 (3)
Cl-Rhl 2.032(4) C 22-R hl 2.197(4) C l-R hl-C ll 88.03(11)
C1-N2 1.368(5) R hl-C ll 2.3786(10) C3-N1-C14 123.7(3)
N1-C3 1.387(5) C23 -Rhl 2.208(4) Cl-Rhl-C18 90.62(15)
C18-Rhl 2.097(4) N 1-C1-N2 103.8(3) Cl-Rhl-C22
163.07(15)
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Figure 4.7: ORTEP projection of complex 4.24 excluding hydrogen atoms for 
clarity, showing atom labelling scheme.
Table 4.5: Selected bond lengths (A) and bond angles (°) of 4.24.
C11-N12 1.358(3) Rhl-C3 2.105(3) Cl 1-Rhl - C12 87.46(7)
Cll-Rhl 2.016(3) Rhl-C4 2.121(3) Cl 1- Rhl- C8  167.02(10)
Rhl-C12 2.3794(7) C11-N26 1.358(3) C ll-R h l-C 3  92.99(10)
Rhl-C8  2.230(3) Cl 1-N12 -C13 125.20(2)
Rhl-C7 2.196(2) N12-C11-N26 
103.7(2)
C3-Rhl-C12 157.31(8)
Due to variations in the steric bulk around the carbene carbon there was the need 
to compare the structure of all the rhodium(I) carbene complexes 4.20-4.24. In 
doing so two planes were chosen to calculate the inter planer angles. The planes 
chosen are the NHC consisting of the five atoms in the heterocycle carbene ring 
and the rhodium coordination plane consisting of Cl-Rhl-C12. The inter planer 
angles and other important angles are listed in Table 4.6 below.
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Table 4.6: Bond angles (°) for compounds 4.20- 4.24 of rhodium complexes of 
general formula [Rh(Cod)Cl(NHC)]
Compound G(interplaner
angle)
N1-C1-N2 Cl-Rhl-Cll C ll-R hl-
(C18-C19)
4.20 76.87 103.80(4) 87.99(14) 165.30(2)
4.21 76.77 103.70(3) 87.67(11) 165.92(11)
4.22 80.31 104.70(4) 89.25(3) 159.6(2)
4.23 76.49 103.80(3) 88.03(11) 163.07(15)
4.24 82.69 103.70(2) 87.46(7) 167.02(10)
From the table presented above, the main structural features of these 
compounds are:
A distorted square planar geometry with Cl-Rh-L angles within the range 
of 87.46-89.25°, the highest being observed in compound 4.22.
An average value of 76.71° inter planar angles for compounds 4.20, 4.21 
and 4.23, 80.31° for 4.22 and 82.69° for 4.24 , thus orientation of the 
NHC with respect to the coordination approaches perpendicular probably 
to reduce steric interactions.
The N1-C1-N2 angle of 103.70° observed around the carbene carbon in 
all complexes. Only 4.22 slightly differ with a value of 104.70°.
Cl-Rhl-(Cod) angles for the complexes ranges from 159.6(2)- 
167.02(10)°, with the highest being observed in 4.24, a significant 
variation from the normal square planar(180°).
Some important bond distances are listed in Table 4.7 in order to see the 
variations in the complexes.
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Table 4.7: Other bond distances (A) for complexes of general formula 
[Rh(Cod)Cl(NHC)]
Compound Rh-C Rh-Cl Nl-Cl Rh-(C15-
C16)
Rh-(C19-
C20)
4.20 2.028(5) 2.386(13) 1.336(6) 2,123(5) 2.206(5)
4.21 2.045(5) 2.387(9) 1.355(5) 2.112(4) 2.202(4)
4.22 2.037(5) 2.377(13) 1.343(6) 2.113(5) 2.213(5)
4.23 2.032(4) 2.379(10) 1.355(5) 2.114(4) 2.197(4)
4.24 2.0163(3) 2.379(7) 1.358(3) 2.121(3) 2.105(3)
-The distances between Rh and the NHC ligands are shorter than distances 
between Rh and the Cod, owing to the strong electron donating ability of 
NHCs.
- There is no significant difference in the C-N bond distance of NHCs, with 
an average value of 1 .35 A (Table 4.7), this indicates a degree of C-N double 
character. This parameter may vary depending on the degree of back 
donation from Rh to the NHC (more back donation decreases the push 
mesomeric effect in the NHC and increases the C-N distance), based on 
these observations, it can be deduced that all the complexes display the same 
level of back donation. Similarly, from Table 4.6 the Nl-Ccarbene-N2 
angles (103.95° on average) are very close.
The chelation of quinNAC-R toward the rhodium centre was achieved by the 
treatment of 4.20 and 4.24 with an equimolar amount AgBF4 , leading to chloride 
abstraction and ligand substitution of chloride by the quinoline nitrogen. All of 
the *H NMR signals of the quinoline hydrogen atoms in 4.25 are shifted 
downfield relative to those in the non chelated rhodium complex 4.20 indicating 
chelation of the qiunNAC-R ligand. The ]H NMR data for the non chelated 
complex 4.20 and that of the corresponding chelated complex 4.25 are 8 = 8.10 
(d, 1H, quin-H), 8.00 (d, 1H, quin-H), 7.75 (d, 1H, quin-H), 7.70 (t, 2H, quin- 
H), 7.45 (t, 1H, quin-H), 6.80 (s, 2H, C H H C ), 6.50 (d, 1H, C ^ W e r) , 5.60 (d, 
1H, CH2iinker), 5.00 (m, 2H, C O D ), 4.10 (s, 3H, C H 3), 3.40 (m, 1H, COD), 3.20 
(m, 1H, COD), 2.30 (m, 4H, C O D ), 1.90 (m, 4H, CO D) and 8 8.75 (d, 1H, quin-
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H), 8.25 (d, 1H, quin-H), 8.10 (d, 1H, quin-H), 7.85 (t, 2H, quin-H), 7.60 (d, 2H, 
CHHC, quin-H), 6.65 (s, 1H, CHHC), 6.25 (d, 1H, CH2iinker), 6.05 (d, 1H, 
CH2i,nker), 5.50 (m, 1H, COD), 4.70 (m, 1H, COD), 4.40 (m, 2H, COD),4.10 (m, 
1H, COD), 3.65 (s, 3H, CH3), 2.80 (m, 1H, COD), 2.40 (m, 4H, COD), 2.10 (m, 
2H, COD) respectively. High resolution MS of complex 4.25 displays a cluster 
of peak M/z = 434.1117 Da (100% intensity) assignable to the [M- BF4]+. 
Elemental analysis gave unacceptable results probably because of contamination 
from silver halides which were difficult to remove.,3C NMR spectrum for 
complex 4.25 could not be obtained because the complex is not soluble in most 
solvents. Suitable crystals for X-ray crystallography were not obtained for 
complex 4.25. Complex 4.26 was not characterised because it is insoluble in 
most solvents such as DCM, acetonitrile and methylene chloride. The use of 
DMSO did help solve the problem of solubility but the JH NMR spectra of both 
chelated and non chelated rhodium complexes are essentially similar possibly 
due to competitive coordination of DMSO. Elemental analysis returned a 
slightly low percentage of carbon presumably due contamination from silver 
halide.
X IRh
DCM f = \
A gBF4
1 hr.
AgBF,
4.20: R = Me
4.24: R = QiunCH2
4.25: R = Me 
4.26: R = QiunCH2
Scheme 4.2: Synthesis of chelated quinoline functionalised Rh(I) NHC 
complexes.
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4.2.2: Synthesis and characterisation of quinoline functionalised 
Ir(I) NHC complexes.
The method for the synthesis of quinoline functionalised Ir(I) NHC complexes 
is similar to that of Rh(I) NHC. Complexes were prepared from the silver 
carbene complexes prepared in chapter 3. Stirring of silver carbene complexes 
with 0.5 equivalent of [Ir(COD)Cl] 2  in DCM at ambient temperature gave the 
corresponding Ir(I)NHC complexes in good yield after work up as shown in 
Scheme 4.3 below.
Characterization of the iridium complexes, 4.27, 4.28, 4.29, 4.30 and 4.31 was 
performed by NMR spectroscopy, elemental analysis and in most cases by X- 
ray crystallography. The l3C NMR data for the coordinating carbene carbons 
appear at 8  180.02 ppm for 4.27, 178.66 for 4.29, 179.56 for 4.30 and 180.57 for 
4.31, indicating the formation of the Ir-C bond. All these signals are within the 
typical range for Ir-C(carbene) observed for analogous complexes [11,23, 24]. 
There is no evidence of coordination between the nitrogen of the quinoline with 
the iridium ion as the 'H NMR shifts corresponding to the proton of the 
quinoline ring are essentially the same to those of the silver complexes. In all the 
iridium complexes prepared, the *H NMR spectra show diasteropic protons for
the CH2 linker ( 5 = 6.35 and 5.50 for 4.27, 8  = 6.25 and 5.95 for 4.28, 8  = 6.35 
and 5.60 for 4.29, 8  = 6.35 and 5.55 for 4.30 and 8  = 6.25 and 5.65 for 4.31 
indicating that this group is out of coordination plane of the molecule thus 
reducing its symmetry [1 1 ].
f = \ [lr(COD)CI]: / = \
DCM, r. temp, 
over night
3.36: R = Me, X = Cl 4.27: R = Me
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3.37: R = Mes, X = Cl 
3.38: R = iPr, X = I 
3.39: R = n-Bu, X = I 
3.41: R = QuinCH2, X = Cl 4.31: R = QuinCH2
4.28: R = Mes 
4.29: R = iPr 
4.30: R = n-Bu
Scheme 4.3: Synthesis quinoline functionalised Ir(I) NHC complexes.
Crystals suitable for X-ray chromatography were not obtained but elemental 
analysis of complex 4.27 gave satisfactory results consistent with the 
formulation of the compound. Elemental analysis of complex 4.28 gave a 
satisfactory result and crystals suitable for X- ray crystallography were obtained 
by diffusion of pentane into the saturated DCM solution of the complex. The 
crystal structure of complex 4.28 and the selected bond distances and bond 
angles are presented in Figure 4.8 and Table 4.8 respectively. The Ir 
coordination is square planar with Ir-Cl 1 (carbene) distance of 2.051(11) which 
is typical for Ir- C single bond [25]. The different trans influences of the carbene 
and chloride ligands lead to different distances between the coordinated COD 
carbons atoms and the Ir. The other parameters obtained from the crystal 
structure in term of bond distances and bond angles are consistent with the 
reported values in the literatures [25, 26].
Figure 4.8: ORTEP projection o f complex 4.28 excluding hydrogen atoms for
clarity showing atom labelling scheme.
C 2 4
C 1 3  C 1 4
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Table 4.8: Selected bond lengths (A) and bond angles (°) of 4.28.
C ll- I r l 2.051(11) Irl -C8 2.177(11) Cl 1-Irl-C4 95.13(4)
C11-N12 1.367(15) Irl- C7 2.159(11) C11 -Irl -C12 87.70(9)
Ir 1 - C12 2.372(2) C25-N12 1.433(14) Cl 1 -Irl -C8  157.9(5)
Ir 1 - C3 2.125(13) C11-N15 Cl 6  124.7(9) C4 -Irl -C12 158.2(4)
Irl-C4 2.096(11) N12-C11-N15 105.6(9) Cl 1-N12-C25 
125.30(9)
The elemental analysis of complex 4.29 gave results consistent with the 
formulation of the compound and crystals suitable for X -ray crystallography 
were obtained by diffusion of n-pentane into a saturated DCM solution of the 
compound. The molecular structure of the complex was unequivocally 
confirmed by means of single X-ray crystallography. Figure 4.9 shows the 
molecular structure of 4.29 which is virtually identical to that of 4.28. The Ir 
centre is in square planar geometry and the Ir-C of 2.045(6) A is in the usual 
range for Ir’-NHC complexes [25, 26]. Selected bond distances and bond angles 
are presented in table 4.9.
C 1 4
C 1 3  *  C 1 5
\  \  C 1 6
S N 3 C2
N1
C 7 C 6
C 5C 1 8
C 1 7in
C 2 0 C24Cf1
C 2 2 C 2 3
Figure 4.9: ORTEP projection o f complex 4.29 excluding hydrogen atoms for
clarity showing atom labelling scheme.
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Table 4.9: Selected bond lengths (A) and bond angles (°) of 4.29.
C l-Irl 2.045(6) Irl-C21 2.196(7) Cl -Irl - C17 93.10(3)
C l-N l 1.357(8) Irl-C22 2.195(6) C l-Irl-C ll 90.04(19)
Irl-C ll 2.3719(16) C1-N2 1.367(8) Cl-Irl-C18 88.5(3)
Irl-Cl 7 2 .1 1 2 (6 ) Cl 1-N15-C16 124.7(9) Cl- Irl- C21 160.0(3)
Irl-Cl 8 2.104(7) N1-C1-N2 103.7(5) C1-N1-C4 124.60(5)
Crystals suitable for X-ray crystallography were not obtained for complex 4.30 
but elemental analysis returned satisfactory results in agreement with the 
proposed structure.
Elemental analysis o f complex 4.31 gave results that are in agreement with the 
formulation of the complex and crystals suitable for X-ray crystallography were 
obtained by diffusion o f n- pentane into saturated DCM solution of the complex. 
The crystal structure and selected bond distances and angles are shown in Figure 
4.10 and Table 4.8 respectively. The iridium exhibits a square planar geometry 
and the Ir-Cl 1 (carbene) bond is typical for an Ir-C single bond [25, 26]. Other 
parameters in terms o f bond lengths and bond angles are similar to that o f 4.28 
and 4.29.
C 3 6
C 6
C 9
C 3 5  
✓ C 3 4
\  \  C 3 1
C 3 7  ^ ' ^ C 3 2  
C 3 0 \  * C 3 3
^28
\ c 2 7
\ N 2 6  C 2 5
\  'X /  }  C 2 4
CT ir. N12
' C13
\ .3 I4n,5
c , 9 \ X £2*C23 
C,ecT7\XlC
N 2 9
C 5
C 4
C 8 ci:
C 2 0
C 2 1
Figure 4.10: ORTEP projection o f complex 4.31 excluding hydrogen atoms for
clarity showing atom labelling scheme.
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Table 4.10: Selected bond lengths (A) and bond angles (°) of 4.31.
Cl 1-Irl 2.022(4) Irl-C 8 2.196(5) Cl 1 -Irl-C4 91.42(11)
C11-N12 1.354(5) Ir l- C7 2.160(4) C 11 -Irl-C12 87.54(12)
Irl -C12 2.3653(11) C11-N26 1.361(5) Cl 1-Irl-C8 168.44(18)
Irl -C3 2.082(4) Cl 1-N12- C13 123.7(3) C8-Irl-C12 82.45(19)
Irl-C4 2.121(4) N12-C11-N26 
104.0(3)
Cl 1-Irl-C7 154.57(19)
To compare the structure o f the three Ir(I) complexes the interplanar angles 
between the planes o f the carbene ring and Ir coordination plane were calculated 
as 0  and tabulated in Table 4.11.
Table 4.11: Bond angles (°) for compounds 4.28, 4.29 and 4.31 of iridium 
complexes of general formula [Ir(Cod)Cl(NHC)].
Compound 0 (interplaner
angle)
N1-C1-N2 C l-Irl-C ll C 11-Irl - 
(C18-C19)
4.28 76.43 105.6(9) 87.70(14) 158.20(4)
4.29 77.79 103.70(5) 90.04(19) 160.00(3)
4.31 86.76 104.03(3) 87.54(3) 168.44(2)
In general, neutral complexes display slight variation in their geometries and the 
main structural features o f these compounds are:
Distorted square planar geometry with Cl-Ir-L of around 87.62° on the 
average for compounds 4.28 and 4.31, and 90.04° for 4.29 (Table 4.11). 
A value of 77.1 l°(on average) with respect to the plane of carbene ring 
and the Ir coordination plane (C l-Ir-C ll) for complexes 4.28 and 4.29 
and 86.76° for complex 4.29 which is almost perpendicular, probably to 
reduce steric interactions.
- C l-Rhl-(Cod) angles for the complexes ranges from 158.20(4)- 
168.44(2)°, with the highest being observed in 4.31, a significant 
variation from the normal square planar(180°).
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Some important bond distances are listed in Table 4.12 in order to see the 
variations in the complexes.
Table 4.12: Other bond distances (A) for complexes of general formula 
[Ir(Cod)Cl(NHC)]
Compound Ir-C Ir-Cl N l-C l Ir-(C15-
C16)
Ir-(C19-
C20)
4.28 2.051(11) 2.372(2) 1.367(15) 2.096(11) 2.177(11)
4.29 2.045(6) 2.372(9) 1.357(8) 2.104(7) 2.196(7)
4.31 2.022(5) 2.365(11) 1.354(5) 2.082(4) 2.196(5)
-The distances between Rh and the NHC ligands are shorter than distances 
between Rh and the Cod, owing to the strong electron donating ability of 
NHCs.
- There is no significant variation in the C-N bond distance of NHCs, with 
an average value o f 1.36 A indicating double bond character (Table 4.12). 
This parameter may vary depending on the degree of back donation from Ir 
to the NHC (more back donation decreases the push mesomeric effect in the 
NHC and increases the C-N distance), based on these observations, it can be 
deduced that all the complexes display the same level of back donation. 
Similarly, from Table 4.11 the N 1-Ccarbene-N2 angles (104.44° on average) 
are very close.
4.27: R = Me 4.32: R = Me
4.31: R = CH2Quin 4.33: R = CH2Quin
Scheme 4.3: Synthesis o f chelated quinoline functionalised Ir(I) NHC 
complexes
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The chelation o f qu inN AC-R with the iridium centre was achieved by the 
treatment o f 4.27 and 4.31 with an equimolar amount AgBF4, leading to the 
ligand substitution o f chloride by the quinoline nitrogen as shown in Scheme 4.3 
above. All of the 'H NMR signals o f the quinoline hydrogen atoms in 4.32 are 
shifted downfleld relative to those in the silver complex 4.20 indicating 
chelation of the q iunN AC-R ligand. The methylene linker protons shifted from 
6.35 and 5.50 ppm for complex 4.20 to 6.80 and 5.90 ppm for complex 4.32 and 
the protons from the imidazole moiety shifted from 6.80, 6.70 ppm to 7.55 and 
6.80 ppm respectively.
Complex 4.33 was not characterized by NMR spectroscopy due to lack of 
suitable solvent for analysis because it is insoluble in most common solvents. In 
high polar solvent such as DMSO, the spectrum of chelated and the non chelated 
complexes are virtually similar possibly due to competitive coordination of 
DMSO. Elemental analysis o f complexes 4.32 and 4.33 returned unacceptable 
results with low percentage o f carbon, nitrogen and hydrogen probably as a 
result of contamination from silver halides.
4.2.3 Attempted synthesis o f Rh(I) and Ir(I) complexes of ligands 
without methylene separating the quinoline
Attempts were made to prepare the Rh(I) and Ir(I) (NHC) complexes o f ligands 
2 (l,3-diquinolin-4,5-dihydroimidazolium tetrafluoroborate) and 4 (1,3-
diquinoline-3,4,5,6-tetrahydropyrimidinium hexaflouro phosphate) by the 
treatment the ligands with the following reagents:
i) Ag20  in dichloromethane, acetonitrile and DMSO
ii) K[N(SiMe3)2 ] and [Rh(COD)Cl]2 in THF
iii) K[N(SiMe3)2 ] and [Ir(COD)Cl]2 in THF
The reaction of the ligands with Ag20  did not yield the expected carbene 
complexes as NMR spectra revealed only the starting salts. Performing the 
reaction at elevated temperature and for longer times did not give the desired 
carbene complexes. However treatment o f the ligands with K[N(SiMe3)2 in THF 
showed that the C2-H has been removed but could not coordinate as addition of 
[ Rh(COD)Cl]2 or [Ir(COD) Cl]2 did not give the desired carbene metal 
complexes.
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Solubility was thought to be responsible for the negative results obtained in the 
preparation o f the silver(I) carbene complexes. With this in mind, it was decided 
to change the tetrafluoroborate and hexafluorophophate counter ions to sodium 
tetrakis [(3, 5-trifluoromethyl) phenyl] borate (NaBArF24). The replacement of 
the counter ion solved the problem of solubility but upon reaction with silver 
oxide followed by [Rh(COD)Cl]2 or [Ir(COD)Cl]2 the desired carbene 
complexes were not formed. After several problems preparing the complexes 
with ligands 2 and 4 we decided to diversify and were successful in the 
synthesis o f a variety o f compounds by slightly varying the structure of the 
ligands.
A variation on this type o f structure has been to add a methylene linker between 
the carbene and the quinoline moiety. This will provide extra flexibility and 
reduce steric strain.
Attempt was also made to synthesise the Rh(I) and Ir(I) (NHC) complexes by 
the reaction of silver(I) (NHC) complex 3.34 prepared in chapter 3 with [Rh 
(COD) Cl]2 and [Ir (COD) Cl]2 in DCM as shown in Scheme 4.4 below.
Scheme 4.4: Attempted o f rigid quinoline functionalised Rh(I) and Ir(I) (NHC) 
carbene complexes.
The reaction did not give the desired product, the NMR looked messy and 
therefore could not be interpreted.
C-H oxidative addition was thought to be another feasible way to obtain the 
rhodium and iridium complexes, though, this would lead to the synthesis of 
Rh(III) and Ir(III) (NHC) carbene complexes. Therefore, following the methods 
reported in the literature [8 ], 1-benzyl-3-quinolinimidazoliumtetraflouroborate 
(6b) was reacted with [Rh (COD)Cl]2 and [Ir(COD)Cl]2 in refluxing acetonitrile 
for 24 hours. However the reaction gave the original mixture, even when the 
reaction was carried out for a longer time (one week). Modification of the 
reaction conditions (refluxing toluene and DMSO) did not produce any of the 
expected products.
+ [M(COD)CI]
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+
+ [MCI(cod)]2
CH3CN/heat
f = \
Scheme 4.5: Attempted o f Rh and Ir carbene complex via oxidative addition
4.3 ir(i) n h c  catalysed hydrogen transfer reactions
4.3.1 Catalysis
A catalyst may be defined as a substance that increases the rate at which a 
chemical reaction approaches equilibrium; thus a catalyst affects the kinetics of 
a reaction rather than the overall thermodynamics [27]. Different catalysts will 
also accelerate one reaction with respect to another, and are thus especially 
valued for their ability to influence product selectivity [28]. In a catalytic cycle, 
the catalyst remained unchanged, aside from degradation or poisoning by side 
reactions.
The importance o f the catalyst can not be over emphasised due to the fact that 
many chemical reactions will not proceed to appreciable extent unless in the 
presence of a suitable catalyst. Apart from the importance o f catalysts to the 
world economy, it is also crucial to the existence o f all living organisms through 
the actions of naturally occurring enzymes. It is worth noting that 75% of all 
chemicals are produced with the application o f some sort of catalyst; and it is up 
to 90% when only those more modem processes are considered [28].
Catalytic reactions are mainly divided into heterogeneous and homogeneous 
systems dependent on the phase relationship o f the catalyst to the substrate. 
Enzymatic catalysis as seen in biological reactions constitutes an additional and 
separate group [27] and these systems are sometimes classified as immobilised 
catalyst [28].
The current work involves homogeneous systems utilising iridium complexes as 
precatalysts, i.e. precursors to the actual catalytic species. The essential
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characteristics o f homogeneous systems have been broadly defined by Comils 
and Herrmann [29]:
i) the catalyst is moderately dispersed in the same phase as the 
reactants;
ii) the catalyst is able to be unequivocally characterised chemically and 
spectroscopically, and thus able to be synthesised in a reproducible 
manner;
iii) new catalysts are able to be rationally designed for specific purposes 
according to known chemical principles;
iv) unequivocally reaction kinetics may be related to each metal atom of 
the catalyst.
Although the catalytic reactions take place at the metal atom, the supporting 
ligands bound to the metal are important for promoting and modifying 
catalytic activity through the prevention o f metal aggregation, stabilisation 
of intermediates, provision o f vacant coordination sites at the metal via 
dissociation equilibria, and modification o f the steric and electronic 
environment about the metal ion [29].
While the market share o f homogeneous catalysis is only 10- 15%, recent 
developments in the application o f transition metal complexes as catalysts 
has led to the prospect o f a wide variety of new, high value organic 
molecules being accessed using relatively simple and affordable substrates 
and procedure [30]. Progress in these areas o f homogeneous catalysis will 
ultimately lead to the synthesis o f highly active, selective, and robust 
catalyst that use cheap substrates to produce important compounds in an 
efficient manner.
Due to time constraints, catalyst testing o f the complexes synthesised in this 
chapter was confined to the hydrogen transfer reduction.
4.5.2 Hydrogen-transfer reduction
The conventional methods for the hydrogenation o f unsaturated bonds have 
involve the use o f molecular hydrogen which has its draw backs due to the 
difficult handling procedures involved with working at high pressures. 
Efforts have since been devoted to developing safer, more cost effective 
methods and transfer hydrogenation represents an ideal alternative.
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Transfer hydrogenation hydrogenates a double bond (e.g. C=C in olefins 
[31], N = 0  [11] in nitro groups and C =0 in carbonyls [33]) by abstracting 
hydrogen from a proton donor source such as isopropanol, usually present in 
excess as the reaction solvent. The reaction is carried out in the presence of 
the catalyst in addition to the base used to assist deprotonation.
The hydrogen transfer reduction o f a carbonyl function catalysed by 
transition metal complexes is well documented [34] and an accepted 
mechanism for the catalytic transfer hydrogenation on the reduction of 
benzophenone is given in Scheme 5 below.
PhCH(OH)Ph
OH
KOH
Ph[lr]
O
Ph
Scheme 4.6: mechanism o f transfer hydrogenation of benzophenone
The attractiveness o f this method lies in its inexpensive starting materials 
and simple experimental procedure, which has been exploited in the 
extensive level o f development in this area. It is generally agreed that this 
research area was spearheaded by Noyori et al in 1995 [35]. They discovered 
that chiral Ru(II) complexes were capable of asymmetric transfer 
hydrogenation at reflux temperature and had sufficient catalytic activity on 
aryl ketones at ambient temperatures. The Noyori catalyst is a Ru(II)Cl2 
centre complexed with chiral (IS , 2S)-N-(p-toluenesulfonyl)-l, 2- 
diphenylethylenediamine [(S,S)-TsDPEN]. Buriak et al explored the 
efficiency o f N-heterocyclic carbene ligands in combination with phosphines
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in hydrogenation o f olefins [36]. Pyridinyl N-Heterocyclic carbene 
complexes have also been used in the reduction of nitroarenes and carbonyls
i n ] .
Rh and Ir are known to be effective catalysts for the transfer hydrogenation 
of unsaturated substrate by hydrogen donors ( e.g. cyclohexene or 2 - 
propanol) [32]. Significantly, transfer hydrogenation of carbonyl compounds 
in iPrOH is the most widely used reaction to test the catalytic properties of 
Rh and Ir because o f its simplicity. It has been established that iridium 
carbene complexes are more active than their rhodium analogues in transfer 
hydrogenation [33].
The catalysis presented in this work involves the use quinoline 
functionalised iridium carbene complexes in transfer hydrogenation.
4.5.3 Results and discussions
The catalytic transfer hydrogenation was examined using 2-propanol as the 
hydrogen source with a KOtBu base promoter.
catalyst, 10% b ase
Scheme 4.7: Catalytic hydrogen transfer o f 4-bromoacetophenone
Two quinoline based iridium carbene complexes were used in catalytic 
hydrogen transfer o f 4-bromoacetophenone:
Me
4.27
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The activity o f iridium complexes 4.27 and 4.31 was tested at different 
concentrations which enable a direct comparison between the effects of the alkyl 
and the quinoline on the N-substituents. The results of the catalytic tests are 
presented in table 4.13 below.
Table 4.13: Catalysis with 4.27 and 4.31 in hydrogen transfer reaction
Entry Catalyst Concentration 
(mole %)
Conversion
(%)
TON
1 4.27 1 99 99
2 4.27 0.1 99 990
3 4.27 0.01 65 6500
4 4.31 1 99 99
5 4.31 0.1 99 990
6 4.31 0.01 78 7800
Conditions: substrate: 1.00 mmol; KOlBu: 1.00 mmol; 80°C; 24hr. Determined 
by NMR.
As presented in the table above, both o f the catalysts showed good catalytic 
activity towards transfer hydrogenation with no significant change when the 
catalyst loading was reduced from 1 mole % to 0.1 mole %. When 0.01 mole % 
of the catalysts was used, the catalysts still showed good activity with virtually 
no difference
In order to evaluate the differences between catalysts 4.27 and 4.31 carbene 
complexes, a low catalyst loading (0.01 mol %) at 80 °C. The yield for the 
transfer hydrogenation o f 4-bromoacetophenone was studied over a period of 3 
hours by taking and running the samples after a given time and the results are 
presented in Figure 4.11 below.
As shown in the diagram below, there is no significant difference between 
catalysts 4.31 and 4.27 as both catalysts appeared to be highly efficient in the 
transfer hydrogenation o f 4-bromoacetophenone to 1-phenylethanol both giving 
over 90% conversion after 180 minutes. The performances o f the iridium 
carbene complexes are comparable to the ones reported by Hahn et al [39], 
though it required longer time to achieve the desired results. It also compares
- 1 4 6 -
C hapter Four: Rh(I) and Ir(I) complexes o f  quinoline functionalised ligands
well with the pyridinyl Ir(I) NHC carbene complexes reported by Peris et al 
[38].
■«— Cat 4.27
Cat 4.33
9 0 -
8 0 -
7 0 -
6 0 -
?  5 0 -
>
4 0 -
3 0 -
2 0 -
200 40 60 80 100 120 140 160 180 200
Time in Minutes
Figure 4.11: Time dependence o f the catalytic transfer hydrogenation of 4- 
bromoacetophenone; 0.01 mol % o f cat. (4.27 and 4.37), KOlBu ( 10 mol%), 10 
mol% of 4-bromoacetophenone, solvent 2-propanol ( 5mL), T = 80 °C
The steric properties o f the carbene may have played important roles in the 
selectivity and reactivity o f the systems. 4.31 is significantly more sterically 
hindered than the 4.27 analogue because o f the presence of the bulky quinoline 
moiety. However this steric differences does not seem to influence the activity 
of the catalyst. Another consideration is partial chelation of the ligand during 
catalysis.
4.4 Conclusions
In this chapter both o f the rhodium(I) carbene complexes and iridium(I) carbene 
complexes were synthesized from the silver(I) carbene described in chapter 3
- 147-
C hapter Four: Rh(I) and Ir(I) com plexes o f  quinoline functionalised ligands
by transmetallation reactions. This procedure was earlier utilised to synthesise 
the iridium pyridinyl NHC complexes [11] producing both chelated and non 
chelated complexes. The replacement of the pyridine moiety with quinoline 
increases the steric bulk which may have significant implications in catalysis. 
While the non chelated carbene complexes were obtained in good yield and 
were fully characterized, the chelated analogues were found to be insoluble in 
most solvents rendering full characterization difficult. To our knowledge the 
rhodium (I) and iridium(I) NHC complexes presented in this work are the first 
of their kind that are functionalised with quinoline except the recent publication 
by Webster et al. The reaction o f quinoline ligands without methylene linker 
under different reaction condition did not give the desired carbene complexes. 
The Ir(I) NHC Complexes tested in transfer hydrogenation reactions showed 
good catalytic activity even at low catalyst loading
4.5 Experimental 
4.5.1 General comments
All reactions were performed under the atmosphere o f dry dinitrogen or argon 
using standard Schlenk techniques, and solvents were purified and dried by 
usual means [40], unless otherwise indicated. Silver(I) NHC complexes were 
prepared as detailed in Chapter 3, and all other reagents were used as received. 
All NMR data are quoted 8/ppm. *H and 13C (proton decoupled) spectra NMR 
were recorded on a Bruker DPX Advance 400 ( *H at 400MHz, 13C at 100.61 
MHz) at ambient temperature, unless otherwise stated, and referenced to SiMe4. 
Electrospray mass spectrometry (ESMS) was performed on a VG Fisons 
Platform II instrument by the department o f Chemistry, Cardiff University. 
Micro analysis was performed by Warwick Analytical Service. All reactions 
involving silver compounds were performed with the exclusion o f light.
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[l-methyl-3->(2-methylquinolme)imidazolin-2-ylidene](l,5- 
cyclooctadiene)rhodium(I) Chloride 4.20
[RhCl(cod)]2 (99mg, 0.2mmol) in 10ml o f DCM  was added to 20 ml of DCM  
solution of [Ag (l-methy-3-(-2-methylquinoline) imidazolin-2 -ylidine)2] [AgCh 
] 3.36 (147mg, 0.40mmol). The reaction mixture was stirred over night and 
filtered through celite to remove silver chloride and any insoluble residue. The 
filtrate was concentrated and hexane was added to precipitate out the desired 
carbene complex as a yellow powder (152mg, 80.42%). Crystals suitable for X- 
ray crystallography were grown by layering diethyl ether on dichloromethane. 
Anal. Calcd. for C22H25N3RhCl: C, 56.20; H, 5.33; N, 8.95%. Found: C, 54.80; 
H, 5.23; N, 8 .66%. 'H  NMR (CDCI3. 400MHZ, 298K): 5 8 .10(d, 1H, J = 8.5 Hz, 
quin-H), 8.00(d, 1H, J = 8.5 Hz, quin-H), 7.75(d, 1H, J = 8.0 Hz, quin-H), 7.70(t, 
2H, J = 6.7 Hz quin-H), 7.45(t, 1H, 7.5 Hz, quin-H), 6.80(s, 2H, CHHC), 6.50(d, 
1H, J = 14.8 Hz CH2ii„ker), 5.60(d, 1H, J = 14.8 Hz CH2lmkc[), 5.00(broad, 2H, 
COD), 4.10(s, 3H, CH3), 3.40(broad, 1H, COD), 3.20(broad, 1H, COD), 2.30(m, 
4H, j=  4.4 Hz, COD), 1.90(m, 4H, J = 4.2 Hz COD). 13C NMR (CDCL3, 
100MHz, 298K): 181.60 (C-Rh), 154.88, 145.53, 135.57, 127.82, 127.05, 
125.86, 125.73, 124.78, 120.78, 118.99, 118.87, 96.93(N-CH3), 66.32, 54.96, 
35.83, 31.33,30.65,27.20, 26.66.
[l-mesityl--3-(2-mc1hylquinoline)imida/.olin-2-ylidenc](l,5- 
cyclooctadiene)rhodium(I) Chloride 4.21
f=\
^  Rh
Following the procedure for the synthesis o f complex 4.20, 4.21 was obtained 
from 3.37 (110 mg, 0.23mmmol) and [RhCl(cod)]2 (58 mg, 0.12mmol) . Yield = 
95 mg (71.00%). Crystals suitable for X- ray crystallography were grown by
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layering diethyl ether on dichloromethane. Anal. Calcd. for C30H33N3RI1CI: C, 
62.78; H, 5.76; N, 7.32%. Found: C, 61.44; H, 5.48; N, 7.06%. ‘H NMR 
(CDCI3. 400MHZ, 298K): 5 8.15(m, 1H,J = 8.4 Hz. quin-H), 8.00(d, 1H,J = 8.1 
Hz. quin-H), 7.80(d, 1H, J = 5.7 Hz quin-H), 7.70(s, 1H, Ar-H), 7.50(t, 2H, J =
7.0 Hz, quin-H), 7.05(t, 2H, quin-H, Ar-H), 6.90( s, 1H, CHHC), 6,70(s, 1H, 
CH HC), 6.50(d, 1H, J = 15.4 H z , C H 2ii„ker), 6.10(d, 1H, J = 15.4 H z CH2iinker), 
4.80(broad, 2H, COD), 3.30(broad, lH,COD),3.00(broad, 1H, COD), 
2.40(broad, 3H, COD), 2.30(s, 3H, p-CH3), 1.80(s, 6H, 0 -CH3), 1.50(broad, 4H, 
COD). I3C NMR (CDCL3,100M HZ, 298K): 155.03, 145.70, 136.61,
135.05, 134.97, 134.01, 132.36, 127.68, 127.52, 126.16, 125.69, 125.48, 124.62, 
121.19, 119.73,118.75, 95.44(NCH2), 55.14, 31.56, 29.58, 26.93, 25.95(p-CH3), 
19.06(o-CH3), 17.06, 15.75. HR-MS for [M -  C l f  = 538.18(100%); calculated, 
538.1730(C30H33N3Rh), found, 538.1751.
[l-isopropyl-3-(2-methylquinoline)imidazolin-2-ylideiie](l,5- 
cyclooctadiene)rhodium(I) Chloride 4.22
Rh
Following the procedure for the synthesis o f complex 4.20, 4.22 was obtained 
from 3.38 (134mg, 0.276mmmol) and [RhCl(cod) ] 2  (68 mg, 0.14mmol) . Yield 
= 110 mg (80.29%). Crystals suitable for X- ray crystallography were grown by 
layering hexane on dichloromethane. Anal. Calcd. for C2 4H29N3RI1CI: C, 57.90; 
H, 5.83; N, 8.4%. Found: C, 53.85; H, 5.59; N, 7.47%. ‘H NMR (CDCI3. 
400MHZ, 298K): 6 8.10(m, 1H, J = 8.5 Hz, quin-H), 8.00(d, 1H, J = 8.4 Hz 
quin-H), 7.70(d, 1H, J = 8.1 Hz quin-H), 7.65(t, 2H, J = 4.1 Hz, quin-H), 7.45( t, 
1H, J = 7.0 Hz, quin-H), 6.80( s, 2H, CHHC), 6.50(d, 1H, J = 14.8 Hz, CH2|inker), 
5.75(m, 1H, J = 6.8  Hz. iPr-H), 5.60(d, 1H, J = 14.8 Hz CH2|inker), 5.00(m, 1H, J 
= 7.6 Hz, COD), 4.90(m, 1H, J = 5.2 Hz ,COD), 3.35(m, 1H, J = 2.6 Hz, COD),
2.1 -2.40(m, 4H, J = 4.5 Hz COD), 1.7-2.00(m, 4H, J = 6.6 Hz, COD), l,5(d, 6H, 
J = 4.2 Hz CH3). I3C NMR (CDCL3,100MHZ, 298K); 180.38(C-Rh), 155.00,
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145.53, 135.60, 127.80, 127.04, 126.74, 125.87, 125.73, 124.76,119.22, 115.25, 
97.17,66.24, 55.19, 50.17, 31.50, 30.46, 27,38, 26.45, 22.19, 21.36, 20.72. HR- 
MS for [M -  Cl]+ = 462.1415(100%): calculated, 462.1417(C24H29N3Rh), found, 
462.1415.
[ 1 -n-buty l-3-(2-methy lq u inoline)imidazolin-2-y lidene] (1,5- 
cyclooctadiene)rhodium(I) Chloride 4.23
JCI
Rh
Following the procedure for the synthesis o f complex 4.20, 4.23 was obtained 
from 3.39 (150mg, 0.300mmmol) and [RhCl(cod)]2 (74 mg, 0.15mmol). Yield 
= 121 mg (79.08%). Crystals suitable for X- ray crystallography were grown by 
layering hexane on dichloromethane. Anal. Calcd. for C25H31N3RI1CI: C, 58.66; 
H, 6.06; N, 8.21%. Found: C, 58.44; H, 6.48; N, 7.37%. ‘H NMR (CDCI3. 
400MHz, 298K): 5 8.10(m, 1H, J = 9.5 Hz, quin-H), 8.00(d, 1H, J = 8.4 Hz, 
quin-H), 7.75(d, 1H, J = 7.9 Hz, quin-H), 7.65(t, 2H, J = 4.8 Hz quin-H), 7.45( t, 
1H, quin-H), 6.75( s, 2H, CH H C), 6.50(d, 1H, J = 14.8 Hz, CH2iinker), 5.60(d, 
1H, J = 14.8 Hz ,C H 2ii„ke,), 5.00(broad, 2H, COD), 4.50(m, 2H, J = 6.1 Hz, 
CH2), 3.30(m, 2H, J = 2.3 Hz, COD), 2.40(m, 2H, J = 3.3 Hz CH2),1.8(m, 4H, J 
= 2.4 Hz ,COD) 1,40(m 2H, J = 7.4, CH2), 1,0(t, 3H, J = 7.4 Hz, CH3). 13C NMR 
(CDCL3, 100MHz, 298K): 178.66(C-Rh), 155.72, 146.45, 136.45, 128.73, 
127.97, 126.76, 126.62, 125.67, 119.86, 119.73, 115.80, 84.35, 83.04, 55.73,
52.42, 50.97, 33.20, 31.87, 29.14, 28.03, 22.97, 22.08. HR-MS for [M-Cl]+= 
476.1578(100%): calculated, 476.1573(C24H29N3Rh), found, 476.1578.
[bis-l^-(2-methyIquinoIme)imidazolin-2-ylidene](l,5- 
cyclooctadiene)rhodium(I) Chloride 4.24
Rh
- 151 -
C hapter Four: Rh(I) and Ir(I) complexes o f  quinoline functionalised ligands
Following the procedure for the synthesis of complex 4.20, 4.24 was obtained 
from 3.41 (300mg, 0.600mmmol) and [RhCl(cod) ] 2  (150 mg, 0.30mmol) . Yield 
= 250 mg (68.87%). Crystals suitable for X- ray crystallography were grown by 
layering hexane on dichloromethane. Anal. Calcd. for C31H30N4RI1CI: C, 62.37; 
H, 5.03; N, 9.39%. Found; C , 61.59; H, 5.13; N, 8.967%. 'H NMR (CDCI3 . 
400MHz, 298K): 6  8.10(m, 2H, J = 8.5 Hz, quin-H), 8.00(d, 2H, J = 8.4 Hz, 
quin-H), 7.75(d, 2H, J = 8.1 Hz, quin-H), 7.65(m, 4H, J = 4.8 Hz, quin-H), 7.50( 
t, 2H, J = 7.0 Hz, quin-H), 6.85( s, 2H, CHHC), 6.50(d, 1H, J = 14.9 Hz 
C H 2ii„ker), 5.80(d, 1H, J = 14.8 Hz C H 2ii„ker), 5.00(broad, 2H, COD), 4.50(broad, 
2H,CH2), 3.30(m, 2H, J = 2.7 Hz, COD), 2.30(m, 4H, J = 4.0 Hz, COD),1.90(m, 
4H, J = 8.5 Hz, COD). 13C NMR (CDCLj, 100MHZ, R.T): 183.45(C-Rh), 
155.64, 146.52, 136.52, 128.78, 128.03, 126.75, 126.61, 125.74,120.58, 119.78, 
98.38(CH2) 67.93, 55.92, 32.84, 30.56, 27.81, 26.98, 21.63. HR-MS for [M- 
Cl]+= 561.1548(100%); calculated, 561.1526(C3|H3oN4Rh), found, 561.1548.
[ 1 -methy l-3-(2-m ethy lq uinoline)imidazolin-2-y lidenej (1,5- 
cyclooctadiene)rhodium(I) tetraflouroborate 4.25
AgBF4 (26 mg, 0.132mmol) was added to a stirred solution of complex 4.20 (62 
mg, 0.132mmol) in 10 ml of DCM. The reaction mixture was stirred for 1 hour 
and reaction filtered through celite to remove silver chloride and any insoluble 
residue. The filtrates was then added drop by drop to a stirring solution of 
hexane to precipitate the compound which was then dried in vacuum to afford 
the desired compound as a deep yellow powder(42 mg, 60.87%). Anal. Calcd. 
for C22H25N 3RI1BF4 : C, 50.70; H, 4.80; N, 8.07%. Found: C, 42.18; H, 4.26; N, 
6.20%. ‘H NMR (CDCI3 . 400MHZ, 298K): 5 8.75(d, 1H, J = 8.5 Hz, quin-H), 
8.25(d, 1H, J = 8.3 Hz, quin-H), 8.10(d, 1H, J = 8.3 Hz, quin-H), 7.85(t, 2H, J =
8.2 Hz,quin-H), 7.60(d, 2H, CHHC, J = 5.3 Hz, quin-H), 6.65(s, 1H, CHHC), 
6.25(d, 1H, J = 15.4 H z , CH2|mlt,), 6.05(d, 1H, J = 15.4 H z, C H 2ii„ker), 
5.50(broad, 1H, COD), 4.70 (broad, 1H, COD), 4.40(broad, 2H,
COD),4.10(broad, 1H, COD), 3.65(s, 3H, CH3), 2.80(broad, 1H, COD),
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2.40(broad, 4H, COD), 2.10(broad, 2H, COD). HRMS for [M-BF4]+: calculated 
for C2 2H2SN3RI1 (M+)434.1104, found, 434.1117.
[l-methyl-3-(2-methylquinoline)iniidazoliii-2-ylidene](l,S- 
cyclooctadiene)iridium(I) Chloride 4.27
/= \
Me-Ny N
[IrCl(cod) ] 2  (180mg, 0.27mmol) in 10ml of DCM was added to 20 mL of DCM 
solution of [Ag (l-methy-3-(-2-methylquinoline) imidazolin-2-ylidine) 2][AgCl2  
] 3.36 (196mg, 0.54mmol). The reaction mixture was stirred over night and 
filtered through celite to remove silver chloride and any insoluble residue. The 
filtrate was concentrated and hexane was added to precipitate the desired 
carbene complex as a yellow powder (210mg, 70.23%). Crystals suitable for X- 
ray crystallography were grown by layering hexane on dichloromethane. Anal. 
Calcd. for C2 2H25N3I1CI: C, 47.25; H, 4.48; N, 7.52%. Found: C, 46.83; H, 4.51; 
N, 6.14%. 'H NMR (CDCI3 . 400MHZ, 298K): 6  8.10(d, 1H, J = 8.5 Hz, quin- 
H), 8.00(d, 1H, J = 8.4 Hz, quin-H), 7.75( d, 1H, J = 8.1 Hz, quin-H), 7.65(t, 1H, 
J =5.6 Hz, quin-H), 7.60(t, 1H, J = 8.5 Hz, quin-H), 7.45(d, 1H, J = 5.6 Hz, 
quin-H), 6.80(s, 1H, CHHC), 6.70(s, 1H, CHHC), 6.35(d, 1H, J = 14.7 Hz, 
C H 2linker), 5.50(d, 1 H, J = 14.7 Hz, CH2,inker), 4.60(m, 2 H, J = 4.6 Hz, COD), 
3.90(s, 3H, CH3), 3.00(m, 1H, J = 4.4 Hz, COD), 2.80(m, 1H, J = 4.10 Hz, 
COD), 2.20(m, 4H, J = 3.2 Hz, COD), 1.70(m, 4H, J = 3.3 Hz, COD). 13C NMR 
(CDCL3, 100MHz, R.T): 180.02 (C-Rh), 155.56, 146.43, 136.42, 128.75,
127.96, 126.75, 126.60, 125.70, 121.38, 119.68, 119.43, 83.40(N-CH3), 55.48, 
51.00(, 36.44), 32.91, 32.12, 30.56, 28.18, 21.63.
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l-mesityI-3-(2-methylquinoline)imidazolin-2-ylidenel(l,5- 
cyclooctadiene)iridium(I) Chloride 4.28
Mes
Following the procedure for the synthesis o f complex was obtained from 3.37 
(200 mg, 0.425mmmol) and [IrCl(cod)]2 (140 mg, 0.21 mmol) . Yield: 151 mg 
(53.55%). Crystals suitable for X- ray crystallography were grown by layering 
hexane on dichloromethane. Anal. Calcd. for C3oH33N3lrCl: C, 54.32; H, 4.98; 
N, 6.34; Cl, 5.37%. Found: C, 53.59; H, 5.08; N, 6.07; Cl, 5.25%. ]H NMR 
(CDC13. 400MHZ, 298K): 6 8.15(m, J -  8.4 Hz, 1H, quin-H), 7.90(d, 1H, J = 8.0 
Hz. quin-H), 7.80(d, 1H, J = 8.1 Hz, quin-H), 7.70(d, 2H, J = 7.0 Hz, Ar-H), 
7.50( t, 1H, J = 7.7 Hz, quin-H), 7.40(t, 1H, J -  10.3 Hz, quin-H), 7.30(t, 1H, J =
7.8 Hz, quin-H ,), 7.1( s, 1H, CHHC), 6,70(s, 1H, CHHC), 6.25(d, 1H, J = 15.2 
Hz, C H 2iinker), 5.95(d, 1H, J = 15.3 Hz, C H 21inker), 4.40(broad, 2 H, COD), 2.90(m, 
lH,COD),2.70(m, 1H, J = 4.8 Hz, COD), 2.30(broad, 4H, COD), 2.2(s, 3H, p- 
CH3), 1.80(s, 6H, o-CH3), 1.50(m, 4H, J = 5.9 Hz, COD). 13C NMR (CDCL3, 
100MHz, 298K):
[ 1 -isopropy l-3-(2-m ethy lq u in o line)im idazolin-2-y liden e | (1,5- 
cyclooctadiene)iridium(I) Chloride 4.29
Following the procedure for the synthesis o f complex was obtained from 3.38 
(120mg, 0.250mmmol) and [IrCl(cod)]2 (83 mg, 0.13mmol) . Yield 121 mg 
(73.78%). Crystals suitable for X- ray crystallography were grown by layering 
hexane on dichloromethane. Anal. Calcd. for C24H29N3lrCl: C, 49.09; H, 4.94; 
N, 7.16%. Found: C, 47.98; H, 5.44; N, 6.98%. 'H NMR (CDCI3 . 400MHZ, 
298K): 6 8.10(m, 1H, J = 8.5 Hz, quin-H), 8.00(d, 1H, J = 8.4 Hz, quin-H), 
7.70(d, 1H, J = 8.2 Hz, quin-H), 7.65(t, 1H, J = 5.8 Hz, quin-H), 7.60( d, 1H, J =
- 154-
C hapter Four: Rh(I) and Ir(I) complexes o f  quinoline functionalised ligands
8.5 Hz, quin-H), 7.45(d, 1H, J = 7.0 Hz, quin-H), 6.80( s, 2H, CHHC), 6.35(d, 
1 H, J = 14.8 Hz, CH 2ii„ker), 5.60(m, 1H, J = 6.8  Hz, iPr-H), 5.50(d, 1H, J = 14.8 
Hz. CHniake,), 4.60(m, 1H, J = 3.5 Hz, COD), 4.50(m, 1H, J = 4.2 Hz, COD), 
3.0(m, 1H, J =5.2 Hz, COD), 2.80(m, 1H, J = 4.0 Hz, COD), 2.20(m, 4H, J =
6.9 Hz, COD), 1.6(m, 4H, J = 6 .6  Hz, COD), l,3(d, 6H, J = 8.0 Hz, CH3). 13C 
NMR (CDCLj, 100MHz, R.T): 178.66(C-Ir), 155.72, 146.45, 136.45, 128.73,
127.97, 126.76, 126.62, 125.67, 124.76, 119.86, 115.80,84.35, 83.04, 55.73,
52.42, 51.23, 33.20, 31.87, 29.14, 28.03, 22.97, 22.08. LRMS-ES for [M -  Cl]+ 
= 552.23(100%).
[l-n-butyl-3-(2-methylquinoline)iniidazolin-2-ylidene](l,5-cyclooctadiene) 
iridium(I) Chloride 4.30
Following the procedure for the synthesis o f complex was obtained from 3.39 
(150mg, 0.30mmol) and [IrCl(cod)]2 (74 mg, 0.15mmol) . Yield: 125 mg 
(69.44%). Anal. Calcd. for C25H3iN3IrCl: C, 49.94; H, 5.16; N, 6.99%. Found: 
C, 49.42; H, 5.43; N, 4.86%. 'H  NMR (CDC13. 400MHZ, 298K): 5 8.1(m, 1H, J 
= 8.5 Hz quin-H), 8.0(d, 1H, J = 8.5 Hz, quin-H), 7.75(d, 1H, J = 8.0 Hz, quin- 
H), 7.65(t, 1H, J = 7.1 Hz quin-H), 7.55( d, 1H, J = 8.5 Hz, quin-H), 7.45( d, 1H, 
J = 7.1 Hz quin-H), 6.80( s, 2H, CHHC), 6.35(d, 1H, J = 14.8 Hz. CH2li„ker), 
5.55(d, 1H, J = 14.8 Hz, CH2ii„ker), 4.60(broad, 2H, COD), 4.40(m, 2H, J = 6.0 
Hz, CH2), 2.90(m, 2H, J = 7.3 Hz COD), 2.20(m, 2H, J = 5.5 Hz CH2), 1.60(m, 
4H, J = 8.3 Hz, COD) 1.4(m 2H, J = 7.3 Hz, CH2), 1.00(t, 3H, J = 7.3 Hz, CH3). 
13C NMR (CDCL3, 100MHz, R.T): 179.56(C-Ir), 155.67, 146.44, 136.43, 
128.73, 127.97, 126.75, 126.61, 125.68, 119.73, 119.57, 119.47, 83.93, 83.64, 
55.65, 51.07, 50.79, 49.27, 32.58, 31.91, 30.56, 29.94, , 28.55, 21.63, 19.04, 
13.12.
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[bis-1 3 -(2 ~methylquinolme)imidazolm-2 -ylidene](l,
cyclooctadiene)iridium(I) Chloride 4.31
5-
Following the procedure for the synthesis o f complex was obtained from 3.41 
(300mg, 0.600mmmol) and [IrCl(cod)]2 (200 mg, 0.30mmol) . Yield: 261 mg 
(62.14%). Crystals suitable for X- ray crystallography were grown by layering 
hexane on dichloromethane. Anal. Calcd. for C31H30N4I1CI: C, 54.23; H, 4.37; 
N, 8.16%. Found: C, 53.73; H, 4.30; N, 7.71%. 'H NMR (CDCI3. 400MHZ, 
298K): 5 8.1(m, 2H, J = 8.5 Hz, quin-H), 8.00(d, 2H, J = 8.5 Hz, quin-H), 
7.75(d, 2H, J = 8.2 Hz. quin-H), 7.65(m, 4H, J = 4.6 Hz, quin-H), 7.50( t, 2H, J 
= 7.0 Hz, quin-H), 6.85( s, 2H, CHHC), 6.25(d, 1H, J = 14.9 Hz, CH2 ii„ker), 
5.65(d, 1H, J = 14.9 Hz, CH 2ii„ker), 4.60(m, 2H, J = 2.8 Hz, COD), 2.90(m, 2H, 
J = 3.0 Hz, COD), 2.10(m, 4H, J = 3.4 Hz, COD), 1.70(m, 4H, J = 11.6 Hz, 
COD). I3C NMR (CDCL3> 100MHZ, 298K): 180.57(C-lr), 155.43, 146.52, 
136.48, 128.81, 128.03, 126.74, 126.60, 125.75, 120.25, 119.60, 84.73(CH2) 
64.85, 55.53, 51.48, 32.47, 28.48, 14.26.
1 -methy l-3-(2-methy lq u inoline)im idazolin-2-y lidene | (1,5- 
cyclooctadiene)iridium(I) tetraflouroborate 4.32
AgBF4 (18 mg, 0.092mmol) was added to a stirred solution of complex 4.27(50 
mg, 0.089mmol) in 10 ml o f  DCM. The reaction mixture was stirred for 1 hour 
and reaction filtered through celite to remove silver chloride and any insoluble
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residue. The filtrates was then added drop by drop to a stirring solution of 
hexane to precipitate the compound which was then dried in vacuum to afford 
the desired compound as a deep yellow powder(42.00 mg, 60.87%). Anal. 
Calcd. for C22H25N3IrBF4: C, 43.33; H, 4.09; N, 6.89%. Found: C, 35.11; H, 
3.10; N, 5.09%. 'H  NMR (CDC13. 400MHZ, 298K): 5 8.80(d, 1H, J = 8.6 Hz, 
quin-H), 8.25(d, 1H, J = 8.4 Hz, quin-H), 8.10(d, 1H, J = 8.4 Hz, quin-H), 
7.90(t, 1H, J = 8.2 Hz, quin-H), 7.85(t, 1H, J = 8.2 Hz, quin-H), 7.60(t, 1H, J = 
7.7 Hz, quin-H), 7.55(s, 1H, CHHC), 6.80(s,lH, CHHC),5.90(d, J = 15.4 Hz, 
1H, CH2ii„to), 5.70(d, 1H, J = 15.4 Hz, CH2ii„ker), 5.50(broad, 1H, COD), 4.70 
(m, 1H, J = 5.2 Hz, COD), 4.00(m, 2H, J = 8.4 Hz, COD),3.80(m, 1H, J = 4.2 
Hz, COD), 3.70(s, 3H, CH3), 2.75(m, 1H, J = 10.2 Hz, COD), 2.3(m, 4H, J = 
7.4 Hz, COD), 2.0(m, 2H, J = 6.7 Hz, COD).
4.5.2: Catalysis
General Comments. All air sensitive experiments were performed under 
nitrogen atmosphere in an MBraun glove box or under dinitrogen by standard 
Schlenk techniques. Isopropanol was distilled from calcium hydride under N2 
atmosphere. The iridium complexes were synthesised as described above and lH 
NMR spectra were recorded using a Bruker Advance D P X 4 0 0  spectrometer.
4.5.3 Transfer hydrogenation
The iridium catalyst precursor was dissolved in a solution of KlBuO (1 mmol) in 
2-propanol and 4-bromoacetophenone (1 mmol) was added in a Schlenk tube. 
The solution heated to 353K for 24 hours, volatiles were evaporated and the 
percentage conversion was calculated by 'H  NMR.
The progress o f the reaction was monitored by GC-MS analysis in order to 
calculate the time dependence o f the transfer hydrogenation of 4- 
bromoacetophenone. Aliquots o f 0.1 mL were taken every 10 minutes for the 
first 1 hour and every 30 minutes for the next hours. The samples were filtered 
through a short pad o f silica, and the silica was washed with DCM.
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4.5.4 X-Ray crystallography
Standard conditions as outlined in section 2.4.7 were used.
Table 4.14: Crystal data and structure refinement for 4.20
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness o f theta = 27.47° 
Absorption correction 
Max and min. transmission
Refinement method
Data/restraints/parameters
Goodness o f fit on F
Final R indices [I>2 sigma(I)]
R indices (all data)
Largest diff. peak hole
C22H25RhN3Cl 
469.81 
150(2) K 
0.71073 A 
Triclinic 
P-l
a = 7.5160(2) A a = 94.2310(10)°
b = 11.4580(3) A p = 99.2930(10)°
c = 11.6750(4) A y = 99.204(2)° 
974.31(5) A3 
2
1.602Mg/m3
1.025mm-l
480
0.13 x 0.07 x 0.01 mm3
3.03 to 27.47°
-9<=h<=9, -14<=k<=14, -15<=1<=15 
15668
4449[Rint = 0.1609]
99.50%
Semi-empirical from equivalents 
0.8782 and 0.9898
Full matrix least square on F2
4449/0/245
1.044
R1 =0.1609, wR2 = 0.1153 
R1 =0.641, wR2 = 0.1488 
1.426 and-2.812e A'3
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Table 4.15: Crystal data and structure refinement for 4.21
C3oH33RhN3ClEmpirical form ula 
Formula w eight 
Temperature 
Wavelength 
Crystal system  
Space group 
Unit cell dim ensions
Volume
Z
Density (calculated)
Absorption coefficient 
F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness o f theta = 27.51° 
Absorption correction 
Max and m in. transmission
Refinement method
Data/restraints/parameters
Goodness o f  fit on F
Final R indices [I>2 sigma(I)]
R indices (all data)
Largest diff. peak hole
573.95 
150(2) K 
0.71073 A 
Orthorhombic 
P212121
a = 9.9380(2) A a = 90°
b =  14.6240(3) A p = 90°
c =  17.8520(4) A y = 90°
2594.49(9) A3 
4
1.469Mg/m3
0.785mm-l
1184
0.10 x 0.05 x 0.05 mm3
3.03 to 27.51 0 
-10<=h <12, -18<=k<= 18, -23<=1<=23 
43795
5932[Rint = 0.0689]
99.60%
Semi-empirical from equivalents 
0.9618 and 0.9256
Full matrix least square on F2
5932/0/319
1.053
R1 = 0.0537, wR2 = 0..0882 
R1 = 0..0423, wR2 = 0.0836 
0.560 and-0.722e A'3
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Table 4.16: Crystal data and structure refinement for 4.22
C24H30RI1N3CIEmpirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness o f theta = 27.61° 
Absorption correction 
Max and min. transmission 
Refinement method 
Data/restraints/parameters 
Goodness o f fit on F2 
Final R indices [I>2 sigma(I)] 
R indices (all data)
Largest d iff peak hole
540.33 
150(2) K 
0.71073 A 
Orthorhombic 
P212121
a = 13.1930(10) A a = 90°
b = 20.8640(2) A p = 90°
c = 8.5280(4) A y -  90°
2347.41(11) A3 
4
1.529Mg/m3 
0.972mm-1 
1108
0.25 x 0.22 x 0.10 mm3
3.01 to 27.61 0
-17<=h< 17, -26<=k<=27, -10<=1<=11 
38012
5371 [Rjnt = 0.0669]
98.70%
Semi-empirical from equivalents 
0.9090 and 0.7931 
Full matrix least square on F2 
5371/3/292
1.057
R1 =0.0669, wR2 = 0.1103 
R1 = 0..0457, wR2 = 0.0996 
0.840 and-0.902e A'3
Table 4.17: Crystal data and structure refinement for 4.23
Empirical formula C25H31RI1N 3CI
Formula weight 511.89
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Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F000
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflection
Completeness o f theta = 27.53°
Absorption correction
Max and min. transmission
Refinement method
Data/restraints/parameters
Goodness of fit on F
Final R indices [I>2 sigma(I)]
R indices (all data)
Largest diff. peak hole
150(2) K 
0.71073 A 
Triclinic 
P-l
a =  10.0680(3) A a = 95.0950(10)°
b = 10.6960(3) A (3 = 91,6400( 10)°
c = 10.8350(4) A y = 98.0910(10)°
1149.61(6) A3 
2
1.479Mg/m3
0.876mm-l
528
0.50 x 0.50 x 0.05 mm3
3.01 to 27.53 °
-12<=h< 13, -13<=k<=13, -14<=1<= 14 
19594
5209[Rint = 0.0956]
98.50%
Semi-empirical from equivalents 
0.9575 and 0.6686 
Full matrix least square on F2 
5371/3/292 
1.060
R1 = 0.0851, wR2 = 0.1124 
R1 -  0..0504, wR2 = 0.0978 
0.747 and-1.059e A'3
Table 4.18: Crystal data and
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system
structure refinement for 4.24
C31H30RI1N4CI 
600.90 
150(2) K 
0.71073 A 
Triclinic
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Space group 
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness o f theta = 27.643° 
Absorption correction 
Max and min. transmission 
Refinement method 
Data/restraints/parameters 
Goodness of fit on F2 
Final R indices [I>2 sigma(I)]
R indices (all data)
Largest diff. peak hole
P-l
a = 11.8769(2) A a = 89.9829(10)°
b = 11.9874(2) A P = 118.0475(10)° 
c = 12.3176(2) A y = 106.1171(9)° 
1469.26(4) A3 
2
1.541Mg/m3
0.883mm-l
696
0.25 x 0.25 x 0.38 mm3 
3.114 to 27.643°
-15<=h< 15, -15<=k<=15, -15<=1<=16 
24833
11368[Rint = 0.052]
97.20%
Semi-empirical from equivalents 
0.800 and 0.800 
Full matrix least square on F2 
11368/0/362 
0.9877
R1 = 0.0526, wR2 = 0.1120 
R1 =0.0461, wR2 = 0.1073 
1.63 and-1.88e A'3
Table 4.19: Crystal data and
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
structure refinement for 4.28
C3oH33lrN3Cl
663.28 
150(2) K 
0.71073 A 
Orthorhombic 
P212121
a = 9.9463(2) A a = 90°
b =  14.5997(3) A 0 = 90°
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Volume
c =  17.8669(5) A 1 = 90° 
2594.51(10) A3
Z 4
Density (calculated) 1.698Mg/m3
Absorption coefficient 5.273mm-1
F000 1312
Crystal size 0 .0 4 x 0 .1 7 x 0 .3 8  mm3
Theta range for data collection 3.014 to 27.394°
Index ranges -12<=h< 10, -18<=k<=18, -23<=1<=:
Reflections collected 42001
Independent reflection 5841[Rint = 0.199]
Completeness o f theta = 27.394° 99.30%
Absorption correction Semi-empirical from equivalents
Max and min. transmission 0.8100 and 0.4100
Refinement method Full matrix least square on F2
Data/restraints/parameters 5841/0/317
Goodness o f fit on F2 0.5948
Final R indices [I>2 sigma(I)] R1 =0.0740, wR2 = 0.1219
R indices (all data) R1 = 0.0422, wR2 = 0.997
Largest diff. peak hole 2.85 and-3.59e A’3
Table 4.20: Crystal data and structure refinement for 4.29
Empirical formula C24H3oIrN3Cl
Formula weight 629.61.28
Temperature 150(2) K
Wavelength 0.71073 A
Crystal system Orthorhombic
Space group P212121
Unit cell dimensions a = 8.562(2) A a = 90°
Volume
b =  13.267(3) A p = 90° 
c = 21.012(5) A y = 90° 
2386.80(10) A3
Z 4
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Density (calculated)
Absorption coefficient 
F000
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness o f theta = 33.73° 
Absorption correction 
Max and min. transmission 
Refinement method 
Data/ restraints/parameters 
Goodness o f fit on F 
Final R indices [I>2 sigma(I)]
R indices (all data)
Largest d iff peak hole
1.752Mg/m3
5.835mm-l
1236
0.20  x 0.20 x 0.10  mm3
2.57 to 33.73 °
-13<=h< 13, -20<=k<=20, -32<=1<=32 
9511
9511[Rint = 0.0589]
99.80%
Semi-empirical from equivalents 
0.5930 and 0.3882 
Full matrix least square on F2 
9511/9/291 
1.036
R1 =0.065, wR2 = 0.1242 
R1 = 0.0500, wR2 = 0.1144 
3.528 and-2.850e A'3
Table 4.21: Crystal data and structure refinement for 4.31
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated) 
Absorption coefficient 
F000
C3iH3oIrN4Cl
686.28 
150(2) K 
0.71073 A 
Triclinic 
P -  1
a = 6.59420(10) A 
b =  12.1294(2) A 
c = 17.2628(3) A 
1298.61(4) A3 
4
1.755Mg/m3 
5.272mm-1 
676
a  = 104.4358(8)° 
P =  100.9896(8)° 
y = 97.8041(10)°
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Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflection 
Completeness o f theta = 23.503° 
Absorption correction 
Max and min. transmission
Refinement method 
Data/restraints/parameters 
Goodness o f fit on F2 
Final R indices [I>2 sigma(I)]
R indices (all data)
Largest diff. peak hole
0.15 x 0.20 x 0.38 mm3 
3.158 to 27.503°
-8<=h< 7, -15<=k<= 15, -21 <=1<=22 
22471
21713[Rint = 0.073]
99.50%
Semi-empirical from equivalents
0.45 and 0.35
Full matrix least square on F 
10018/0/335
0.9719
R1 =0.0469, wR2 = 0.1073 
R1 =0.0417, wR2 = 0.1029 
2.13 and-1.79e A'3
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CHAPTER FIVE
5.1 Conclusions
Ligands containing both phosphorus and nitrogen donor have been shown to 
form strong metal phosphorus bonds and weak nitrogen bonds [1] and are 
important in many catalytic reactions [2, 3]. In realisation o f this many groups 
have made the natural progression from unidentate mono carbenes towards 
mixed donor chelating carbenes. The interest stems from the potential 
advantages a hemilabile ligand may offer to a catalytic reaction. A number of 
research groups have successfully incorporated a second donor to the carbene 
ligand, with early progress being made with pyridine functions as the N- 
substituents [1 ,4 , and 5]. In furtherance o f the use o f a hemilabile group on N- 
substituents quinoline based imidazolium salts were thought to be ideal 
candidates. Towards this end, a series o f quinoline based imidazolidinium salts 
have been synthesised and characterised as precursors to the corresponding 
NHC ligands. A range o f  N-substituents imparts variable steric bulk to the 
imidazolium rings.
Crystallographically characterised examples include the saturated 1,3- 
diquinolin-4, 5-dihydroimidazoluim tetraflouroborate 2b, the unsaturated 
imidazolium salts 6a-6c, and the analogous methylene bridged quinoline- 
functionalised imidazolium salts 9a- 9f.
An additional example reported includes the acridine based imidazolium salt 16 
which can offer a secondary donor group for chelation as well as sp3 hybridized 
carbons. The sp3 hybridized carbon can make the ligand chiral and increase the 
steric bulk if required.
Quinoline based pyrimidinium salt 4 was also prepared following the same 
procedure for 2b was crystallographically characterised. All the quinoline based 
salts are new compound as there is no reported synthesis o f any o f them 
A g ^ H C )  complexes have reported to be a versatile transmetallation reagents 
for the preparation o f transition metal- NHC complexes. Accordingly, a range of 
Ag1 complexes o f methylene bridge quinoline functionalised NHC ligands were 
prepared by reaction o f the corresponding imidazolium salts with Ag20  in
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DCM. O f these Ag*(NHC) complexes 3.36-3.41 , two (3.36 and 3.37) were 
Crystallographically characterised with the silver geometry in both cases being a 
quasi linear. Additional A g1 complexes o f quinoline functionalised NHC ligands 
were synthesised in a  similar manner and utilised as transmetallation agent in 
the synthesis o f Pdn(NHC) complexes 3.42 and 3.43. Efforts to prepare other 
Pdn(NHC) complexes were not successful due to high insolubility o f the 
complexes in most solvents. Indeed difficulty was encountered in separating the 
desired complexes from the silver halides.
The synthesis o f a series o f Rh(I) (NHC) o f the methylene bridged quinoline 
functionalised NHC ligands via transmetallation from Ag(I) complexes is 
reported. All the rhodium  complexes were fully characterised and the 
crystallographic data show consistent pattern. The reaction of the [Rh(cod)Cl]2 
with Ag20  gave the neutral rhodium complexes 4.20-4.24 and there was no 
evidence o f chelation between the nitrogen o f the quinoline ring and the 
rhodium metal as evidenced by the JH NM R data being essentially similar to 
that of the corresponding Ag(I) complexes from which they were made. 
Chelation was achieved by the reaction o f Rh(I) (NHC) complexes with one 
equivalent o f AgBF4 in DCM. However the chelated Rh(I) (NHC) complexes 
could not be fully characterised due to high insolubility o f the compounds in 
most solvent. Attempts to improve the solubility by replacing the 
tetraflouroborate counter ion with B arf solve the problem o f solubility but 
difficulty was encountered in separation.
In a similar fashion Ir (I) (NHC) complexes 4.27-4.32 were synthesised via 
transmetallation o f the corresponding Ag(I) complexes with [Ir(cod)Cl)2 in 
DCM. The trend observed for the rhodium complexes are essentially similar to 
that o f the iridium complexes. Thus both chelated and non chelated Ir(I) (NHC) 
complexes were prepared.
Finally two o f the neutral Ir (I) (NHC) complexes prepared 4.27 and 4.31 were 
catalytically tested towards transfer hydrogenation o f 4-bromoacetophenone. 
The two iridium complexes have shown good activity upon hydrogen transfer 
reduction of carbonyl in 4 -bromoacetophenone at different catalyst 
concentrations.
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5.2 Future work
Attempts to prepare the unsymmetrical quinoline based unsaturated imidazolium 
and pyrimidinium salts following the established procedures [5] were not 
successful. However it will be interesting if the following quinoline and acridine 
based ligands will be prepared and investigated.
It will be interesting to compare these potential pincer ligands with the pincer 
ligands reported by Gibson, Cavell, Danopoulos and Crabtree.
Also to be investigated are the metal complexes 2b and 4 which we were unable 
to prepare in this work.
It is recommended that the quinoline based palladium complexes prepared in 
this work be tested in some important catalytic reactions such as Heck coupling 
reactions.
The Rh(I) and Ir(I) (NHC) complexes should be tested in different catalytic 
reaction such as reduction o f  alkenes via direct hydrogenation and transfer 
hydrogenation. Efforts should be to isolate pure soluble chelated versions o f the
N ^ /
R
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Rh(I) and Ir(I) (NHC) complexes , their catalytic activities compared with that 
o f the unchelated complexes and the results obtained compared with that of the 
iridium pyridinyl N-heterocyclic carbene complexes reported by Wang et al [6]. 
Other interesting future work will be to look into the metal complexes of the 
ligands reported in chapter two such as Pt, Ni, Co, and Fe.
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APPENDIX
Tables of bond distances and angles
Table A l . l :  Bond lengths for 1, 3-diquinoline-3, 4, 5, 6-
tetrahydropyrimidinium hexaflouro phosphate (4 ):
Bond lengths (A)
C1-N2 1.317(3)
C l-N l 1.317(3)
C l- HI 0.9500
C2-N1 1.479(3)
C2- C3 1.513(3)
C2- H2A 0.9900
C2 -H2B 0.9900
C3- C4 1.507(3)
C3- H3A 0.9900
C3- H3B 0.9900
C4-N2 1.485(3)
C4- H4A 0.9900
C4- H4B 0.9900
C5 -C6 1.365(3)
C5-C13 1.422(3)
C5-N1 1.439(3)
C6- C l 1.417(3)
C6- H6 0.9500
C l  -C8 1.356(4)
C l- H7 0.9500
C8- C9 1.417(3)
C8- H8 0.9500
C9-C10 1.418(3)
Bond angles (°)
N 2 -C l-N l 124.
N2-C1-H 1 117.
Bond lengths (A)
C 9-C 13 1.419(3)
C10-C11 1.351(3)
C 10-H 10 0.9500
C 11-C 12 1.413(3)
C l 1- HI 1 0.9500
C12- N3 1.322(3)
C l2- H I2 0.9500
C13 -N3 1.370(3)
C14-C15 1.371(3)
C l4- C22 1.425(3)
C 14-N 2 1.429(3)
C 15-C 16 1.405(3)
C 15-H 15 0.9500
C 16-C 17 1.365(3)
C 16-H 16 0.9500
C 17-C 18 1.415(3)
C 17-H 17 0.9500
C l 8 - C22 1.415(3)
C 18-C 19 1.422(3)
C l9- C20 1.353(4)
C 19-H 19 0.9500
C20- C21 1.403(4)
C20- H20 0.9500
Bond angles (°)
C l-  C 8 - H 8 119.6
C9- C 8- H 8 119.6
Bond lengths (A)
C21-N4 1.323(3)
C21-H21 0.9500
C22- N4 1.372(3)
F l-P l 1.6054(16)
F2-P1 1.5933(18)
F3-P1 1.5912(16)
F4-P1 1.5876(18)
F5-P1 1.5784(18)
F6-P1 1.5853(17)
Bond angles (°) 
C20-C19-C18 119.4(2)
C20-C 19-H 19 120.3
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N l- C l- HI 117.9 C8-C9-C10 122.8(2) C18-C19-H 19 120.3
N1-C2-C3 109.03(18) C8-C9-C13 119.3(2) C19-C20-C21 119.2(2)
N 1-C2- H2A 109.9 C10-C9-C13 117.9(2) C19-C20-H20 120.4
C3- C2- H2A 109.9 C l 1-C10-C9 119.5(2) C21-C20-H20 120.4
N1-C2- H2B 109.9 C l 1-C10-H10 120.3 N4-C21-C20 124.6(2)
C3- C2- H2B 109.9 C 9-C 10-H 10 120.3 N4-C21-H21 117.7
H2A- C2- H2B 108.3 C10-C1-C12 118.7(2) C20-C21-H21 117.7
C4-C3-C2 109.48(19) C10-C11-H11 120.7 N4-C22-C18 123.2(2)
C4- C3- H3A 109.8 C12-C11-H11 120.7 N4-C22-C14 118.6(2)
C2- C3- H3A 109.8 N3-C12-C11 124.6(2) C18-C22-C14 118.2(2)
C4- C3- H3B 109.8 N3-C12-H12 117.7 C1-N1-C5 120.71(18)
C2- C3- H3B 109.8 C l 1-C12-H12 117.7 C1-N1-C2 120.41(18)
H3A- C3 -H3B 108. N3-C13-C9 122.2(2) C5-N1-C2 118.73(18)
N2-C4-C3 108.91(17) N3-C13-C5 119.63(19) C1-N2-C14 120.32(18)
N2- C4- H4A 109.9 C9-C13-C5 118.18(19) C1-N2-C4 120.78(19)
C3- C4- H4A 109.9 C15-C14-C22 120.7(2) C14-N2-C4 118.88(17)
N2- C4- H4B 109.9 C15-C14-N2 120.38(19) C12-N3-C13 117.06(19)
C3- C4 -H4B 109.9 C22-C14-N2 118.9(2) C21-N4-C22 116.5(2)
H4A- C4- H4B 108.3 C14-C15-C16 120.3(2) F5-P1-F6 91.17(11)
C6- C5-C13 121.4(2) C14-C15-H15 119.8 F5-P1-F4 90.55(12)
C6- C5-N1 120.3(2) C16-C15-H15 119.8 F6-P1-F4 90.78(11)
C13-C5-N1 118.33(19) C17-C16-C15 120.6(2) F5-P1-F3 89.22(10)
C5- C6- C7 119.7(2) C17-C16-H16 119.7 F6-P1-F3 179.52(11)
C5- C6- H6 120.2 C15-C16-H16 119.7 F4-P1-F3 89.49(10)
C7 -C6 -H6 120.2 C16-C17-C18 120.3(2) F5-P1-F2 179.18(11)
C8- C7- C6 120.6(2) C16-C17-H17 119.8 F6-P1-F2 89.24(11)
C8- C7 -H7 119.7 C18-C17-H17 119.8 F3-P1-F2 90.36(10)
C6- C7- H7 119.7 C22-C18-C17 119.8(2) F5-P1-F1 90.66(10)
C l-  C8 -C9 120.9(2) C22-C18-C19 117.1(2) F6-P1-F1 90.50(10)
C17-C18-C19 123.1(2) F4-P1-F1
F3-P1-F1
F2-P1-F1
178.22(11)
89.22(9)
88.64(9)
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Table A1.2: Bond Lengths and angles for l-benzyl-3-quinolinimidazolium 
tetraflouroborate (6a):
F1-B2 1.386(2) C15-H151 0.994
B2-F3 1.386(2) C16-C17 1.404(3)
B2-F4 1.387(2) C16-H161 0.942
B2-F5 1.387(2) C17-H171 0.944
N6-C7 1.391(2) C18-C19 1.419(2)
N6-C10 1.3405(19) C18-C27 1.369(2)
N6-C18 1.4411(19) C19-N20 1.367(2)
C7-C8 1.349(2) C19-C24 1.424(2)
C7-H71 0.961 N20-C21 1.315(2)
C8-N9 1.381(2) C21-C22 1.416(2)
C8-H81 0.963 C21-H211 0.942
N9-C10 1.324(2) C22-C23 1.361(2)
N9-C11 1.4846(19) C22-H221 0.946
C10-H101 0.961 C23-C24 1.411(2)
C11-C12 1.498(2) C23-H231 0.964
C l l - H l l l 1.005 C24-C25 1.417(2)
C11-H112 0.922 C25-C26 1.365(2)
C12-C13 1.389(3) C25-H251 0.972
C12-C17 1.376(3) C26-C27 1.410(2)
C13-C14 1.381(3) C26-H261 1.000
C13-H131 0.922 C27-H271 0.956
C14-C15 1.360(4)
C14-H141 0.955
C15-C16 1.373(4)
Bond angles (°) Bond angles (°)
F1-B2-F3 108.2815) C15-C16-H161 122.2
F1-B2-F4 109.03(16) C17-C16-H161 117.7
F3-B2-F4 110.49(16) C16-C17-C12 119.8(2)
F1-B2-F5 110.07(15) C16-C17-H171 123.0
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F3-B2-F5 109.55(16) C12-C17-H171 117.1
F4-B2-F5 109.40(15) C14-C15-H151 118.7
C7-N6-C10 108.30(13) C16-C15-H151 120.9
C7-N6-C18 124.30(13) C15-C-16-C17 120.0(2)
C10-N6-C18 127.40(13) N6-C18-C19 119.76(14)
N6-C7-C8 106.97(14) N6-C18-C27 118.31(14)
N6-C7-H71 124.4 C19-C18-C27 121.88(14)
C8-C7-H71 128.6 C18-C19-N20 119.85(14)
C7-C8-N9 107.09(15) C18-C19-C24 117.31(14)
C7-C8-H81 131.2 N20-C19-C24 122.83(15)
N9-C8-H81 121.7 C19-N20-C21 117.12(14)
C8-N9-C10 109.25(13) N20-C21-C22 124.60(15)
C8-N9-C11 125.68(14) N20-C21-H211 116.6
C10-N9-C11 124.91(14) C22-C21-H211 118.8
N6-C10-N9 108.38(14) C21-C22-C23 118.32(16)
N6-C10-H101 124.8 C21-C22-H221 123.0
N9-C10-H101 126.8 C23-C22-H221 118.7
N9-C11-C12 111.31(14) C22-C23-C24 119.98(15)
N9-C11-H111 110.0 C22-C23-H231 119.9
C12-C11-H111 110.2 C24-C23-H231 120.1
N9-C11-H112 100.3 C19-C24-C23 117.13(15)
C12-C11-H112 111.1 C19-C24-C25 119.96(15)
HI 1-C11-H112 113.6 C23-C24-C25 122.91(14)
C11-C12-C13 119.83(18) C24-C25-C26 120.57(15)
Cl 1-C12-C17 121.41(18) C24-C25-H251 117.2
C13-C12-C17 118.75(19) C26-C25-H251 122.3
C12-C13-C14 121.2(2) C25-C26-C27 120.31(15)
C12-C13-H131 118.5 C25-C26-H261 121.8
C14-C13-H131 120.3 C27-C26-H261 117.8
C13-C14-C15 119.8 C26-C27-C18 119.95(15)
C13-C14-H14 117.5 C26-C27-H27 118.2
C15-C14-H141 122.5 C18-C27-H271 121.8
C14-C15-C16 120.4(2)
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Table A1.3: Bond length for 1-methyl-3-qiunolinimidazolium iodide (6c)
Bond lengths (A) Bond lengths (A)
C1-C2 1.367(4) C8-N1 1.325(4)
C-C9 1.428(4) C8-H8 0.9500
C1-N2 1.439(4) C9-N1 1.365(4)
C2-C3 1.411(4) C10-N3 1.319(4)
C2-H2 0.9500 C10-N2 1.340(4)
C3-C4 1.364(4) C10-H10 0.9500
C3-H3 0.9500 C11-C12 1.347(4)
C4-C5 1.409(4) C11-N2 1.386(4)
C4-H4 0.9500 C l l - H l l 0.9500
C5-C6 1.420(4) C12-N3 1.382(4)
C5-C9 1.423(4) C12-H12 0.9500
C-C7 1.356(4) C13-N3 1.461(4)
C6-H6 0.9500 C13-H13A 0.9800
C7-C8 1.399(4) C13-H13B 0.9800
C7-H7 0.9500 C13-H13C 0.9800
Table A1.4: Bond angles for 1-methyl-3-qiunolinimidazolium iodide (6c)
Bond angles (°) Bond angles (°)
C2-C1-C9 121.3(3) N1-C9-C1 119.5(2)
C2-C1-N2 118.7(2) C5-C9-C1 117.2(2)
C9-C1-N2 119.8(2) N3-C10-N2 108.9(2)
C1-C2-C3 120.5(3) N3-C10-H10 125.5
C1-C2-H2 119.8 N2-C10-H10 125.5
C3-C2-H2 119.8 C12-C11-N2 106.9
C4-C3-C2 120.0(3) C12-C11-H11 126.6
C4-C3-H3 120.0 N2-C11-H11 126.6
C2-C3-H3 120.0 C l 1-C12-N3 107.5(3)
C3-C4-C5 120.7(3) C11-C12-H12 126.3
C3-C4-H4 119.7 N3-C12-H12 126.3
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C5-C4-H4 119.7 N3-C13-H13A 109.5
C4-C5-C6 123.0(3) N3-C13-H13B 109.5
C4-C5-C9 120.3(2) H13-A13-13B 109.5
C6-C5-C9 116.7(3) N3-C13-H13C 109.5
C7-C6-C5 119.5(3) H13-C13-H13 109.5
C7-C6-H6 120.2 H13-C13-H13C 109.5
C5-C6-H6 120.2 C8-N1-C9 116.8(2)
C6-C7-C8 119.4(3) C 10-N2-C11 108.1(2)
C6-C7-H7 120.3 C10-N2-C1 127.4(2)
C8-C7-H7 120.3 C l 1-N2-C1 124.4(2)
N1-C8-C7 124.3(3) C10-N3-C12 108.6(2)
N1-C8-H8 117.9 C10-N3-C13 125.3(3)
C7-C8-H8 117.9 C12-N3-C13 125.9(3)
N1-C9-C5 123.2(2)
Table A1.5: Bond lengths for 1-mesityl 3-(-2-methylquinoline)imidazolium
chloride 9b:
Bond lengths (A) Bond lengths (A) Bond lengths (A)
C1-N2 1.323(3) C7-C8 1.389(4) C19-H19 0.9500
C l-N l 1.340(3) C7-C11 1.515(4) C20-C21 1.373(4)
C l-H l 0.9500 C8-C9 1.390(4) C20-H20 0.9500
C2-C3 1.356(3) C8-H8 0.9500 C21-C22 1.409(4)
C2-N1 1.374(3) C9-C12 1.500 C21-H21 0.9500
C2-H2 0.9500 C10-H10A 0.9800 C22-N3 1.374(3)
C3-N2 1.370(3) C13-N2 1.463(3) B1-F2 1.333(4)
C3-H3 0.9500 C13-C14 1.506(3) B1-F4A
C4-C5 1.392(3) C13-H13A 0.9900 1.360(10)
C4-C9 1.402(3) C13-H13B 0.9900 B1-F3 1.383(3)
C4-N1 1.446(3) C14-N3 1.306(3) B l-F l 1.393(4)
C5-C6 1.377(3) C14-C15 1.406(3) B1-F4 1.402(3)
C5-C10 1.507(4) C15-C16 1.354(3) B1-F2A 1.414(9)
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C6-C7 1.382(4) C15-H15
C6-H6 0.9500 C16-C17
C10-H10B 0.9800 C16-H16
C10-H10C 0.9800 C17-C22
C11-H11A 0.9800 C17-C18
C11-H11B 0.9800 C18-C19
C11-H11C 0.9800 C18-H18
C12-H12A 0.9800 C19-C20
C12-H12B 0.9800
C12-H12C 0.9800
0.9500 B1-F1A 1.425(8)
1.410(4) F1-F4A 1.06(3)
0.9500 F-F1A 1.57(2)
1.414(3) F1A-F2 1.17(2)
1.418(3) F2-F2A 1.23(2)
1.350(4) F2A-F4 1.58(3)
0.9500 F4-F4A 1.37(3)
1.402(4)
Table A1.6: Bond angles for 1-mesityl 3-(-2-methylquinoline)imidazolium 
chloride 9b:
Bond angles (°) 
N2-C1-N1 108.2(2)
Bond angles (°) 
C19-C18-H18 119.7
N2-C1-H1 126.5 C17-C18-H18 119.7
N1-C1-H1 125.9 C18-C19-C20 120.5(2)
C-C2-N1 107.0(2) C18-C19-H19 119.7
C3-C2-H2 126.5 C20-C19-H19 119.7
N1-C2-H2 126.5 C21-C20-C19 120.5(3)
C2-C3-N2 107.0(2) C21-C20-H20 119.8
C2-C3-H3 126.5 C19-C20-H20 119.8
N2-C3-H3 126.5 C20-C21-C22 120.5(2)
C5-C4-C9 123.0(2) C20 C21 H21 119.8
C5-C4-N1 119.3(2) C22-C21-H21 119.8
C9-C4-N1 117.6(2) N3-C22-C21 119.0(2)
C6-C5-C4 117.5(2) N3-C22-C17 122.4(2)
C6-C5-C10 120.8(2) C21-C22-C17 118.7(2)
C4-C5-C10 121.7(2) C1-N1-C2 108.5(2)
C5-C6-C7 122.5(2) C1-N1-C4 126.2(2)
C5-C6-H6 118.8 C2-N1-C4 109.3(2)
C7-C6-H6 118.8 C1-N2-C13 125.3(2)
C6-C7-C8 118.0(2) C3-N2-C13 125.0(2)
C6-C7 -C ll 121.1(3) C14-N3-C22 117.13(19)
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C8-C7-C11 120.9(3)
C7-C8-C9 122.8(3)
C7-C8-H8 118.6
C9-C8-H8 118.6
C8-C9-C4 116.1(2)
C8-C9-C12 122.2(2)
C4-C9-C12 121.6(2)
C5-C10H-10A 109.5
C5-C10-0H10B 109.5
H10A-C10-H10B 109.5
C5-C10-H10C 109.5
HIOA-CIO-HIOC 109.5
HIOB-CIO-HIOC 109.5
C7-C11-H11A 109.5
C7-C11-H1 IB 109.5
HI 1 A-Cl 1-H1 IB 109.5
C7-C11-H11C 109.5
HI 1 A-Cl 1-H11C 109.5
HI 1B-C11-H11C 109.5
C9-C12-H12A 109.5
C9-C12-H12B 109.5
H12A-C12-H12B 109.5
C9-C12-H12C 109.5
H12A-C12-H12C 109.5
H12B-C12-H12C 109.5
N2-C13-C14 112.9(2)
N2-C13-H13A 109.0
C14-C13-H13A 109.0
N2-C13-H13B 109.0
C14-C13-H13B 109.0
H13A-C13-H13B 107.8
N3-C1-C15 124.4(2)
N3-C14-C13 119.7(19)
C15-C14-C13 116.5
F2-B1-F4A 120.3(10)
F2-B1-F3 111.9(3)
F4A-B1-F3 126.9(11)
F2-B1-F1 111.1(3)
F4A-B1-F1 45.1(12)
F3-B1-F1 107.8(3)
F2-B1-F4 111.4(3)
F4A-B1-F4 59.4(12)
F3-B1-F4 110.2(2)
F1-B1-F4 104.1(3)
F2-B1-F2A 52.9(11)
F4A-B1-F2A 118.1(16)
F3-B1-F2 100.0(7)
F1-B1-F2A 152.0(7)
F4-B1-F2A 68.5(12)
F2-B1-F1A 50.2(10)
F4A-B1-F1A 102.8(13)
F3-B1-F1A 102.8(6)
F1-B1-F1A 67.7(10)
F4-B1-F1A 146.8(7)
F2A-B1-F1A 103.0(15)
F4A-F1-B1 65.8(7)
F4A-F- FI A 110.5(12)
B1-F1-F1A 57.1(6)
F2-F1A-B1 60.8(5)
F2-F1A-F1 109.2(8)
B1-F1A-F1 55.2(6)
F1A-F2-F2A 135.6(10)
F1A-F2-B1 68.9(7)
F2A-F2-B1 66.9(7)
F2-F2A-B1 60.1(6)
F2-F2A-F4 106.3(8)
B1-F2A-F4 55.4(7)
F4A-F4-B1 58.8(6)
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C16-C15-C14 119.2(2) F4A-F4-F2A 107.1(10)
C16-C15-H15 120.4 B1-F4-F2A 56.1(7)
C14-C15-H15 120.4 F1-F4A-B1 69.0(8)
C15-C16-C17 119.2(2) F1-F4A-F4 130.1(10)
C15-C16-H16 120.4 B1-F4A-F4 61.8(8)
C17-C16-H16 120.4
C16-C17-C22 117.7(2)
C22-C17-C18 119.3(2)
C19-C18-C17 120.6(2)
Table A1.7 : Bond lengths for 1-isopropyl -3-(2-methylquinoline) imidazolium 
iodide (9c)
Bond lengths (A) Bond lengths (A) Bond lengths (A)
N l-C l 1.30(2) C4-C5 1.53(2) C20-C21 1.52(2)
N1-C2 1.42(2) C7-C8 1.4888 C20-C22 1.57(2)
N1-C4 1.50(2) N3-C12 1.3899 C23-C24 1.4359
N2-C3 1.34(2) N3-C8 1.3899 N6-C28 1.3899
N2-C1 1.369(19) C8-C9 1.3888 N6-C24 1.3899
N2-C7 1.515(15) C9-C10 1.3898 C24-C25 1.3888
N4-C18 1.31(2) C10-C11 1.3899 C25-C26 1.3898
N4-C17 1.37(2) C11-C12 1.3888 C26-C27 1.3899
N4-C20 1.475(19) C11-C16 1.3899 C27-C28 1.3888
N5-C17 1.30(2) C12-C13 1.3899 C27-C32 1.3899
N5-C19 1.41(2) C13-C14 1.3898 C28-C29 1.3899
N5-C23 1.421(16) C14-C15 1.3888 C29-C30 1.3898
C2-C3 1.35(3) C15-C16 1.3899 C30-C31 1.3888
C4-C6 1.46(2) C18-C19 1.34(3) C31-C32 1.3888
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Table A1.8 : Bond angles for 1-isopropyl -3-(2-methylquinoline) imidazolium 
iodide (9c)
Bond angles (°) 
C1-N1-C2 111.4(11)
C1-N1-C4 124.4(11)
C2-N1-C4 124.2(12)
C3-N2-C1 109.8(15)
C3-N2-C7 120.7(13)
C1-N2-C7 129.5(13)
C18-N4-C17 104.7(15)
C18-N4-C20 128.7(15)
C17-N4-C20 126.5(14)
C17-N5-C19 106.8(15)
C17-N5-C23 124.5(11)
C19-N5-C23 128.5(13)
N1-C1-N2 105.9(12)
C3-C2-N1 103.6(13)
N2-C3-C2 109.3(16)
C6-C4-N1 110.5(14)
C6-C4-C5 109.7(14)
N1-C4-C5 109.7(13)
C8-C7-N2 111.2(5)
C12-N3-C8 120.1
C9-C8-N3 120.0
C9-C8-C7 120.7
N3-C8-C7 119.2
C8-C9-C10 120.0
C9-C10-C11 120.1
C12-C11-C16 120.0
C12-C11-C10 120.0
C16-C11-C10 120.1
Cl 1-C12-N3 120.0
Bond angles (°) 
C11-C12-C13 120.0
N3-C12-C13 120.0
C14-C13-C12 120.0
C15-C14-C13 120.0
C14-C15-C16 120.0
C11-C16-C15 120.1
N5-C17-N4 111.2(14)
N4-C18-C19 112.5(16)
C18-C19-N5 104.8(15)
N4-C20-C21 109.9(13)
N4-C20-C22 107.6(14)
C21-C20-C22 114.3(15)
N5-C23-C24 120.1(5)
C28-N6-C24 120.1
C25-C24-N6 120.0
C25-C24-C23 125.0
N6-C24-C23 114.8
C24-C25-C26 120.0
C25-C26-C27 120.0
C28-C27-C32 120.0
C28-C27-C26 120.0
C32-C27-C26 120.1
C27-C28-N6 120.0
C27-C28-C29 120.0
N6-C28-C29 120.0
C30-C29-C28 120.0
C31-C30-C29 120.0
C30-C31-C32 120.0
C27-C32-C31 120.1
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Table A1.9: Bond lengths for Bis-1, 3- (2-methylquinolin) imidazolium chloride 
(9f)
Bond lengths (A) Bond lengths (A) Bond lengths (A)
N2-C3
N2-C6
N2-C18
C3-C4
C3-H31
C4-N5
C4-H41
N5-C6
N5-C7
C6-H61
C7-C8
C7-H72
C7-H71
C8-N9
C8-C13
N9-C10
C10-C11
1.474(3)
1.335(3)
1.467(3)
1.350(3)
0.943
1.383(3)
0.959
1.327(3)
1.461(3)
0.940
1.511(3)
0.991
0.962
1.316(3)
1.407(3)
1.371(3)
1.41(3)
C10-C17
C11-C12
C11-C14
C12-C13
C12-H121
C13-H131
C14-C15
C14-H141
C15-C16
C15-H151
C16-C17
C16H161
C17-H171
C18-C19
C18-H181
C19-N20
1.415(3)
1.413(3)
1.420(4)
1.362(4)
0.942
0.940
1.370(3)
0.933
1.400(3)
0.956
1.360(4)
0.966
0.938
1.514(3)
0.975
1.323(3)
C19-C24
N20-C21
C21-C28
C22-C23
C22-C25
C23-C24
C23-H231
C24-H241
C25-C26
C25-H251
C26-C27
C26-H261
C27-C28
C27-H271
C28-H281
1.40(3)
1.410(4)
1.415(3)
1.414(3)
1.416(4)
1.360(3)
0.938
0.962
1.366(4)
0.963
1.394(4)
0.916
1.365(4)
0.945
0.971
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Table A1.10: Bond angles for Bis-1, 3- (2-methylquinolin) imidazolium 
chloride (9f)
Bond angles (°) Bond angles (°) Bond angles (°)
C3-N2-C6 108.7(2)
C3-N2-C18 126.6(2)
C6-N2-C18 124.7(2)
N2-C3-C4 107.4(2)
N2-C3-H31 124.9
C4-C3-H31 127.7
C3-C4-N5 106.6(2)
C3-C4-H41 127.3
N5-C4-H41 126.0
C4-N5-C6 109.0(2)
C4-N5-C7 125.6(2)
C6-N5-C7 125.0(2)
N2-C6-N5 108.3(2)
N2-C6-H61 124.7
N5-C6-H61 127.0
N5-C7-C8 112.07(19)
N5-C7-H72 109.8
C8-C7-H72 109.0
N5-C7-H71 107.4
C8-C7-H71 108.5
H72-C7-H71 110.0
C7-C8-N9 117.6(2)
C7-C8-C13 118.4(2)
N9-C8-C13 124.0(2)
C8-N9-C10 117.5(2)
N9-C10-C11 122.5(2)
N9-C10-C17 118.8(2)
Cl 1-C10-C17 118.7(2)
C10-C11-C12 117.7(2)
C10-C11-C14 119.2(2)
C13-C12-H121 118.9
C8-C13-C12 119.2(2)
C8-C13-H131 119.5
C12-C13-H131 121.3
C l 1-C14-C15 120.1(2)
C l 1-C14-H141 118.3
C15-C14-H141 121.6
C14-C15-C16 120.4(2)
C l 1-C10-C17 118.7(2)
C10-C11-C12 117.7(2)
C10-C11-C14 119.2(2)
C12-C11-C14 123.1(2)
C l 1-C12-C13 119.2(2)
C l 1-C12-H121 121.9
C13-C12-H121 118.9
C8-C13-C12 119.2(2)
C8-C13-H131 119.5
C12-C13-H131 121.3
C l 1-C14-C15 120.1(2)
C l 1-C14-H141 118.3
C15-C14-H141 121.6
C14-C15-C16 120.4(2)
C14-C15-H151 117.9
C16-C15-H151 121.
C15-C16-C17 120.7(2)
C15-C16-H161 119.2
C17-C16-H161 120.2
C10-C17-C16 120.8(2)
C10C17H171 120.3
C16-C17-H171 118.9
C19-C18-H181 108.1
N2-C18-H182 108.3
C19-C18-H182 107.7
H181-C18 H182 111.4
C18-C19-N20 113.7(2)
C18-C19-C24 122.4(2)
N20-C19-C24 123.9(2)
C19-N20-C21 117.2(2)
N20-C21-C22 123.1(2)
N20-C21-C28 118.4(3)
C22-C21-C28 118.5(2)
C21-C22-C23 117.2(2
C21-C22-C25 119.7(2)
C23-C22-C25 123.2(3)
C22-C23-C24 119.8(3)
C22-C23-H231 118.8
C24-C23-H231 121.3
C19-C24-C23 118.8(2)
C19-C24-H241 121.5
C23-C24-H241 119.7
C22-C25-C26 120.3(3)
C22-C25-H251 117.4
C26-C25-H251 122.2
C25-C26-C27 119.8(3)
C25-C26-H261 119.3
C27-C26-H261 120.9
C26-C27-C28 121.5(3)
C26-C27-H271 118.2
C28-C27-H271 120.3
C21-C28-C27 120.2(3)
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C12-C11-C14 123.1(2) N2-C18-C19 113.0(2) C21-C28-H281 120.3
Cl 1-C12-C13 119.2(2) N2-C18-H181 108.4 C27-C28-H281 119.5
Cl 1-C12-H121 121.9
Table A l . l l :  Bond lengths and angles for [Ag (l-methy-3-(-2-methylquinoline) 
imidazolin-2-ylidine) 2][AgCl2 ] (3.36)
Bond lengths (A) Bond angles (°) Bond angles (°)
C1-N2 1.351(14) N2-C1-N1 104.0(10) C12-C13-C14 120.0
C l-N l 1.353(16) N 2-C l-A gl 130.6(8) C9-C14-C13 120.0
C l-A gl 2.106(12) N l-C l-A g 125.2(9) C l-A g l-C l 170.8(8)
C2-C3 1.32(2) C3-C2-N1 107.8(11) Cl-A gl-A g2 94.6(4)
C2-N1 1.378(16) C2-C3-N2 105.8(12) C l-A gl-A g2 94.6(4)
C3-N2 1.392(19) N2-C5-C6 112.7(13) C l-A gl-A g2 85.4(4)
C4-N1 1.480(19) C1-N1-C2 110.1(11) C l-A gl-A g2 85.4(4)
C5-N2 1.446(18) C1-N1-C4 125.4(12) Ag2-Agl-Ag2 180.0(3)
C5-C6 1.48(2) C2-N1-C4 122.4(12) Cll-A g2-Cll 176.6(11)
N3 -C6 1.3900 C1-N2-C3 109.9(9) Cll-Ag2-Agl 88.3(5)
N3-C10 1.3900 C1-N2-C5 119.3(10) Cll-Ag2-Agl 88.3(5)
C6-C7 1.3900 C3-N2-C5 130.2(10) Cll-Ag2-Agl 91.7(5)
C7-C8 1.3900 C6-N3-C10 120.0 Cll-Ag2-Agl 91.7(5)
C8-C9 1.3900 N3-C6-C7 120.0 Agl-Ag2-Agl 180.0
C9-C14 1.3900 N3-C6-C5 116.5(11)
C9-C10 1.3900 C7-C6-C5 123.5(10)
C10-C11 1.3900 C6-C7-C8 120.0
C11-C12 1.3900 C9-C8-C7 120.0
C12-C13 1.3900 C14-C9-C10 120.0
C13-C14 1.3900 C14-C9-C8 120.0
Cll-Ag2 2.290(5) C10-C9-C8 120.0
A gl-C l 2.106(12) C9-C10-C11 120.0
Agl-Ag2 3.201(4) C9-C10-N3 120.0
Agl-Ag2 3.300(4) C l 1-C10-N3 120.0
Ag2-Cll 2.290(5) C12-C11-C10 120.0
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Ag2-Agl 3.201(4) C l 1-C12-C13 120
Table A1.12: Bond lengths and angles for [Ag (l-mesityl-3-(-2-
methylquinoline) imidazolin-2-ylidine) Cl] 3.37
Bond lengths (A) Bond angles (°) Bond angles (°)
A gl-A gl 3.8010(5) A gl-A gl-C12 37.997(17) C4-C16-H161 128.2
Agl-C12 3.2126(10) A gl-A gl-C12 57.31(2) C8-C17-C9 119.1(3)
Agl-C12 2.3501(9) C12-Agl-C12 95.30(3) C8-C17-N5 118.0(3)
A gl-C l 3 2.090(3) A g l-A g l-C l 3133.23(10) C9-C17-N5 123.0(3)
N3-C4 1.384(4) C12-Agl-C13 95.29(10) C15-C18-C10 120.5(4)
N3-C6 1.474(4) C12-Agl-C13 169.03(10) C15-C18-C22 122.0(4)
N3-C13 1.342(5) Agl-C12-Agl 84.70(3) C10-C18-C22 117.5(4)
C4-C16 1.344(5) C4-N3-C6 123.9(3) C21-C19-H193 112.7
C4-H41 0.950 C4-N3-C13 111.1(3) C21-C19-H191 108.8
N5-C14 1.320(5) C6-N3-C13 125.0(3) H193-C19-H191 107.4
N5-C17 1.373(5) N3-C4-C16 106.9(3) C21-C19-H192 110.3
C6-C14 1.516(5) N3-C4-H41 124.8 H193-C19-H192 108.2
C6-H62 0.974 C16-C4-H41 128.2 H191-C19-H192 109.4
C6-H61 0.967 C14-N5-C17 117.2(3) C9-C20-C25 120.0(4)
C7-C21 1.396(5) N3-C6-C14 111.6(3) C9-C20-H201 119.4
C7-C23 1.390(5) N3-C6-H62 108.1 C25-C20-H201 120.6
C7-H71 0.957 C14-C6-H62 107.4 C19-C21-C7 120.6(4)
C8-C17 1.422(5) N3-C6-H61 109.2 C19-C21-C10 120.3(4)
C8 C27 1.366(6) C14-C6-H61 109.7 C7-C21-C10 119.1(3)
C8 H81 0.932 H62-C6-H61 110.9 N11-C22-C18 118.9(3)
C9 C12 1.421(6) C21-C7-C23 121.6(3) N11-C22-C23 118.0(3)
C9 C17 1.410(6) C21-C7-H71 119.2 C18-C22-C23 123.1(3)
C9 C20 1.417(5) C23-C7-H71 119.2 C22-C23-C7 117.3(3)
C10C18 1.399(5) C17-C8-C27 120.1(4) C22-C23-C26 121.5(3)
CIO C21 1.384(6) C17-C8-H81 120.2 C7-C23-C26 121.2(3)
C10-H101 0.948 C27-C8-H81 119.8 C14-C24-C12 119.2(4)
N11-C13 1.353(4) C12-C9-C17 117.6(3) C14-C24-H241 120.4
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N11-C16 1.389(5) C12-C9-C20 122.8(4) C12-C24-H241 120.3
N11-C22 1.445(4) C17-C9-C20 119.6(4) C20-C25-C27 120.7(4)
C12-C24 1.371(6) C18-C10-C21 121.3(4) C20-C25-H251 119.6
C12-H121 0.934 C18-C10-H101 119.0 C27-C25-H251 119.7
C14-C24 1.407(5) C21-C10-H101 119.7 C23-C26-H262 109.5
C15-C18 1.510(6) C13-N11-C16 110.9(3) C23-C26-H263 111.4
C15-H152 0.945 C13-N11-C22 122.6(3) H262-C26-H263 108.2
C15-H153 0.960 C16-N11-C22 126.5(3) C23-C26-H261 111.2
C15-H151 0.961 C9-C12-C24 118.9(4) H262-C26-H261 106.3
C16-H161 0.945 C9-C12-H121 119.3 H263-C26-H261 110.1
C18-C22 1.389(5) C24-C12-H121 121.8 C25-C27-C8 120.6(4)
C19-C21 1.509(5) N11-C13-N3 104.9(3) C25-C27-H271 119.4
C19-H193 0.950 N11-C13-Agl 123.7(3) C8-C27-H271 120.0
C19-H191 0.942 N3-C13-Agl 131.4(2)
C19-H192 0.945 C6-C14-N5 116.2(3)
C20-C25 1.366(7) C6-C14-C24 119.7(3)
C20-H201 0.931 N5-C14-C24 124.1(3)
C22-C23 1.391(5) C18-C15-H152 109.5
C23-C26 1.498(5) C18-C15-H153 111.6
C24-H241 0.936 H152-C15-H153 105.3
C25-C27 1.409(7) C18-C15-H151 113.5
C25-H251 0.946 H152-C15-H151 107.4
C26-H262 0.954 H153-C15-H151 109.1
C26-H263 0.962 N11-C16-C4 106.2(3)
C26-H261 0.954 N11-C16-H161 125.6
C27-H271 0.930
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Table 1.13: Bond lengths and angles for 1-methyl-3-(2-
methylquinoline)imidazolin-2-ylidene]( 1,5-cyclooctadiene)rhodium(I) Chloride
4.20
Bond lengths (A)
C l-N l 1.356(6)
C1-N2 1.362(7)
C l-R hl 2.028(5)
C2-C3 1.345(8)
C2-N1 1.371(7)
C2-H2 0.9500
C3-N2 1.394(7)
C3-H3 0.9500
C4-N1 1.466(7)
C4-H4A 0.9800
C4-H4B 0.9800
C4-H4C 0.9800
C5-N2 1.461(6)
C5-C6 1.508(7)
C5-H5A 0.9900
C5-H5B 0.9900
C6-N3 1.320(7)
C6-C7 1.420(7)
C7-C8 1.378(8)
C7-H7 0.9500
C8-C9 1.412(7)
C8-H8 0.9500
C9-C10 1.408(7)
C9-C14 1.417(7)
Bond angles (°)
N1-C1-N2 103.8(4)
N l-C l-R h l 131.4(4)
N 2-C l-R hl 124.9(4)
C3-C2-N1 107.1(5)
C3-C2-H2 126.5
N1-C2-H2 126.5
C2-C3-N2 106.3(5)
C2-C3-H3 126.9
N2-C3-H3 126.9
N 1-C4-H4A 109.5
N 1-C4-H4B 109.5
H4A-C4-H4B 109.5
N 1-C4-H4C 109.5
H4A-C4-H4C 109.5
H4B-C4-H4C 109.5
N2-C5-C6 113.9(4)
N2-C5-H5A 108.8
C6-C5-H5A 108.8
N2-C5-H5B 108.8
C6-C5-H5B 108.8
H5A-C5-H5B 107.7
N3-C6-C7 123.5(5)
N3-C6-C5 114.7(5)
C7-C6-C5 121.8(5)
Bond angles (°)
Rhl-C16-H16 86.6
C18-C17-C16 112.8(4)
C 18C17H 17A 109.0
C 16C17H 17A 109.0
C18C17H 17B 109.0
C16-C17-H17B 109.0
H17A-C17-H17B 107.8
C19-C18-C17 113.3(4)
C19-C18-H18A 108.9
C17-C18-H18A 108.9
C19-C18-H18B 108.9
C17-C18-H18B 108.9
H18A-C18-H18B 107.7
C20-C19-C18 125.8(5)
C20-C19-Rhl 73.0(3)
C18-C19-Rhl 106.6(4)
C20-C19-H19 117.1
C18-C19-H19 117.1
Rhl-C19-H19 90.5
C19-C20-C21 125.3(5)
C19-C20-Rhl 70.9(3)
C21-C20-Rhl 111.6(4)
C19-C20-H20 117.3
C21-C20-H20 117.3
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C10-C11 1.372(8)
C10-H10 0.9500
C11-C12 1.405(8)
C ll -H l l 0.9500
C12-C13 1.377(8)
C12-H12 0.9500
C13-C14 1.416(7)
C13-H13 0.9500
C14-N3 1.378(7)
C15-C16 1.410(7)
C15-C22 1.499(8)
C15-Rhl 2.123(5)
C15-H15 0.9500
C16-C17 1.526(7)
C16-Rhl 2.126(5)
C16-H16 0.9500
C17-C18 .526(8)
C17-H17A 0.9900
C17-H17B 0.9900
C18-C19 1.524(8)
C18-H18A 0.9900
C18-H18B 0.9900
C19-C20 1.375(8)
C19-Rhl 2.206(5)
C19-H19 0.9500
C20-C21 1.506(8)
C20-Rhl 2.233(6)
Appendix
C8-C7-C6 118.8(5)
C8-C7-H7 120.6
C6-C7-H7 120.6
C7-C8-C9 119.8(5)
C7-C8-H8 120.1
C9-C8-H8 120.1
C10-C9-C8 123.5(5)
C10-C9-C14 119.1(5)
C8-C9-C14 117.4(5)
C l 1-C10-C9 120.8(5)
C l 1-C10-H10 119.6
C9-C10-H10 119.6
C10-C11-C12 120.1(5)
C10-C11-H11 120.0
C12-C11-H11 120.0
C13-C12-C11 120.8(5)
C13-C12-H12 119.6
C l 1-C12-H12 119.6
C12-C13-C14 119.8(5)
C12-C13-H13 120.1
C14-C13-H13 120.1
N3-C14-C13 117.8(5)
N3-C14-C9 122.8(5)
C13-C14-C9 119.4(5)
C16-C15-C22 125.7(5)
C16-C15-Rhl 70.7(3)
C22-C15-Rhl 111.4(4)
Rhl-C20-H20 87.4
C20-C21-C22 112.5(5)
C20-C21-H21A 109.1
C22-C21-H21A 109.1
C20-C21-H21B 109.1
C22-C21-H21B 109.1
H21A-C21-H21B 107.8
C15-C22-C21 113.5(4)
C15-C22-H22A 108.9
C21-C22-H22A 108.9
C15-C22-H22B 108.9
C21-C22-H22B 108.9
H22A-C22-H22B 107.7
C1-N1-C2 111.9(4)
C1-N1-C4 124.5(5)
C2-N1-C4 123.5(4)
C1-N2-C3 111.0(4)
C1-N2-C5 124.1(4)
C3-N2-C5 124.7(4)
C6-N3-C14 117.9(5)
C l-R hl-C 15 92.0(2)
C l-R hl-C 16 93.2(2)
C15-Rhl-C16 38.8(2)
C l-R hl-C 19 158.3(2)
C15-Rhl-C19 97.2(2)
C16-Rhl-C19 82.0(2)
C l-R hl-C 20 165.5(2)
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Appendix
C20-H20 0.9500 C16-C15-H15 117.2 C15-Rhl-C20 80.7(2)
C21-C22 1.544(8) C22-C15-H15 117.2 C16-Rhl-C20 88.8(2)
C21-H21A 0.9900 Rhl-C15-H15 87.8 C19-Rhl-C20 36.1(2)
C21-H21B 0.9900 C15-C16-C17 123.8(5) C l-R hl-C ll 87.99(14)
C22-H22A 0.9900 C15-C16-Rhl 70.5(3) C15-Rhl-Cll 161.31(15)
C22-H22B 0.9900 C17-C16-Rhl 113.0(4) C16-Rhl-Cll 159.89(15)
Rhl-C ll 2.3862(13) C15-C16-H16 118.1 C19-Rhl-Cll 89.44(15)
C17-C16-H16 118.1 C20-Rhl-Cll 95.03(15)
Table A1.14: Bond lengths and angles for [l-mesityl-3-(2-
methylquinoline)imidazolin-2-ylidene]( 1,5-cyclooctadiene)rhodium(I) Chloride
4.21
Bond lengths (A)
C l-N l 1.355(5)
C1-N2 1.355(5)
C l-R hl 2.043(4)
C2-C3 1.336(6)
C2-N1 1.397(5)
C2-H2 0.9500
C3-N2 1.379(5)
C3-H3 0.9500
C4-C9 1.394(6)
C4-C5 1.396(6)
C4-N1 1.447(5)
C5-C6 1.406(6)
C5-C10 1.497(6)
Bond angles (°)
N1-C1-N2 103.7(3)
N 1-C l-R hl 130.8(3)
N 2-C l-R h l 125.3(3)
C3-C2-N 1 106.4(4)
C3-C2-H2 126.8
N1-C2-H2 126.8
C2-C3-N2 106.8(4)
C2-C3-H3 126.6
N2-C3-H3 126.6
C9-C4-C5 122.8(3)
C9-C4-N 1 117.3(3)
C5-C4-N1 119.8(4)
C4-C5-C6 116.8(4)
Bond angles (°)
C22-C21-H21 119.8
N3-C22-C17 122.7(4)
N3-C22C21 118.2(3)
C17-C22-C21 119.1(4)
C24-C23-C30 123.6(5)
C24-C23-Rhl 70.9(3)
C30-C23-Rhl 111.2(3)
C24-C23-H23 118.2
C30-C23-H23 118.2
Rhl-C23-H23 88.0
C23-C24-C25 125.3(5)
C23-C24-Rhl 72.7(3)
C25-C24-Rhl 109.6(3)
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C6-C7 1.385(7)
C6-H6 0.9500
C7-C8 1.378(6)
C7-C11 1.512(6)
C8-C9 1.410(6)
C8-H8 0.9500
C9-C12 1.505(5)
C10-H10A 0.9800
C10-H10B 0.9800
C10-H10C 0.9800
C11-H11A 0.9800
C11-H11B 0.9800
C11-H11C 0.9800
C12-H12A 0.9800
C12-H12B 0.9800
C12-H12C 0.9800
C13-N2 1.451(5)
C13-C14 1.521(6)
C13-H13A 0.9900
C13-H13B 0.9900
C14-N3 1.320(5)
C14-C15 1.419(6)
C15-C16 1.360(6)
C15-H15 0.9500
C16-C17 1.403(6)
C16-H16 0.9500
C17-C22 1.415(5)
Appendix
C4-C5-C10 121.3(4)
C6-C5-C10 121.9(4)
C7-C6-C5 122.1(4)
C7-C6-H6 118.9
C5-C6 H6 118.9
C8-C7-C6 119.1(4)
C8-C7-C11 119.7(4)
C6-C7-C11 121.2(4)
C7-C8-C9 121.6(4)
C7-C8-H8 119.2
C9-C8-H8 119.2
C4-C9-C8 117.4(4)
C4-C9-C12 121.8(3)
C8-C9-C12 120.8(4)
C5-C10-H10A 109.5
C5-C10-H10B 109.5
H 1OA-C10-H 1 OB 109.5
C5-C10-H10C 109.5
H 1 OA-C 10-H IOC 109.5
H10B-C10-H10C 109.5
C7-C11-H11A 109.5
C7-C11-H11B 109.5
H11A-C11-H11B 109.5
C7-C11-H11C 109.5
HI 1A-C11-H11C 109.5
HI 1B-C11-H11C 109.5
C9-C12H-12A 109.5
C23-C24-H24 117.3
C25-C24-H24 117.3
Rhl-C24-H24 87.6
C26-C25-C24 115.7(5)
C26-C25-H25A 108.4
C24-C25-H25A 108.4
C26-C25-H25B 108.4
C24-C25-H25B 108.4
H25A-C25-H25B 107.4
C25-C26-C27 115.3(5)
C25-C26-H26A 108.5
C27-C26-H26A 108.5
C25-C26-H26B 108.5
C27-C26-H26B 108.5
H26A-C26-H26B 107.5
C28-C27-C26 122.7(5)
C28-C27-Rhl 70.4(3)
C26-C27-Rhl 112.9(3)
C28-C27-H27 118.7
C26-C27-H27 118.7
Rhl-C27-H27 86.7
C27-C28-C29 126.8(5)
C27-C28-Rhl 71.3(3)
C29-C28-Rhl 110.8(3)
C27-C28-H28 116.6
C29-C28-H28 116.6
Rhl-C28-H28 87.9
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Appendix
C1-C18 .417(6) C9-C12-H12B 109.5 C30-C29-C28 116.9(6)
C18-C19 1.352(7) H12A-C12-H12B 109.5 C30-C29-H29A 108.1
C18-H18 0.9500 C9-C12-H12C 109.5 C28-C29-H29A 108.1
C19-C20 1.408(6) H12A-C12-H12C 109.5 C30-C29-H29B 108.1
C19-H19 0.9500 H12B-C12-H12C 109.5 C28-C29-H29B 108.1
C20-C21 .366(6) N2-C13-C14 112.6(3) H29A-C29-H29B 107.3
C20-H20 0.9500 N2-C13-H13A 109.1 C29-C30-C23 113.8(5)
C21-C22 1.421(6) C14-C13-H13A 109.1 C29-C30-H30A 108.8
C21-H21 0.9500 N2-C13-H13B 109.1 C23-C30-H30A 108.8
C22-N3 1.365(5) C14-C13-H13B 109.1 C29-C30-H30B 108.8
C23-C24 1.369(6) H13A-C13-H13B 107.8 C23-C30-H30B 108.8
C23-C30 1.514(7) N3-C14-C15 122.9(4) H30A-C30-H30B 107.7
C23-Rhl 2.202(4) N3-C14-C13 118.6(3) C1-N1-C2 111.1(3)
C23-H23 0.9500 C15-C14-C13 118.5(4) C1-N1-C4 124.3(3)
C24-C25 1.509(7) C16-C15-C14 118.8(4) C2-N1-C4 123.7(3)
C24-Rhl 2.179(4) C16-C15-H15 120.6 C1-N2-C3 111.9(3)
C24-H24 0.9500 C14-C15-H15 120.6 C1-N2-C13 124.0(3)
C25-C26 1.480(7) C15-C1-C17 120.2(4) C3-N2-C13 123.9(3)
C25-H25A 0.9900 C15-C16-H16 119.9 C14-N3-C22 118.1(3)
C25-H25B 0.9900 C17-C16-H16 119.9 C l-R hl-C 28 94.63(17)
C26-C27 1.515(7) C16-C17-C22 117.2(4) C l-R hl-C 27 93.45(15)
C26-H26A 0.9900 C16-C17-C18 124.5(4) C28-Rhl-C27 38.31(15)
C26-H26B 0.9900 C22-C17-C18 118.3(4) C l-R hl-C 24 157.59(17)
C27-C28 1.389(6) C19-C18-C17 121.6(4) C28-Rhl-C24 94.88(19)
C27-Rhl 2.123(4) C19-C18-H18 119.2 C27-Rhl-C24 81.68(17)
C27-H27 0.9500 C17-C18-H18 119.2 Cl-Rhl-C23 165.92(17)
C28-C29 1.499(7) C18-C19-C20 120.1(4) C28-Rhl-C23 81.26(16)
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C28-Rhl 2.112(4) C18-C19-H19 120.0 C27-Rhl-C23 91.58(18)
C28-H28 0.9500 C20-C19-H19 120.0 C24-Rhl-C23 36.42(16)
C29-C30 1.476(7) C21-C20-C19 120.5(4) C l-R hl-C ll 87.67(11)
C29-H29A 0.9900 C21-C20-H20 119.8 C28-Rhl-Cll 159.29(13)
C29-H29B 0.9900 C19-C20-H20 119.8 C27-Rhl-Cll 162.22(13)
C30-H30A .9900 C20-C21-C22 120.3(4) C24-Rhl-Cll 90.55(14)
C30-H30B 0.9900 C20-C21-H21 119.8 C23-Rhl-Cll 91.55(13)
R hl-C ll 2.3865(9)
Table A1.15: Bond lengths and angles for [ 1 -isopropyl-3 -(2-
methylquinoline)imidazolin-2-ylidene](l,5-cyclooctadiene)rhodium(I) Chloride 
4.22
Bond lengths (A) Bond angles (°) Bond angles (°)
C l-N l 1.343(6) N1-C1-N2 104.7(4) C20-C19-RM 112.9(4)
C1-N2 1.345(6) N l-C l-R h l 129.8(3) C18-C19-H19 117.8
C l-Rhl 2.037(5) N2-C1-RM 125.1(4) C20-C19-H19 117.8
C2-C3 1.351(8) C3-C2-N1 105.8(5) Rhl-C19-H19 87.1
C2-N1 1.389(7) C3-C2 -H2 127.1 C21-C20-C19 114.5(4)
C2-H2 0.9500 N1-C2-H2 127.1 C21-C20-H20A 108.6
C3-N2 1.369(7) C2-C3-N2 106.9(5) C19-C20-H20A 108.6
C3-H3 0.9500 C2-C3-H3 126.5 C21-C20-H20B 108.6
C4-N1 1.477(6) N2-C3-H3 126.5 C19-C20-H20B 108.6
C4-C6 1.506(8) N1-C4-C6 109.8(4) H20A-C20-H20B 107.6
C4-C5 1.521(7) N1-C4-C5 110.2(5) C22-C21-C20 114.2(5)
C4-H4 1.0000 C6-C4-C5 112.4(5) C22-C21-H21A 108.7
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C5-H5A 0.9800
C5-H5B 0.9800
C5-H5C 0.9800
C6-H6A 0.9800
C6-H6B 0.9800
C6-H6C 0.9800
C8-N2 1.467(7)
C8-C9 1.525(7)
C8-H8A 0.9900
C8-H8B 0.9900
C9-N3 1.311(7)
C9-C10 1.413(7)
C10-C11 1.381(7)
CIO-HIO 0.9500
C11-C12 1.422(7)
C ll-H ll 0.9500
C12-C17 1.396(7)
C12-C13 1.422(7)
C13-C14 1.371(8)
C13-H13 0.9500
C14-C15 1.405(8)
C14-H14 0.9500
C15-C16 1.364(7)
C15-H15 0.9500
C16-C17 1.425(7)
C16-H16 0.9500
C17-N3 1.378(6)
Appendix
N1-C4-H4 108.1
C6-C4-H4 108.1
C5-C4-H4 108.1
C4-C5-H5A 109.5
C4-C5-H5B 109.5
H5A-C5-H5B 109.5
C4-C5-H5C 109.5
H5A-C5-H5C 109.5
H5B-C5-H5C 109.5
C4-C6-H6A 109.5
C4-C6-H6B 109.5
H6A-C6-H6B 109.5
C4-C6-H6C 109.5
H6A-C6-H6C 109.5
H6B-C6-H6C 109.5
N2-C8-C9 110.7(4)
N2-C8-H8A 109.5
C9-C8-H8A 109.5
N2-C8-H8B 109.5
C9-C8-H8B 109.5
H8A-C8-H8B 108.1
N3-C9-C10 24.6(5)
N3-C9-C8 115.7(5)
C10-C9-C8 119.7(5)
C11-C10-C9 118.5(5)
C l 1-C10-H10 120.8
C9-C10-H10 120.8
C20-C21-H21A 108.7
C22-C21-H21B 108.7
C20-C21-H21B 108.7
H21A-C21-H21B 107.6
C23-C22-C21 125.4(6)
C23-C22-Rhl 72.6(3)
C21-C22-Rhl 108.8(3)
C23-C22-H22 117.3
C21-C22-H22 117.3
Rhl-C22-H22 88.5
C22-C23-C24 123.0(6)
C22-C23-Rhl 71.5(3)
C24-C23-Rhl 110.4(4)
C22-C23-H23 118.5
C24-C23-H23 118.5
Rhl-C23-H23 88.1
C23-C24-C25 113.2(5)
C23-C24-H24A 108.9
C25-C24-H24A 108.9
C23-C24-H24B 108.9
C25-C24-H24B 108.9
H24A-C24-H24B 107.8
C18-C25-C24 113.9(5)
C18-C25-H25A 108.8
C24-C25-H25A 108.8
C18-C25-H25B 108.8
C24-C25-H25B 108.8
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C18-C19 1.410(9)
C18-C25 1.496(9)
C18-Rhl 2.113(5)
C18-H18 0.9500
C19-C20 1.523(7)
C19-Rhl 2.127(5)
C19-H19 0.9500
C20-C21 1.522(8)
C20-H20A 0.9900
C20-H20B 0.9900
C21-C22 1.495(7)
C21-H21A 0.9900
C21-H21B 0.9900
C22-C23 1.367(8)
C22-Rhl 2.213(5)
C22-H22 0.9500
C23-C24 1.506(9)
C23-Rhl 2.226(5)
C23-H23 0.9500
C24-C25 1.516(10)
C24-H24A 0.9900
C24-H24B 0.9900
C25-H25A 0.9900
C25-H25B 0.9900
R hl-C ll 2.3755(13)
C13-C26 1.758(9)
C12-C26 1.788(9)
Appendix
C10-C11-C12 118.7(5)
C10-C11-H11 120.6
C12-C11-H11 120.6
C17-C12-C13 120.0(4)
C17-C12-C11 118.0(5)
C13-C12-C11 122.0(5)
C14-C13-C12 119.1(5)
C14-C13-H13 120.5
C12-C13-H13 120.5
C13-C14-C15 121.0(5)
C13-C14-H14 119.5
C15-C14-H14 119.5
C16-C15-C14 120.8(5)
C16-C15-H15 119.6
C14-C15-H15 119.6
C15-C16-C17 119.5(5)
C15-C16-H16 120.2
C17-C16-H16 120.2
N3-C17-C12 123.1(5)
N3-C17-C16 117.4(5)
C12-C17-C16 119.5(4)
C19-C18-C25 125.7(6)
C19-C18-Rhl 71.1(3)
C25-C18-Rhl 110.5(4)
C19-C18-H18 117.1
C25-C18-H18 117.1
Rhl-C18-H18
88.3
H25A-C25-H25B 107.7
C1-N1-C2 111.1(4)
C1-N1-C4 125.0(4)
C2-N1-C4 123.7(4)
C1-N2-C3 111.4(5)
C1-N2-C8 125.7(5)
C3-N2-C8 122.8(5)
C9-N3-C17 117.1(5)
C l-Rhl-C18 88.1(2)
C l-R hl-C 19 93.1(2)
C18-Rhl-C19 38.8(2)
C l-R hl-C 22 164.3(2)
C18-Rhl-C22 96.6(2)
C19-Rhl-C22 81.5(2)
C l-R hl-C 23 159.6(2)
C18-Rhl-C23 81.2(2)
C19-Rhl-C23 89.4(2)
C22-Rhl-C23 35.9(2)
C l-R hl-C ll 89.24(13)
C18-Rhl-Cll 159.1(2)
C19-Rhl-Cll 162.05(18)
C22-Rhl-Cll 91.45(14)
C23-Rhl-Cll 94.52(17)
C13-C26-C12 106.8(6)
C13-C26-H26A 110.4
C12-C26-H26A 110.4
C13-C26-H26B 110.4
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C26-H26A
C26-H26B
Appendix
0.9900 C18-C19-C20 124.5(5) C12-C26-H26B 110.4
0.9900 C18-C19-Rhl 70.0(3) H26A-C26-H26B 108.6
Table A1.16: Bond lengths and angles for [l-n-butyl-3-(2-
methylquinoline)imidazolin-2-ylidene](l,5-cyclooctadiene)rhodium(I) Chloride
4.23
Bond lengths (A)
C l-N l 1.355(5)
C1-N2 1.368(5)
Cl-Rhl 2.032(4)
C2-C3 1.340(6)
C2-N2 1.379(5)
C2-H2 0.9500
C3-N1 1.387(5)
C3-H3 0.9500
C4-N2 1.467(5)
C4-C5 1.508(6)
C4-H4A 0.9900
C4-H4B 0.9900
C5-N3 1.320(5)
C5-C6 1.405(6)
C6-C7 1.361(6)
C6-H6 0.9500
C7-C8 1.416(6)
C7-H7 0.9500
C8-C13 1.407(6)
Bond angles (°)
N1-C1-N2 103.8(3)
N 1-C l-R hl 126.4(3)
N 2-C l-R hl 129.6(3)
C3-C2-N2 106.7(4)
C3-C2-H2 126.6
N2-C2-H2 126.6
C2-C3-N1 107.0(4)
C2-C3-H3 126.5
N1-C3-H3 126.5
N2-C4-C5 112.4(3)
N2-C4-H4A 109.1
C5-C4-H4A 109.1
N2-C4-H4B 109.1
C5-C4-H4B 109.1
H4A-C4-H4B 107.9
N3-C5-C6 124.6(4)
N3-C5-C4 115.6(4)
C6-C5-C4 119.8(4)
C7-C6-C5 118.9(4)
Bond angles (°)
C25-C18-Rhl 111.3(3)
C19-C18-H18 117.8
C25-C18-H18 117.8
Rhl-C18-H18 87.3
C18-C19-C20 123.6(4)
C18-C19-Rhl 70.0(2)
C20-C19-Rhl 113.4(3)
C18-C19-H19 118.2
C20-C19-H19 118.2
Rhl-C19-H19 86.6
C19-C20-C21 114.2(3)
C19-C20-H20A 108.7
C21-C20-H20A 108.7
C19-C20-H20B 108.7
C21-C20-H20B 108.7
H20A-C20-H20B 107.6
C22-C21-C20 113.9(3)
C22-C21-H21A 108.8
C20-C21-H21A 108.8
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C8-C9 1.415(6) C7-C6-H6 120.5 C22-C21-H21B 108.8
C9-C10 1.364(6) C5-C6-H6 120.5 C20-C21-H21B 108.8
C9 -C9 0.9500 C6-C7-C8 119.5(4) H21A-C21-H21B 107.7
C10-C11 1.403(6) C6-C7-H7 120.3 C23-C22-C21 123.2(4)
CIO-HIO 0.9500 C8-C7-H7 120.3 C23-C22-Rhl 72.3(2)
C11-C12 1.360(6) C13-C8-C9 119.1(4) C21-C22-Rhl 109.3(3)
C ll-H ll 0.9500 C13-C8-C7 117.4(4) C23-C22-H22 118.4
C12-C13 1.416(5) C9-C8-C7 123.4(4) C21-C22-H22 118.4
C12-H12 0.9500 C10-C9-C8 120.0(4) Rhl-C22-H22 88.4
C13-N3 1.380(5) C10-C9-H9 120.0 C22-C23-C24 123.5(4)
C14-N1 1.464(5) C8 -9-H9 120.0 C22-C23-Rhl 71.4(2)
C14-C15 1.518(6) C9-C10-C11 120.9(4) C24-C23-Rhl 111.5(3)
C14-H14A 0.9900 C9-C10-H10 119.6 C22-C23-H23 118.2
C14-H14B 0.9900 C l 1-C10-H10 119.6 C24-C23-H23 118.2
C15-C16 1.509(6) C12-C11-C10 120.3(4) Rhl-C23-H23 87.1
C15-H15A 0.9900 C12-C11-H11 119.8 C23-C24-C25 112.9(3)
C15-H15B 0.9900 C10-C11-H11 119.8 C23-C24-H24A 109.0
C16-C17 1.522(6) C l 1-C12-C13 120.2(4) C25-C24-H24A 109.0
C16-H16A 0.9900 C l 1-C12-H12 119.9 C23-C24-H24B 109.0
C16-H16B 0.9900 C13-C12-H12 119.9 C25-C24-H24B 109.0
C17-H17A 0.9800 N3-C13-C8 123.2(4) H24A-C24-H24B 107.8
C17-H17B 0.9800 N3-C13-C12 117.4(4) C18-C25-C24 113.4(3)
C17-H17C 0.9800 C8-C13-C12 119.4(4) C18-C25-H25A 108.9
C18-C19 1.395(5) N1-C14-C15 113.3(3) C24-C25-H25A 108.9
C18-C25 1.520(5) N1-C14-H14A 108.9 C18-C25-H25B 108.9
C18-Rhl 2.097(4) C15-C14-H14A 108.9 C24-C25-H25B 108.9
C18-H18 0.9500 N1-C14-H14B 108.9 H25A-C25-H25B 107.7
- 196-
Appendix
C19-C20 1.517(5) C15-C14-H14B 108.9 C1-N1-C3 111.1(3)
C19-Rhl 2.114(4) H14A-C14-H14B 07.7 C1-N1-C14 125.2(3)
C19-H19 0.9500 C16-C15-C14 111.4(4) C3-N1-C14 123.7(3)
C20-C21 1.530(6) C16-C15-H15A 109.3 C1-N2-C2 111.3(3)
C20-H20A 0.9900 C14-C15-H15A 109.3 C1-N2-C4 124.3(3)
C20-H20B 0.9900 C16-C15-H15B 109.3 C2-N2-C4 124.3(3)
C21-C22 1.502(6) C14-C15-H15B 109.3 C5-N3-C13 116.4(3)
C21-H21A 0.9900 H15A-C15-H15B 108.0 Cl-R hl-C 18 90.62(15)
C21-H21B 0.9900 C15-C16-C17 113.8(4) C l-R hl-C 19 95.45(15)
C22-C23 1.373(6) C15-C16-H16A 108.8 C18-Rhl-C19 38.70(15)
C22-Rhl 2.197(4) C17-C16-H16A 108.8 C l-R hl-C 22 163.07(15)
C22-H22 0.9500 C15-C16-H16B 108.8 C18-Rhl-C22 97.47(16)
C23-C24 1.508(6) C17-C16-H16B 108.8 C19-Rhl-C22 81.99(15)
C23-Rhl 2.208(4) H16A-C16-H16B 107.7 Cl-Rhl-C23 160.58(15)
C23-H23 0.9500 C16-C17-H17A 109.5 C18-Rhl-C23 81.65(16)
C24-C25 1.530(6) C16-C17-H17B 109.5 C19-Rhl-C23 89.62(15)
C24-H24A 0.9900 H17A-C17-H17B 109.5 C22-Rhl-C23 36.32(14)
C24-H24B 0.9900 C16-C17-H17C 109.5 C l-R h l-C ll 88.03(11)
C25-H25A 0.9900 H17A-C17-H17C 109.5 C18-Rhl-C ll 159.47(11)
C25-H25B 0.9900 H17B-C17-H17C 109.5 C19-Rhl-C ll 161.73(11)
2.3786(10) C19-C18-C25 124.3(4) C22-Rhl-Cll 89.46(11)
C19-C18-Rhl 71.3(2) C23-Rhl-Cll 93.01(11)
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Table A1.17: Bond lengths and angles for [bis-1,3-(2-
methylquinoline)imidazolin-2-ylidene](l, 5-cyclooctadiene)rhodium(I) Chloride 
4.24
Bond lengths (A) Bond angles ((3) Bond angles (°)
Rhl-C12 2.3794(7) C12-Rhl-C3 158.31(8) C14-N15-C16 117.8(2)
Rhl-C3 2.105(3) C12-Rhl-C4 162.93(8) N15-C16-C17 118.8(2)
Rhl-C4 2.121(3) C3-Rhl-C4 38.70(10) N15-C16-C21 122.5(2)
Rhl-C7 2.196(2) C12-Rhl-C7 89.99(8) C17-C16-C21 118.8(2)
Rhl-C8 2.230(3) C3-Rhl-C7 97.74(10) C16-C17-C18 120.3(3)
R h l-C ll 2.016(3) C4—R hl-C 7 82.16(11) C16-C17-H171 118.7
C3-C4 1.400(4) C12-Rhl-C8 93.69(8) C18-C17-H171 120.9
C3-C10 1.514(4) C3-Rhl-C8 81.19(10) C17-C18-C19 121.0(3)
C3-H31 0.979 C4-Rhl-C8 88.89(10) C17-C18-H181 119.9
C4-C5 1.523(4) C7-Rhl-C8 36.16(10) C19-C18-H181 119.1
C4-H41 0.989 C12-Rhl-Cl 1 87.46(7) C18-C19-C20 120.0(3)
C5-C6 1.531(4) C 3-R hl-C l 1 92.99(10) C18-C19-H191 119.6
C5-H52 0.972 C 4-R hl-C l 1 93.80(10) C20-C19-H191 120.4
C5-H51 0.976 C 7-R hl-C l 1 156.82(11) C19-C20-C21 120.6(3)
C6-C7 1.505(4) C 8 -R h l-C ll 167.02(10) C19-C20-H201 119.0
C6-H62 0.970 R hl-C3-C4 71.26(15) C21-C20-H201 120.4
C6-H61 0.980 R hl-C3-C10 110.76(18) C16-C21-C20 119.3(2)
C7-C8 1.374(4) C4-C3-C10 126.0(2) C16-C21-C22 117.2(2)
C7-H71 0.975 Rhl-C3-H31 110.3 C20-C21-C22 123.5(2)
C8-C9 1.514(4) C4-C3-H31 117.0 C21-C22-C23 120.0(2)
C8-H81 0.977 C10-C3-H31 112.4 C21-C22-H221 120.6
C9-C10 1.528(4) C3-C4-Rhl 70.04(15) C23-C22-H221 119.4
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C9-H92 0.985 C3-C4-C5 125.5(3) C14-C23-C22 118.9(2)
C9-H91 0.969 Rhl-C4-C5 112.58(19) C14-C23-H231 119.8
C10-H102 0.967 C3-C4-H41 115.5 C22-C23-H231 121.3
C10-H101 0.982 Rhl-C4-H41 110.8 N12-C24-C25 106.8(2)
C11-N12 1.358(3) C5-C4-H41 113.4 N12-C24-H241 124.4
C11-N26 1.358(3) C4-C5-C6 112.7(2) C25-C24-H241 128.7
N12-C13 1.466(3) C4-C5-H52 108.3 C24-C25-N26 106.3(2)
N12-C24 1.388(3) C6-C5-H52 108.1 C24-C25-H251 129.0
C13-C14 1.512(3) C4-C5-H51 108.5 N26-C25-H251 124.7
C13-H132 0.986 C6-C5-H51 109.7 C25-N26-C11 111.7(2)
C13-H131 0.982 H52-C5-H51 109.5 C25-N26-C27 124.2(2)
C14-N15 1.313(3) C5-C6-C7 113.5(2) C11-N26-C27 124.1(2)
C14-C23 1.426(4) C5-C6-H62 106.9 N26-C27-C28 114.2(2)
N15-C16 1.372(3) C7-C6-H62 108.5 N26-C27-H272 107.2
C16-C17 1.413(4) C5-C6-H61 109.2 C28-C27-H272 108.9
C16-C21 1.421(4) C7-C6-H61 109.5 N26-C27-H271 107.1
C17-C18 1.367(4) H62-C6-H61 109.1 C28-C27-H271 109.6
C17-H171 0.944 C6-C7-Rhl 106.55(18) H272-C27-H271 109.8
C18-C19 1.409(4) C6-C7-C8 126.7(3) C27-C28-N29 114.6(2)
C18-H181 0.940 Rhl-C7-C8 73.24(15) C27-C28-C37 122.0(2)
C19-C20 1.364(4) C6-C7-H71 113.8 N29-C28-C37 123.3(2)
C19-H191 0.951 Rhl-C7-H71 108.4 C28-N29-C30 117.7(2)
C20-C21 1.416(4) C8-C7-H71 116.4 N29-C30-C31 123.0(2)
C20-H201 0.954 Rhl-C 8-C 7 70.60(15) N29-C30-C35 118.2(3)
C21-C22 1.416(3) R hl-C8-C9 110.60(18) C31-C30-C35 118.8(3)
C22-C23 1.349(4) C7-C8-C9 124.7(3) C30-C31-C32 119.7(3)
C22-H221 0.944 Rhl-C8-H81 108.1 C30-C31-C36 117.0(2)
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C23 -H231 0.941 C7-C8-H81 116.6 C32-C31-C36 123.3(3)
C24-C25 1.343(4) C9-C8-H81 114.8 C31-C32-C33 120.1(3)
C24-H241 0.945 C8-C9-C10 112.6(2) C31-C32-H321 118.9
C25-N26 1.391(3) C8-C9-H92 108.1 C33-C32-H321 121.0
C25-H251 0.952 C10-C9-H92 107.9 C32-C33-C34 120.4(3)
N26-C27 1.462(3) C8-C9-H91 109.6 C32-C33-H331 120.0
C27-C28 1.516(4) C10-C9-H91 109.9 C34-C33-H331 119.6
C27-H272 0.985 H92-C9-H91 108.7 C33-C34-C35 120.8(3)
C27-H271 0.974 C9-C10-C3 112.7(2) C33-C34-H341 120.4
C28-N29 1.317(3) C9-C10-H102 108.3 C35-C34-H341 118.7
C28-C37 1.414(4) C3-C10-H102 108.1 C30-C35-C34 120.2(3)
N29-C30 1.375(3) C9-C10-H101 110.0 C30-C35-H351 119.9
C30-C31 1.406(4) C3-C10-H101 109.3 C34-C35-H351 119.9
C30-C35 1.421(4) H102-C10-H101I 108.3 C31-C36-C37 119.9(3)
C31-C32 1.418(4) R h l-C l 1-N1 129.86(18) C31-C36-H361 120.3
C31-C36 1.415(4) R h l-C l 1-N26126.25(18) C37-C36-H361 119.8
C32-C33 1.361(4) N12-C11-N26 103.7(2) C28-C37-C36 119.0(3)
C32-H321 0.950 C l 1-N12-C13 125.2(2) C28-C37-H371 120.1
C33-C34 1.404(5) C l 1-N12-C24 111.5(2) C36-C37-H371 120.9
C33-H331 0.939 C13-N12-C24 122.9(2) C138-C39-C140 117.3(3)
C34-C35 1.364(4) N12-C13-C14 110.8(2) C138-C39-H392 107.3
C34-H341 0.953 N12-C13-H132 105.9 C140-C39-H392 106.7
C35-H351 0.951 C14-C13-H132 108.1 C138-C39-H391 108.7
C36-C37 1.364(4) N12-C13-H131 109.9 C140-C39-H391 105.0
C36-H361 0.955 C14-C13-H131 110.5 H392-C39-H391 112.0
C37-H371 0.943 H132-C13-H131 111.5
C138-C39 1.713(4) C13-C14-N15 116.6(2)
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C39-C140 1.676(4) C13-C14-C23 119.8(2)
C39-H392 0.994 N15-C14-C23 123.6(2)
C39-H391 0.993
Table A1.18 Bond lengths and angles for l-mesityl-3-(2- 
methylquinoline)imidazolin-2-ylidene]( 1,5-cyclooctadiene)iridium(I) Chloride
4.28
Bond lengths (A)
Irl -C12 2.372(2)
Irl-C3 2.125(13)
Irl-C4 2.096(11)
Irl-C7 2.159(11)
Irl-C8 2.177(11)
Irl-C l 1 2.051(11)
C3-C4 1.456(16)
C3-C10 1.532(18)
C3-H31 0.991
C4-C5 1.509(18)
C4-H41 0.984
C5-C6 1.477(15)
C5-H51 0.970
C5-H52 0.970
C6-C7 1.510(17)
C6-H61 0.975
C6-H62 0.969
C7-C8 1.389(16)
C7-H71 0.984
Bond angles (°)
C12-Irl-C3 161.2(4)
C12-Irl-C4 158.2(4)
C 3-Irl-C4 40.4(4)
C12-Irl-C7 91.5(3)
C3-Irl-C7 92.5(5)
C 4-Irl-C7 79.9(4)
C12-Irl-C8 89.6(4)
C 3-Irl-C8 82.5(5)
C 4-Irl-C8 95.3(5)
C 7-Irl-C8 37.4(4)
C12-Irl-Cl 1 87.7(3)
C 3-Irl-C l 1 93.1(4)
C 4-Irl-C l 1 95.3(4)
C 7 -Ir l-C ll 164.6(5)
C 8-Irl-C l 1 157.9(5)
Irl-C 3-C 4 68.7(8)
Irl-C3-C10 113.8(9)
C4-C3-C10 118.7(13)
Irl-C3-H31 115.0
Bond angles (°)
C14-N15-C16 125.0(9)
C l 1-N15-C16 124.7(9)
N15-C16-C17 117.0(9)
N15-C16-C22 120.4(9)
C17-C16-C22 122.5(10) 
C16-C17-C18 121.1(10) 
C16-C17-C19 117.5(9)
C18-C17-C19 121.4(9)
C17-C18-H181 109.3
C17-C18-H182 109.9
H181-C18-H182 108.9 
C17-C18-H183 110.7
H181-C18-H183 109.3 
H182-C18-H183 108.8 
C17-C19-C20 120.9(10) 
C17-C19-H191 119.5
C20-C19-H191 119.7
C19-C20-C21 119.2(10) 
C19-C20-C24 119.0(11)
- 2 0 1  -
Appendix
C8-C9 1.512(18) C4-C3-H31 116.0 C21-C20-C24 121.7(11)
C8-H81 0.981 C10-C3-H31 116.0 C20-C21-C22 123.1(11)
C9-C10 1.512(16) C3-C4-Irl 70.9(7) C20-C21-H211 117.8
C9-H91 0.968 C3-C4-C5 128.6(13) C22-C21-H211 119.1
C9-H92 0.976 M -C 4-C 5 113.7(7) C16-C22-C21 116.5(11)
C10-H101 0.972 C3-C4-H41 111.7 C16-C22-C23 120.5(11)
C10-H102 0.971 Irl-C4-H41 112.2 C21-C22-C23 122.9(11)
C11-N12 1.367(15) C5-C4-H41 112.5 C22-C23-H231 109.5
C11-N15 1.347(14) C4-C5-C6 113.3(14) C22-C23-H232 108.8
N12-C13 1.389(14) C4-C5-H51 108.1 H231-C23-H232 109.5
N12-C25 1.433(14) C6-C5-H51 108.2 C22-C23-H233 111.7
C13-C14 1.330(16) C4-C5-H52 108.6 H231-C23-H233 108.3
C13-H131 0.935 C6-C5-H52 108.9 H232-C23-H233 109.1
C14-N15 1.402(13) H51-C5-H52 109.8 C20-C24-H241 108.2
C14-H141 0.936 C5-C6-C7 113.8(12) C20-C24-H242 108.8
N15-C16 1.426(13) C5-C6-H61 108.0 H 241-C24-H242 110.1
C16-C17 1.413(14) C7-C6-H61 108.8 C20-C24-H243 109.9
C16-C22 1.416(14) C5-C6-H62 107.7 H241-C24-H243 110.5
C17-C18 1.489(14) C7-C6-H62 108.5 H242-C24-H243 109.3
C17-C19 1.406(15) H61-C6-H62 110.0 N12-C25-C26 114.3(9)
C18-H181 0.964 Irl-C7-C6 113.4(7) N12-C25-H251 107.9
C18-H182 0.960 Irl-C7-C8 72.0(7) C26-C25-H251 108.1
C18-H183 0.966 C6-C7-C8 123.6(14) N12-C25-H252 108.4
C19-C20 1.380(15) Irl-C7-H71 112.7 C26-C25-H252 107.8
C19-H191 0.936 C6-C7-H71 114.2 H251-C25-H252 110.3
C20-C21 1.401(18) C8-C7-H71 113.6 C25-C26-N27 116.9(9)
C20-C24 1.527(16) Irl-C8-C7 70.6(7) C25-C26-C35 119.9(10)
- 2 0 2 -
Appendix
C21-C22 1.372(16) M -C 8-C 9 109.2(8) N27-C26-C35 123.2(10)
C21-H211 0.930 C7-C8-C9 123.5(14) C26-N27-C28 116.9(9)
C22-C23 1.497(16) Irl-C8-H81 113.6 N27-C28-C29 117.3(9)
C23-H231 0.966 C7-C8-H81 115.7 N27-C28-C33 123.3(10)
C23-H232 0.964 C9-C8-H81 115.0 C29-C28-C33 119.4(10)
C23-H233 0.964 C8-C9-C10 117.0(11) C28-C29-C30 119.8(10)
C24-H241 0.961 C8-C9-H91 107.8 C28-C29-H291 119.6
C24-H242 0.963 C10-C9-H91 109.0 C30-C29-H291 120.6
C24-H243 0.959 C8-C9-H92 106.9 C29-C30-C31 120.3(12)
C25-C26 1.502(15) C10-C9-H92 107.3 C29-C30-H301 119.4
C25-H251 0.970 H91-C9-H92 108.7 C31-C30-H301 120.3
C25-H252 0.975 C3-C10-C9 113.0(12) C30-C31-C32 119.9(11)
C26-N27 1.348(13) C3-C10-H101 108.7 C30-C31-H311 120.4
C26-C35 1.412(15) C9-C10-H101 108.8 C32-C31-H311 119.7
N27-C28 1.379(13) C3-C10-H102 108.8 C31-C32-C33 121.4(11)
C28-C29 1.413(14) C9-C10-H102 107.8 C31-C32-H321 119.9
C28-C33 1.413(15) H101-C10-H102 109.6 C33-C32-H321 118.7
C29-C30 1.371(14) Ir l-C l 1-N12 123.7(8) C28-C33-C32 119.2(11)
C29-H291 0.936 Ir l-C l 1-N15 130.6(9) C28-C33-C34 117.7(11)
C30-C31 1.421(17)
N12-C11-N15 105.6(9) C32-C33-C34 123.1(11)
C l 1-N12-C13 110.2(9) C33-C34-C35 119.3(12)
C30-H301 0.938
C11-N12-C25 125.3(9) C33-C34-H341 119.5
C31-C32 1.356(16) C13-N12-C25 123.9(9) C35-C34-H341 121.2
C31-H311 0.938 N12-C13-C14 106.8(10) C26-C35-C34 119.6(11)
C32-C33 1.395(16)
N12-C13-H13 125.6 C26-C35-H351 119.2
C14-C13-H131 127.6 C34-C35-H351 121.2
C32-H321 0.935
C13-C14-N15 107.9(10)
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C33-C34 1.415(17) C13-C14-H141 126.7
C34-C35 1.374(17) N15-C14-H141 125.4
C34-H341 0.934 C14-N15-C11 109.5(10)
C35-H351 0.937
Table A1.19: Bond lengths and angles for [1-isopropyl-3-(2-
methylquinoline)imidazolin-2-ylidene]( 1,5-cyclooctadiene)iridium(I) Chloride 
4.29
Bond lengths (A) Bond angles (°) Bond angles (°)
C l-N l 1.357(8) N1-C1-N2 103.7(5) C1-N1-C2 111.0(6)
C1-N2 1.367(8) N l-C l-I r l 130.1(5) C1-N1-C4 124.6(5)
C l-Irl 2.045(6) N 2-C l-Irl 125.8(5) C2-N1-C4 124.1(6)
C2-C3 1.340(10) C3-C2-N1 106.9(6) C1-N2-C3 111.6(6)
C2-N1 1.390(8) C2-C3-N2 106.8(6) C1-N2-C7 124.5(6)
C3-N2 1.374(9) N1-C4-C5 110.1(6) C3-N2-C7 123.9(6)
C4-N1 1.471(9) N 1-C4-C6 109.7(6) C8-N3-C16 118.0(6)
C4-C5 1.518(12) C5-C4-C6 112.6(7) C l-Ir l-C l 8 88.5(3)
C4-C6 1.531(10) N2-C7-C8 111.2(6) C l-Irl-C 17 93.1(3)
C7-N2 1.472(9) N3-C8-C9 123.1(7) C18-Irl-C17 39.3(3)
C7-C8 1.499(10) N3-C8-C7 116.8(7) C l-Irl-C 22 163.6(3)
C8-N3 1.324(9) C9-C8-C7 120.1(7) C18-Irl-C22 97.1(3)
C8-C9 1.432(10) C10-C9-C8 119.2(7) C17-Irl-C22 81.8(3)
C9-C10 1.358(11) C9-C10-C11 119.8(7) C l-Irl-C21 160.0(3)
C10-C11 1.411(10) C10-C11-C16 117.8(6) C18-Irl-C21 81.0(3)
C11-C16 1.429(9) C10-C11-C12 123.8(7) C17-Irl-C21 89.4(3)
C11-C12 1.439(10) C16-C11-C12 118.5(6) C22-Irl-C21 36.3(3)
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C12-C13 1.368(12) C13-C12-C11 120.4(7) C l-Irl-C l 1 90.09(18)
C13-C14 1.432(12) C12-C13-C14 120.4(7) C18-M-C11 159.1(2)
C14-C15 1.366(10) C15-C14-C13 120.2(7) C17-Irl-Cll 161.5(2)
C15-C16 1.413(9) C14-C15-C16 120.9(7) C22-Irl-Cll 90.04(19)
C16-N3 1.379(9) N3-C16-C15 118.4(6) C21-Irl-Cll 93.8(2)
C17-C18 1.419(11) N3-C16-C11 122.1(6) C25-C12-C25 41.5(10)
C17-C24 1.531(10) C15-C16-C11 119.5(6) C13-C13-C25 85.6(6)
C 17-Irl 2 .112(6) C18-C17-C24 124.2(7) C13-C13-C25 56.5(5)
C18-C19 1.509(11) C18-C17-Irl 70.0(4) C25-C13-C25 35.5(9)
C18-Irl 2.104(7) C24-C17-Irl 114.4(5) C12-C25-C13 105.2(9)
C19-C20 1.513(12) C17-C18-C19 124.6(7)
C20-C21 1.532(11) C17-C18-Irl 70.6(4)
C21-C22 1.367(11) C19-C18-Irl 112.2(5)
C21-Irl 2.196(7) C18-C19-C20 113.3(6)
C22-C23 1.533(10) C19-C20-C21 112.3(6)
C22-Irl 2.195(6) C22-C21-C20 122.9(7)
C23-C24 1.547(11) C22-C21-M 71.8(4)
Cl 1-Irl 2.3719(16) C20-C21-Irl 111.8(5)
C12-C25 1.648(17) C21-C22-C23 124.3(7)
C12-C25 1.786(18) C21-C22-Irl 71.9(4)
C13-C13 1.296(13) C23-C22-Irl 110.0(4)
C13-C25 1.759(14) C22-C23-C24C1 112.6(6)
C13-C25 2.103(16) C17-C24-C23 113.9(5)
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Table A1.20: Bond lengths and angles for [bis-l,3-(2-
methylquinoline)imidazolin-2-ylidene](l, 5-cyclooctadiene)iridium(I) Chloride
4.31
Bond lengths (A)
Irl-C12 2.3653(11)
Irl-C3 2.082(4)
Irl-C4 2.121(4)
Irl-C7 2.160(4)
Irl-C8 2.196(5)
Irl-C l 1 2.022(4)
C3-C4 1.416(7)
C3-C10 1.518(6)
C3-H31 0.960
C4-C5 1.515(6)
C4-H41 0.998
C5-C6 1.543(8)
C5-H52 0.987
C5-H51 0.977
C6-C7 1.531(7)
C6-H62 0.982
C6-H61 0.965
C7-C8 1.379(8)
C7-H71 0.990
C8-C9 1.534(8)
C8-H81 0.996
C9-C10 1.554(7)
C9-H92 0.981
Bond angles (°)
C12-Irl-C3 158.86(14)
C12-Irl-C4 161.77(14)
C3-Irl-C4 39.36(19)
C12-M-C7 90.72(14)
C3-Irl-C7 98.15(19)
C4-Irl-C7 82.45(19)
C12-Irl-C8 94.70(14)
C3-Irl-C8 81.47(18)
C4-Irl-C8 89.95(18)
C7-Irl-C8 36.9(2)
C12-Irl-Cl 1 87.54(12)
C 3-Irl-C l 1 92.36(17)
C 4-Irl-C l 1 91.42(17)
C 7 -Irl-C ll 154.57(19)
C 8-Irl-C l 1 168.44(18)
Irl-C3-C4 71.8(3)
Irl-C3-C10 113.7(3)
C4-C3-C10 124.7(4)
Irl-C3-H31 114.7
C4-C3-H31 112.8
C10-C3-H31 112.9
Irl-C4-C3 68.8(2)
Irl-C4-C5 113.5(3)
Bond angles (°)
H132-C13-H131I 112.3
C13-C14-N15 116.5(4)
C13-C14-C19 119.7(4)
N15-C14-C19 123.8(4)
C14-N15-C16 117.3(4)
N15-C16-C17 123.4(4)
N15-C16-C23 117.8(4)
C17-C16-C23 118.7(4)
C16-C17-C18 116.9(4)
C16-C17-C20 119.1(4)
C18-C17-C20 124.0(4)
C17-C18-C19 119.6(4)
C17-C18-H181 120.5
C19-C18-H181 119.9
C14-C19-C18 118.9(4)
C14-C19-H191 121.6
C18-C19-H191 119.5
C17-C20-C21 120.3(5)
C17-C20-H201 120.0
C21-C20-H201 119.7
C20-C21-C22 121.2(5)
C20-C21-H211 119.4
C22-C21-H211 119.4
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C9-H91 0.984 C3-C4-C5 124.5(4) C21-C22-C23 119.1(5)
C10-H101 0.968 Irl-C4-H41 111.6 C21-C22-H221 119.3
C10-H102 0.965 C3-C4-H41 116.5 C23-C22-H221 121.7
C11-N12 1.354(5) C5-C4-H41 113.1 C16-C23-C22 121.5(5)
C11-N26 1.361(5) C4-C5-C6 112.8(4) C16-C23-H231 117.8
N12-C13 1.461(5) C4-C5-H52 108.6 C22-C23-H231 120.7
N12-C24 1.383(5) C6-C5-H52 106.7 N12-C24-C25 106.7(4)
C13-C14 1.512(6) C4-C5-H51 110.6 N12-C24-H241 125.3
C13-H132 0.971 C6-C5-H51 108.1 C25-C24-H241 128.0
C13-H131 0.978 H52-C5-H51 109.9 C24-C25-N26 106.6(4)
C14-N15 1.318(5) C5-C6-C7 113.0(4) C24-C25-H251 127.7
C14-C19 1.424(6) C5-C6-H62 108.2 N26-C25-H251 125.7
N15-C16 1.372(6) C7-C6-H62 108.8 C25-N26-C11 111.1(3)
C16-C17 1.414(6) C5-C6-H61 108.4 C25-N26-C27 126.3(4)
C16-C23 1.420(6) C7-C6-H61 111.6 C11-N26-C27 122.5(3)
C17-C18 1.426(6) H62-C6-H61 106.6 N26-C27-C28 114.2(3)
C17-C20 1.418(6) C6-C7-Irl 108.6(3) N26-C27-H271 107.6
C18-C19 1.362(7) C6-C7-C8 25.2(5) C28-C27-H271 109.0
C18-H181 0.939 Irl-C7-C8 72.9(3) N26-C27-H272 108.6
C19-H191 0.955 C6-C7-H71 113.7 C28-C27-H272 110.1
C20-C21 1.365(7) Irl-C7-H71 114.9 H271-C27-H272 107.2
C20-H201 0.965 C8-C7-H71 114.1 C27-C28-N29 114.5(4)
C21-C22 1.416(8) Irl-C8-C7 70.1(3) C27-C28-C33 121.4(4)
C21-H211 0.931 Irl-C8-C9 111.9(3) N29-C28-C33 123.9(4)
C22-C23 1.364(7) C7-C8-C9 123.8(5) C28-N29-C30 117.0(4)
C22-H221 0.954 Irl-C8-H81 112.1 N29-C30-C31 122.6(4)
C23-H231 0.942 C7-C8-H81 115.0 N29-C30-C37 118.8(4)
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C24-C25 1.344(6) C9-C8-H81 114.8 C31-C30-C37 118.6(4)
C24-H241 0.951 C8-C9-10 112.3(4) C30-C31-C32 117.8(4)
C25-N26 1.388(5) C8-C9-H92 107.7 C30-C31-C34 119.2(5)
C25-H251 0.947 C10-C9-H92 110.8 C32-C31-C34 123.0(5)
N26-C27 1.460(5) C8-C9-H91 111.4 C31-C32-C33 119.3(4)
C27-C28 1.521(6) C10-C9-H91 109.2 C31-C32-H321 119.9
C27-H271 0.981 H92-C9-H91 105.2 C33-C32-H321 120.8
C27-H272 0.969 C9-C10-C3 111.7(4) C28-C33-C32 119.2(4)
C28-N29 1.327(6) C9-C10-H101 111.3 C28-C33-H331 120.2
C28-C33 1.415(6) C3-C10-H101 111.3 C32-C33-H331 120.6
N29-C30 1.374(6) C9-C10-H102 106.3 C31-C34-C35 121.0(5)
C30-C31 1.415(7) C3-Cl 0-H 102 106.5 C31-C34-H341 119.1
C30-C37 1.422(7) H101-C10-H102 109.5 C35-C34-H341 119.9
C31-C32 1.416(7) Ir l-C l 1-N12 130.5(3) C34-C35-C36 120.0(5)
C31-C34 1.415(7) Ir l-C l 1-N26 125.4(3) C34-C35-H351 118.8
C32-C33 1.357(7) N12-C11-N26 104.0(3) C36-C35-H351 121.1
C32-H321 0.956 C11-N12-C13 123.7(3) C35-C36-C37 120.3(5)
C33-H331 0.940 C 11 -N 12-C24 111.5(3) C35-C36-H361 120.5
C34-C35 1 .366(8) C13-N12-C24 124.7(3) C37-C36-H361 119.2
C34-H341 0.944 N12-C13-C14 111.2(4) C30-C37-C36 120.8(5)
C35-C36 1.412(9) N12-C13-H132 107.2 C30-C37-H371 119.5
C35-H351 0.933 C14-C13-H132 109.4 C36-C37-H371 119.7
C36-C37 1.367(8) N12-C13-H131 107.7
C36-H361 0.946 C14-C13-H131 108.9
C37-H371 0.935
